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ABSTRACT 
 
Protein kinases are a large class of enzymes that regulate a wide array of vital cellular 
processes. Their dysregulation has been associated with fatal diseases including 
cancer, cardiovascular, and metabolic diseases. Hence, they have been important drug 
targets for years. While an enormous wealth of information about the structure and 
functions of kinases is available to date, a comprehensive mechanism of allosteric 
regulation of activity remains elusive. This thesis aims to investigate the role of 
conformational dynamics in the allosteric regulation and binding cooperativity of kinases 
using the cAMP-dependent protein kinase (PKA) as a model system. In this work, we 
demonstrated how allostery in PKA is propagated by changes in the hydrogen bond 
network between residues. We showed that different nucleotides and inhibitors modulate 
the allosteric cooperativity of PKA to different extent. Using NMR spectroscopy, we 
established how ligands influence substrate binding affinity by altering the kinase’s 
conformational dynamics through suppression and formation of sparsely-populated high-
energy states. The findings of this work provide a new paradigm for designing more 
effective therapeutic agents that can steer the conformational landscape of kinases to 
better fine-tune their activity and functions.
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CHAPTER 1 INTRODUCTION 
1.1 Cyclic AMP-dependent Protein Kinase A 
1.1.1 Architecture and Function 
 Protein kinases are an important class of enzymes responsible for catalyzing 
phosphoryl transfer. Protein phosphorylation, which is the transfer of the -phosphate 
group from adenosine triphosphate (ATP) to the hydroxyl group of serine, threonine, or 
tyrosine residues, represents a vital regulatory mechanism in modulating the activities of 
a multitude of proteins central to cell survival and growth in eukaryotic cells [1]. In fact, 
protein kinases constitute 2% of the human genome and approximately 30% of human 
proteins are phosphorylated [2]. Since these proteins are involved in crucial cellular 
processes such as cell cycle, cell proliferation, metabolism, and muscle contractility [3], 
improper regulation of protein kinases is associated with fatal diseases including cancer, 
cardiovascular diseases, and diabetes [4-7].  
 Among the 518 known protein kinases in the mammalian genome [2], the 
catalytic subunit of the cyclic-AMP dependent protein kinase A (PKA) was the first 
protein kinase to be crystallized [8, 9]. In the inactive state, PKA exists as a 
heterotetrameric holoenzyme consisting of two catalytic (PKA-C) and two regulatory 
(PKA-R) subunits, which, upon cyclic AMP binding, dissociate to release the active 
catalytic subunits [10, 11]. PKA is a serine/threonine phosphoryl transferase that 
recognizes the amino acid sequence R-R-X-S/T- where X is any amino acid and  is a 
hydrophobic residue [12, 13]. The core of the catalytic subunit of PKA consists of a small 
lobe (N-lobe), and a large lobe (C-lobe). These lobes are connected by a linker, and 
flanked by two motifs, a helical motif in the N-terminus (A) and a loosely structured tail 
in the C-terminus, which wraps around the kinase (Figure 1.1)[8, 9, 14]. Its bilobal 
architecture is highly conserved in the eukaryotic protein kinase (EPK) superfamily. 
Hence, it serves as a model kinase where basic biophysical questions widely applicable 
for the EPK superfamily can be addressed. The small lobe, consisting of five antiparallel 
 strands and a conserved helix (C helix), binds and orients the phosphates of ATP for 
efficient phosphoryl transfer, while the large lobe, which is mainly -helical, provides the 
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scaffold for substrate binding [14]. Between the two lobes lies the active site cleft, 
composed of several loops and short -strands, where most of the conserved residues 
converge to orchestrate the phosphoryl transfer. 
 
Figure 1.1. Architecture of the catalytic subunit of cAMP-dependent protein kinase. 
The subdomains of PKA-C, color-coded according to the regions defined by Hanks and Hunter [15]. The 
catalytic subunit is composed of a small lobe or N-lobe that binds and orients ATP for phosphoryl transfer, 
and a large lobe or C-lobe that serves as a docking site for substrate. Between the two lobes is the active 
site cleft where most conserved residues important for catalysis converge. PDB ID: 1ATP. 
 
 Within the small lobe is the highly dynamic glycine-rich loop (GxGxxG), whose 
orientation correlates with the opening and closing of the active site cleft during catalysis 
[14]. The backbone amide group of Ser53 in this loop orients the -phosphate of ATP for 
transfer (Figure 1.2A). Another key element in the small lobe is the highly conserved C-
helix, which brings the different segments of the kinase together and whose orientation 
determines kinase activity. The C-helix in an active kinase must be positioned properly 
such that its conserved Glu91 will form an ion pair with the conserved Lys72 of -strand 
3, which interacts with the  and  phosphates of ATP (Figure 1.2B). In the inactive 
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conformation, the C-helix is either disordered or rotated out with Glu91 residue facing 
the solvent [16, 17]. This configuration is typical of inactive kinases, such as Src-family 
tyrosine kinases and the cyclin-dependent kinases. For cyclin-dependent kinases, the C-
helix is normally displaced from the active site and the conserved salt-bridge is not 
formed [18]. Only upon binding of cyclin does the C-helix undergo a conformational 
change to position the Glu51 in the active state [19] (Figure 1.2C). In addition, the C-
helix also interacts with the different domains of the kinase. For PKA, His87 interacts 
with the phosphorylated Thr197 in the activation loop in the closed conformation; Lys92 
forms an ion pair with the carboxylate ion of the C-terminal residue Phe350; and the side 
chain of Arg93 forms a cation- interaction with the aromatic ring of Trp30 of the A-helix 
(Figure 1.2B). All these interactions are important to stabilize the C-helix in the 
orientation that is optimal for catalysis [14]. 
 The linker region (residues 120-127) interacts with the adenine ring of ATP by 
hydrogen bonding between backbone carbonyl of Glu121 and N6 of the adenine ring, 
and backbone amide of Val123 and N1 of the adenine ring, while the side chain of 
Glu127 interacts with the 2’ and 3’ OH groups of the ribose ring (Figure 1.2A). Most 
ATP-competitive inhibitors bind in the hydrophobic pocket occupied by the adenine ring 
and form hydrogen bonds with one or more residues in the linker region. 
 The large lobe, on the other hand, contains conserved loops situated at the 
active site cleft that play a pivotal role in catalysis (Figure 1.2A). The catalytic loop 
(residues 166-171) contains Asp166 that functions as a catalytic base, Lys168 that 
interacts with the -phosphate of ATP, and Asn171 that interacts with the secondary 
Mg2+ ion (termed Mg2) that is coordinated with the  and  phosphates of ATP. The 
conserved DFG loop (residues 184-187) includes the Asp184 that binds to the primary 
Mg2+ ion (termed Mg1) that bridges the  and  phosphates of ATP. The activation loop 
contains the phosphorylation site Thr197 that, upon phosphorylation, becomes more 
ordered and shifts the enzyme in an active conformation. The peptide positioning loop 
(or P + 1 loop) provides the site for the tethering of the substrate. Specifically, the side 
chains of Leu198, Pro202, and Leu205 form a hydrophobic pocket for the P + 1 residue 
of substrate (Figure 1.2D). Glu203 binds with the P-6 Arg, and Tyr204 makes a 
hydrogen bond with Glu230, which binds with the P-2 Arg of the substrate. The entire 
segment from DFG loop to the conserved APE motif, better known as the activation 
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segment, is one of the two elements that distinguish eukaryotic from eukaryotic-like 
kinases in prokaryotes [20, 21]. The activation segment is fixed to the F helix via the 
conserved ion pair interaction between Glu208 of the APE motif and Arg280 (Figure 
1.2D). 
 
 
Figure 1.2. Important motifs in eukaryotic protein kinases. 
(A) Interactions between ATP and residues in the active site cleft. (B) Interactions of the side chains of the 
C residues with different motifs of the protein. (C) The orientation of the C-helix, that is important for the 
activity of kinases such as CDK2, is determined by the formation of the conserved salt bridge between Lys 
in 3 and Glu in C. (D) Interactions between the peptide positioning loop and pseudosubstrate, as well as 
other motifs of the large lobe of PKA-C. PDB ID: 1HCL (inactive CDK2), 1FIN (active CDK2), 1ATP (PKA) 
 
 At the core of the large lobe are the highly stable helices (E, F, and H) that 
are found to be resistant to H/D exchange (except for G) [22]. The highly hydrophobic 
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F-helix, located at the interior of the large lobe, serves as a hub where the stacks of 
hydrophobic side chains traversing both lobes called spines (discussed later) are firmly 
anchored and helps secure the key residues for substrate binding, catalysis, and 
regulation[23]. The G, H, and I helices (termed as GHI subdomain), unique to eukaryotic 
protein kinases, serve as a docking site for substrate or regulatory proteins [20, 24]. 
 Flanking either end of PKA-C are two segments that optimize the catalytic 
efficiency and increase the stability of the enzyme. The N-terminal segment, contains a 
myristoylation motif (GNAAAAK) followed by an amphipathic A-helix (residues 10-30). 
The A-helix tethers to the C-helix through cation- interactions between Trp30 and the 
side chains of Arg93 (C-helix) and Arg190 (-strand 9) [25] (Figure 1.2B). The N-
terminal portion is also the site of different post-translational modifications including 
myristoylation of N-terminal Gly, deamidation of Asn2, and phosphorylation at Ser10 
[14]. On the other hand, the C-terminal tail consists of a flexible segment that wraps 
around both lobes with each end firmly anchored to each lobe. The C-terminal tail has 
been described into three main segments: N-lobe tether (residues 340-350), active site 
tether (residues 320-339), and the C-lobe tether (residues 300-319) [26]. The N-lobe 
tether contains the FxxF motif at the C-terminus, which is found to be the recognition site 
of PDK1, docks into the hydrophobic or PDK1 interacting fragment (PIF) pocket in the 
small lobe and contributes to the stability of the C-helix [27]. The portion of the active site 
tether composed of residues 320-327 acts as a gate that controls entry and exit of ATP 
[28], while that containing residues 328-334 contains an acidic cluster that helps attract 
basic substrates to the active site with Tyr330 participating in the P-3 recognition site 
upon adopting a closed conformation [29]. Within the C-terminal tail is another 
phosphorylation site, Ser338, which is performed in a cis-fashion, i.e. its active site 
catalyzes its own phosphorylation, during the kinase maturation process and is critical 
for a fully functional kinase [30]. 
 Although the analysis of structure-function relationships illuminated many of the 
conserved features of kinases, the role of many highly conserved residues has been 
difficult to rationalize on the basis of the primary sequence alone. Using a bioinformatics 
method, known as local spatial pattern alignment, Kornev and Taylor aligned several 
structures of Ser/Thr and Tyr kinases in their active and inactive states, and identified a 
series of residues that were highly conserved spatially. These motifs, which were 
  6 
hydrophobic in nature, were named as spines [16, 23, 31, 32](Figure 1.3). Eventually, a 
unifying hypothesis by which eukaryotic protein kinases are activated or inactivated 
through the assembly and disassembly of these hydrophobic spines has been proposed 
[16, 23, 32]. In PKA, the regulatory or R-spine is composed of two residues from the N-
lobe: Leu95 from C-helix and Leu106 from  strand 4, and two residues from the C-lobe: 
Tyr164 from the HRD (or YRD for PKA) motif of the catalytic loop and Phe185 from DFG 
loop (Figure 1.3A). Protein kinases constantly switch between active (assembled R 
spine) and inactive (broken R spine) states. Disassembly of R spine (Figure 1.3B) most 
commonly stem from flipping of the phenylalanine residue of the DFG loop (“DFG-out” 
conformation) or displacement of C-helix. Either phosphorylation of activation loop, 
which would bring the phenylalanine side chain in the DFG loop in its proper 
conformation (“DFG-in”), or binding of regulatory molecules such as cyclins for CDK2, 
which would fix the alignment of C-helix, would assemble the R-spine (Figure 1.2C). On 
the other hand, the catalytic or C-spine, composed of Val57, Ala70, Met128, Leu172, 
Leu173, Ile174, Leu227, and Met231, is completed by the adenine ring upon ATP 
binding, where it fuses the side chains of the C-spine, coupling the two lobes of the 
kinase together and committing it to catalysis (Figure 1.3A). Both of the spines are 
docked into the highly hydrophobic F-helix, fixing the positions of the nucleotide, 
substrate, and the residues in the catalytic machinery [23]. The hydrophobic side chains 
surrounding the spine, termed as shell, contribute to the catalytic activity of the enzyme 
by stabilizing the R-spine residues in the small lobe. In PKA, the shell residues include 
Val104, Met120 (also known as gatekeeper residue), and Met118 [16]. 
 Using the hydrophobic spine model, kinases can be viewed as having two 
functions: the canonical (or catalytic) function, which is the transfer of phosphate, and 
the noncanonical (or scaffolding) function, which involves the allosteric activation of 
other kinases [32]. The latter function is aptly exemplified by pseudokinases, which are 
kinases that do not possess the ability to transfer phosphate due to lack of conserved 
residues required for catalysis or occupation of adenine binding site by other 
hydrophobic side chain, but can still either function as scaffolds, allosteric activators, or 
catalysts by nonconventional mechanism [33, 34]. Recent work has shown that ATP-
competitive inhibitors such as PLX4720 can paradoxically activate BRAF probably via 
the noncanonical function as allosteric activator [35]. Furthermore, by mutating the C-
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spine residue (A481F) in BRAF, it has been shown that a pseudokinase can be formed 
in which the adenine binding site is blocked by the phenylalanine side chain but can still 
activate wild-type BRAF or CRAF through dimerization [36]. Based on these findings, we 
examined how the chemical groups occupying the active site can possibly uncouple the 
two functions of a kinase. 
 
 
Figure 1.3. Hydrophobic spines and their role in the activity of eukaryotic protein kinases. 
A. The hydrophobic side chains in PKA-C constituting the regulatory (R, red) and catalytic (C, yellow) 
spines. The adenine ring completes the C-spine. The shell residues (teal) stabilize the R-spine. Both spines 
are docked into the hydrophobic F-helix. B. The R-spine is broken in an inactive BRAF kinase (PDB: 1UWH) 
while it is assembled in active BRAF (PDB: 3C4C). 
 
1.1.2 Conformational States and Dynamics 
 Active protein kinases toggle between different conformational states. X-ray 
crystallographic data of PKA-C identified three major conformational states: namely, 
open (apo form), intermediate (binary, or nucleotide-bound form), and closed (ternary, or 
both nucleotide and substrate/pseudosubstrate-bound form) [37-39] (Figure 1.4A). 
These states have been well-characterized structurally and dynamically [14]. NMR[40, 
41] and fluorescence[42] measurements, as well as molecular dynamics simulations 
data[41], have demonstrated that the conformational landscape of kinases is modulated 
by the changes in the conformational dynamics of the enzyme induced by ligand binding. 
The apo state is in a dynamically uncommitted state, represented as an ensemble of 
interchanging conformations [41]. Nucleotide binding then activates the enzyme 
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dynamically and allosterically, shifting it into a dynamically committed state, where the 
two lobes of the kinase are engaged and primed for catalysis. While binding of the 
substrate shifts the equilibrium toward the closed state with persistent s-ms dynamics 
that correlate with the catalytic turnover rate, binding of minimum pseudosubstrate 
sequence, PKI5-24, greatly attenuated the dynamics of the enzyme, shifting it to a 
dynamically quenched state. This is corroborated by thermocalorimetric data showing 
that substrate binding is entropically-driven, while binding of pseudosubstrate inhibitor is 
enthalpically-driven [41]. In the dynamically committed state, the catalytically important 
loops exhibited synchronous motions in the microsecond-millisecond (s-ms) timescale 
that correlate to the opening and closing of the active site cleft [40, 41]. The importance 
of synchronous dynamics in catalysis is further underscored in the case of the mutant 
Y204A, where mutation of Tyr204 that is distal from the active site, though X-ray 
crystallography has shown that it is structurally indistinguishable from the wild type 
enzyme, desynchronizes the motion of the two lobes of the kinase, reducing its catalytic 
efficiency [43]. Concomitant to its impairment of catalytic machinery is the loss of binding 
cooperativity [44]. 
 
1.1.3 Regulation 
 Due to the pivotal role that PKA plays in a number of crucial cellular processes, 
its activity and localization must be tightly regulated. In the cell, two proteins bind to the 
catalytic subunit of PKA with high affinity and specificity. They both inhibit and direct the 
localization of the PKA-C. First is PKA-R, which dimerizes and binds to PKA-C to form 
the inactive holoenzyme [14]. It contains the dimerization/docking domain at the N-
terminus, which is not only involved in dimer formation of PKA-R, but also serves as the 
docking site for A-kinase anchoring proteins (AKAPs), which anchor the kinase to 
specific subcellular location [45]. The dimerization/docking domain is followed by a linker 
region, which contains the inhibitory sequence that is recognized by PKA-C, and then 
followed by two cAMP binding domains. Increased level of cAMP as a consequence of 
-adrenergic stimulation results in cAMP binding to PKA-R that will induce 
conformational change, unleashing the catalytic subunit [10].  
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Figure 1.4. The conformational states and energy landscape of PKA-C. 
(A) The three main conformational states of PKA-C that have been characterized structurally are open (apo, 
PDB: 1J3H), intermediate (binary, PDB: 1BKX), and closed (PDB: 1ATP). (B) The conformational energy 
landscape of PKA-C changes in response to ligand binding. The apo is dynamically uncommitted and 
samples a wide variety of conformations. Binding of ATP poised the enzyme for catalysis by synchronizing 
its dynamics (dynamically committed). Binding of substrate (such as phospholamban, PLN) forms the 
Michaelis complex with persistent dynamics, while binding of pseudosubstrate (such as PKI5-24) or excess 
Mg2+ quenches the relevant dynamics (dynamically quenched). Adapted from [41] 
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 On the other hand, protein kinase inhibitor (PKI) is another protein that performs 
similar regulatory functions as PKA-R, but is independent of cAMP concentration. PKI is 
a 75-residue heat-stable protein that binds PKA-C with high affinity (Ki ~0.2 nM) [46] and 
contains two important domains: the kinase inhibitory domain (residues 1-24) [47] and 
the nuclear export signal (NES) domain (residues 37-46) [48]. The kinase inhibitory 
domain consists of the high-affinity region at the N-terminus followed by the 
pseudosubstrate sequence that docks into the active site cleft of PKA-C, responsible for 
inhibiting the kinase; while the NES domain consists of a leucine-rich amphipathic helix 
that is responsible for shuttling the kinase out of the nucleus [49]. In its free form, PKI is 
mostly unstructured , with nascent helices in each of the two domains [48]. 
 
 
Figure 1.5. Regulation of activity and intracellular localization of PKA-C in the cell. 
Both the regulatory subunit (R) and PKI inhibit and direct the localization of the catalytic (C) subunit of PKA-
C. The R subunit binds with the C subunit to form an inactive tetramer (holoenzyme) that can be activated 
by binding of cyclic AMP (cAMP). The A-kinase anchoring protein (AKAP) directs the subcellular localization 
of the holoenzyme through its interaction with the R subunit. Meanwhile, PKI contains a pseudosubstrate 
sequence that binds with a nanomolar affinity to the C subunit to inhibit it, and a nuclear export signal to 
recruit exporting proteins such as Chromosomal Maintenance 1 (CRM) to help shuttle PKA-C out of the 
nucleus. GPCR: G-protein coupled receptor, CREB: cAMP response-element binding protein 
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1.2 NMR Spectroscopy to Probe Protein Dynamics 
 Proteins exist as ensembles of interchanging conformers displaying a wide array 
of motions spanning a large range of timescales from picosecond-nanosecond, such as 
bond librations and side chain rotations, to microsecond-millisecond, such as global 
conformational changes during ligand binding or protein folding. These conformational 
fluctuations are the driving forces for overcoming energy barriers in a free energy 
landscape (Figure 1.6A). The protein structures solved by X-ray crystallography usually 
represent the lowest energy or “ground state” conformations. Protein function, such as 
catalysis, allosteric regulation, folding, or ligand binding, often involves the transition to 
the higher-energy, lowly-populated states or “excited states”. These transitions are 
chemical exchange processes. To fully understand protein function, one must study the 
kinetics and thermodynamics of the conformational dynamics undergone by proteins as 
they explore the high-energy states. A steadily increasing number of studies in the 
literature have demonstrated how protein dynamics are coupled to function [50-52]. 
NMR spectroscopy proves to be a powerful tool among many others in studying protein 
dynamics for a number of reasons. While both X-ray crystallography and NMR 
spectroscopy provide site-specific information of the protein under study, only NMR 
spectroscopy has the advantage of probing these protein motions or conformational 
dynamics over a wide range of timescales (from picosecond to kilosecond). A huge 
arsenal of NMR experiments is available to capture these motions at different ranges of 
timescales (Figure 1.6B). Furthermore, compared to other methods of spectroscopy 
used to measure protein dynamics (such as fluorescence, hydrogen-deuterium 
exchange mass spectroscopy, etc.), NMR has the advantage of being non-invasive and 
can interrogate multiple probes at various sites of the proteins simultaneously. The 
theory of chemical exchange will be presented first, followed by the three experiments 
used to measure protein dynamics in the microsecond-millisecond (s-ms) timescale, 
namely, the Carr-Purcell-Meiboom Gill (CPMG)[53, 54] relaxation dispersion, Chemical 
Exchange Saturation Transfer (CEST)[55, 56], and TROSY Hahn-Echo [57]. This 
section concludes by describing the experiments used to measure the picosecond-
nanosecond (ps-ns) timescale dynamics of the protein. 
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Figure 1.6. The different timescales of protein motions and the NMR techniques that cover these 
timescales. 
A. The conformational fluctuations in a protein at different time scales can be viewed as an energy 
landscape. B. The different NMR experiments used to probe dynamics at different time scales and the 
relevant protein motions. Adapted from [50]  
 
1.2.1 Chemical Exchange 
 A nuclear spin that is exchanging between at least two different chemical 
environments or states as a result of conformational change or chemical reaction is said 
to be undergoing chemical exchange [58]. Due to the difference in the chemical 
environment, its chemical shift or resonance frequency changes with time, resulting in 
increased transverse relaxation rate. Suppose that a nuclear spin is exchanging 
between two different environments A and B: 
 1
1
k
k
A B

  (1.1) 
where 𝑘1and 𝑘−1 are the rate constants for the forward and reverse reactions, 
respectively. The rate equations that govern the time-dependence of the concentration 
of spins in the two states are given by [58]: 
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At equilibrium, 
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The equilibrium population of spins in state A, 𝑝𝐴, is given by: 
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  (1.6) 
where 𝑘𝑒𝑥 is the chemical exchange rate constant: 
 
1 1exk k k    (1.7) 
and 
 1A Bp p    (1.8) 
The evolution of magnetization, 𝐌, in a magnetic field, 𝐁, is described by the Bloch 
equations[59]: 
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where 𝛾 is the gyromagnetic ratio, and 𝑅 is the relaxation rate constant. The Bloch 
equations can be expressed alternatively as: 
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where 𝐸 is the identity operator, 𝑅1 and 𝑅2 are the longitudinal and transverse relaxation 
rate constants, respectively, 𝜔 is the chemical shift, and 𝑀𝑧0 is the equilibrium z 
magnetization. For spins in two states A and B, the Bloch equations for the transverse 
coherence in the absence of chemical exchange are given by: 
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In the presence of chemical exchange between states A and B, the Bloch equations will 
be modified as follows: 
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These equations are known as Bloch-McConnell equations [60], whose solution is given 
by: 
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and eigenvalues 𝜆+ and 𝜆− equal to: 
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where ∆𝜔 = 𝜔𝐵 − 𝜔𝐴 and ∆𝑅2
0 = 𝑅2𝐵
0 − 𝑅2𝐴
0 . The Fourier transform of 𝑀𝐴
+(𝑡) and 𝑀𝐵
+(𝑡) 
gives the resulting NMR spectrum. 
 On the basis of the relative values of 𝑘𝑒𝑥 and Δ𝜔, the chemical exchange 
process can be categorized into three regimes: 
 
𝑘𝑒𝑥 < Δ𝜔 Slow exchange 
𝑘𝑒𝑥 ≈ Δ𝜔 Intermediate exchange 
𝑘𝑒𝑥 > Δ𝜔 Fast exchange 
 
 A simple illustration depicting two scenarios is shown in Figure 1.7. If the 
populations of the two states are equal (𝑝𝐴 = 𝑝𝐵 = 0.5, Figure 1.7A), under slow 
exchange limit, i.e. 𝑘𝑒𝑥 ≪ Δ𝜔, two peaks will be observed, each at their respective 
chemical shifts. From the Bloch-McConnell equations, we get: 
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Under slow exchange limit, the off-diagonal terms are negligible, so the Bloch-McConnell 
equations reduce to: 
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with solution equal to: 
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The effect of chemical exchange is to broaden the linewidth or increase the transverse 
relaxation rate constant by a quantity, 𝑅𝑒𝑥: 
 
0
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where 𝑅𝑒𝑥 is the chemical exchange contribution to the transverse relaxation rate 
constant. Equation (1.21) indicates that the two peaks observed at 𝜔𝐴 and 𝜔𝐵 have 
linewidths that will be broadened by chemical exchange according to the following 
relations: 
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Under slow exchange limit, 𝑅𝑒𝑥 is equal to 𝑘1 or 𝑘−1 for state A and B, respectively. As 
the exchange rate increases, the resonance positions change and the peaks broaden 
until they coalesce when 𝑘𝑒𝑥 ≈ ∆𝜔 (Figure 1.7A). At this regime, the nucleus is said to 
be in intermediate exchange. Further increase in exchange rate would result in the 
appearance of a single peak at the population-weighted average chemical shift, ?̅? =
𝑝𝐴𝜔𝐴 + 𝑝𝐵𝜔𝐵, whose linewidth becomes sharper as 𝑘𝑒𝑥 increases (Figure 1.7A) 
according to the following relation: 
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This is known as the fast exchange limit (𝑘𝑒𝑥 ≫ ∆𝜔) with: 
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 If the populations are skewed (Figure 1.7B) such that, 𝑝𝐴 > 𝑝𝐵, (as in the case of 
proteins in ground state exchanging with a lowly-populated excited state), in the slow 
exchange limit, the intensities of the two peaks are scaled according to their relative 
  16 
populations. As 𝑘𝑒𝑥 increases, chemical exchange broadens the peaks to a different 
extent as dictated by their respective 𝑅𝑒𝑥 (eqn 1.23), with the minor peak being more 
preferentially broadened (since 𝑝𝐴 ≫ 𝑝𝐵, 𝑘1 ≪ 𝑘−1) such that the minor peak becomes 
completely undetected. The major peak continues to broaden as 𝑘𝑒𝑥 increases and 
eventually sharpens as it enters the fast exchange regime (Figure 1.7B). Hence, the 
observation of a single peak does not necessarily mean fast exchange in the chemical 
shift time scale [61]. 
 
 
Figure 1.7. NMR spectrum of peaks undergoing two-state exchange at different regimes. 
Simulated NMR spectra showing how the linewidths, intensities and peak positions change in different 
exchange regimes for spins undergoing two-state exchange (A) when the two states are equally populated 
(𝑝𝐴 = 𝑝𝐵 = 0.50), and (B) when the population is skewed (𝑝𝐴 > 𝑝𝐵). In slow exchange limit, when 𝑘𝑒𝑥 ≪
|∆𝜔|, two peaks will be observed at their respective chemical shifts, with the relative intensities proportional 
to the populations. In the intermediate exchange regime, 𝑘𝑒𝑥 ≈ |∆𝜔|, the two peaks will be broadened and 
coalesce. In the fast exchange regime, 𝑘𝑒𝑥 ≫ |∆𝜔|, a single peak will be observed at the population-
weighted average chemical shift. If the population is skewed, as 𝑘𝑒𝑥 increases, the minor peak gets more 
preferentially broadened that it could go undetected. 
 
 Alternatively, the static magnetic field, 𝐵0, dependence of 𝑅𝑒𝑥 for the observed 
peak can determine the NMR chemical shift time scale in systems with 𝑝𝐴 > 𝑝𝐵[62]. In 
slow exchange limit, 𝑅𝑒𝑥 is independent of 𝐵0 since 𝑅𝑒𝑥 = 𝑘1 = 𝑝𝐵𝑘𝑒𝑥 for the major peak, 
while in the fast exchange limit, 𝑅𝑒𝑥 ∝  𝐵0
2 since 𝑅𝑒𝑥 =
𝑝𝐴𝑝𝐵∆𝜔
2
𝑘𝑒𝑥
 and ∆𝜔 ∝ 𝐵0. Therefore, a 
scaling factor, 𝛼, defined as follows [62]: 
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can be used to determine the exchange regime in chemical shift time scale. Under the 
condition when 𝑝𝐴 > 0.7 and 𝑅2𝐴
0 = 𝑅2𝐵
0 , 
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with the following relations between 𝛼 and exchange regime: 
0 ≤ 𝛼 < 1 Slow exchange 
𝛼 ≈ 1 Intermediate exchange 
1 < 𝛼 ≤ 2 Fast exchange 
 
 
1.2.2 Microsecond-millisecond Timescale Dynamics 
 Enzyme catalysis [52], allosteric regulation[51], ligand binding, and protein 
folding [63] are some of the important cellular processes that occur in the microsecond-
millisecond time scale. These dynamic processes exemplify chemical exchange that will 
stochastically modulate the isotropic chemical shift, increasing the transverse relaxation 
rate constant and thereby broadening the linewidth. 
 A number of NMR relaxation experiments can be used to measure this chemical 
exchange contribution at the s-ms timescale including 𝑅1𝜌 [64], Carr-Purcell-Meiboom-
Gill [53, 54](CPMG) relaxation dispersion, Chemical Exchange Saturation Transfer 
(CEST) [55, 56], ZZ exchange[65], and TROSY Hahn-Echo [57]. Each method has its 
own strengths and limitations, but ultimately, the choice of method to use depends on 
the timescale of the exchange process, 𝜏𝑒𝑥, which is dictated by the exchange rate 
constant, 𝑘𝑒𝑥: 𝜏𝑒𝑥 = 1/𝑘𝑒𝑥. While a brief description of each experiment will be given 
below, emphasis will be placed on CPMG, CEST, and TROSY Hahn-Echo. The readers 
are referred to the following references for an in-depth description of 𝑅1𝜌 [66] and ZZ-
exchange experiments [67].  
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Figure 1.8. Principle of CPMG relaxation dispersion. 
(A) A series of refocusing  pulses, or spin echoes, is systematically applied to suppress the effect of 
chemical exchange on the transverse relaxation rate. As the frequency of pulses, 𝜐𝐶𝑃𝑀𝐺, increases, the 
chemical exchange contribution is increasingly suppressed, so the linewidth becomes sharper. (B) The 
CPMG relaxation dispersion curve is obtained by plotting the effective transverse relaxation rate constant, 
𝑅𝑒𝑥, as a function of the frequency of pulses, 𝜐𝐶𝑃𝑀𝐺. The chemical exchange contribution to the transverse 
relaxation rate constant, 𝑅𝑒𝑥, is then obtained from the difference between the observed 𝑅2 at 𝜐𝐶𝑃𝑀𝐺 → 0 
and 𝜐𝐶𝑃𝑀𝐺 → ∞. 
 
 CPMG, CEST, and 𝑅1𝜌 experiments are typically used to probe the chemical 
exchange process when the excited state is “invisible” or not detected by measuring the 
relaxation properties of the ground state. In CPMG, a series of  pulses, called spin-
echoes, is applied and the effective transverse relaxation rate constant, 𝑅2,𝑒𝑓𝑓, is 
measured as a function of the rate of radiofrequency field application, 𝜈𝐶𝑃𝑀𝐺 [68] (Figure 
1.8). The spin-echo sequence, 
𝜏𝑐𝑝
2
− 180 −
𝜏𝑐𝑝
2
, in which 𝜏𝑐𝑝 is the spacing between 
successive 180 pulses, serves to refocus the transverse magnetization by the 
application of 180 pulse in the middle to invert the sense of precession. Chemical 
exchange will cause the transverse magnetization to diphase quickly. A train of spin 
echoes with varying 𝜏𝑐𝑝 or 𝜈𝐶𝑃𝑀𝐺 (=
1
2𝜏𝑐𝑝
) is hence systematically applied to 
progressively suppress the effect of chemical exchange to 𝑅2 (Figure 1.8). In a 
constant-time CPMG experiment, the effective transverse relaxation rate constant at a 
particular 𝜈𝐶𝑃𝑀𝐺 value is evaluated by comparing the intensity of the peak (𝐼) with that of 
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the reference spectrum (𝐼0) that is recorded without the CPMG pulses, according to the 
following expression: 
 
0
2,
ln
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CPMG
I
I
R
T
    (1.29) 
where 𝑇𝐶𝑃𝑀𝐺 is  the total relaxation delay. The exchange contribution, 𝑅𝑒𝑥, is then 
obtained from the difference in 𝑅2 at infinite and no pulsing: 
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 The relaxation dispersion curves are then typically fit to a two-state model to 
extract the kinetic (𝑘𝑒𝑥), thermodynamic (𝑝𝐴, 𝑝𝐵) and structural (∆𝜔) parameters. For a 
two-state exchange model, the Carver-Richards equation gives the general expression 
that applies to all exchange regimes[69-71]: 
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where: 
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In fast exchange limit, the Carver-Richard equation can be approximated as[72]: 
 
2
0
2 2
2 tanh
21
1
ex cp
A B
cp ex ex cp
k
p p
R R
k k


 
  
                  
 
 
  (1.36) 
In addition, for highly skewed population between two states (𝑝𝐴 ≫ 𝑝𝐵), a simple 
equation was derived by Ishima and Torchia[61]: 
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The typical shapes of CPMG relaxation dispersion profiles for fast, intermediate, and 
slow exchange are shown in Figure 1.9B. 
 
 
Figure 1.9. Comparison between CPMG and CEST. 
(A) The CPMG pulse sequence is composed of a series of refocusing  pulses applied with different 
spacing, 𝜏𝑐𝑝, at a constant relaxation delay, 𝑇𝐶𝑃𝑀𝐺, to suppress the chemical exchange contribution to the 
transverse relaxation rate constant. (B) Typical CPMG relaxation dispersion profiles showing how the shape 
of the curves changes as the exchange regime changes. (C) The CEST pulse sequence consists of the 
application of a weak 𝐵1 field at different offset for a long time, 𝑇𝐸𝑋, and the variation in the ground state 
peak intensity is monitored. (D) Typical CEST profiles showing how the widths of the dips change as 𝐵1 is 
varied. Adapted from [56] 
 
 If the exchange rate is too fast, 𝑘𝑒𝑥 > 10000 𝑠
−1, one cannot use CPMG 
experiment and pulse at a rate comparable to the high 𝑘𝑒𝑥 because of the limitation of 
the hardware and the concomitant sample heating. In this case, the 𝑅1𝜌 rotating frame 
relaxation experiment can be used [66]. The 𝑅1𝜌 experiment is similar to CPMG except 
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that the radiofrequency field is applied to spin-lock the magnetization in the rotating 
frame. The relaxation rate constant of the component of magnetization that lies along the 
effective field in the rotating frame, called 𝑅1𝜌, is measured as a function of the applied 
effective field, 𝜔𝑒, where 𝜔𝑒 = √ΔΩ2 + 𝜔1
2, ΔΩ is the resonance offset given by ΔΩ = 𝜔 −
𝜔0, 𝜔1 is the amplitude of the spin-lock field. The 𝑅1𝜌 for a two-state exchange in fast-
exchange limit is given by: 
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On the other hand, if the exchange rate is too slow (𝑘𝑒𝑥 <  200𝑠
−1), the relaxation time 
must be kept long enough to observe and accurately quantify a significant change in 
intensity. In this case, chemical exchange saturation transfer (CEST) experiment is the 
more appropriate method to use. Unlike CPMG, CEST is based on the longitudinal 
magnetization [55, 56]. Since 𝑅1 is almost always an order of magnitude smaller than 𝑅2, 
the relaxation time can be extended for a long period of time to allow more exchange 
processes to happen, resulting in significant loss in intensity. Figure 1.9 compares the 
two methods. In the CEST experiment, a weak radiofrequency 𝐵1 field is applied at 
varying frequency offset for a long period of time, typically 300-500 ms, and the change 
in intensity of the ground state peak is monitored [56]. If the 𝐵1 field is applied on 
resonance with the ground state resonance frequency, there will be saturation of the 
energy levels, leading to a loss in signal. Similarly, saturation of the excited state peak 
will occur when the applied field is on resonance with it, but in addition, due to chemical 
exchange, this saturation will be transferred to the ground state and will result in the 
decrease in signal intensity of the ground state peak. A typical CEST profile, shown in 
Figure 1.9D, is a plot of the relative intensity (𝐼 𝐼0
⁄ ) of the ground state peak as a 
function of frequency offset. The data are fitted using the Bloch-McConnell equation and 
the parameters 𝑘𝑒𝑥, 𝑝𝐵, ∆𝜔 can be obtained. For more reliable parameters, CEST is 
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carried out in at least two 𝐵1 fields.  The width of the dips broadens as the magnitude of 
𝐵1 increases (Figure 1.9D).  
 For larger proteins with MW > 50 kDa, the chemical exchange contribution, 𝑅𝑒𝑥, 
can be determined using the TROSY Hahn-echo experiment [57]. TROSY Hahn-echo 
takes advantage of the different relaxation properties of the two components of the 
scalarly coupled 15N doublet due to the interference between the dipole-dipole (DD) and 
chemical shift anisotropy (CSA) (discussed later): 
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where 𝑅2
𝛼 and 𝑅2
𝛽
 are the transverse relaxation rate constants for the slow relaxing and 
fast relaxing doublet components, respectively, 𝑅2
0 is the intrinsic transverse relaxation 
rate constant for in-phase 15N magnetization, 𝜂𝑥𝑦 is the cross-correlation rate constant 
between DD and CSA, and 𝑅1
𝐻 is the longitudinal rate constant for the 1HN spin from 
interactions with neighboring 1H spins. For spins undergoing exchange, 𝑅2
0 is obtained 
from the ratio 𝜅 = 𝑅2
0 𝜂𝑥𝑦⁄ , where 𝜅 is a proportionality constant that is independent of 
chemical exchange and internal dynamics in large proteins. The values of 𝜅 can be 
calculated theoretically [73, 74] or experimentally from the trimmed mean of 1 +
(𝑅2
𝛼−𝑅1
2𝐻𝑧𝑁𝑧) 2⁄
𝜂𝑥𝑦
 over all nonexchanging residues, where 𝑅1
2𝐻𝑧𝑁𝑧 is the longitudinal two-spin 
order relaxation rate constant. 𝑅1
2𝐻𝑧𝑁𝑧 can be approximated as the sum of the 
longitudinal rate constants of 1HN and 15N, i.e. 𝑅1
2𝐻𝑧𝑁𝑧 ≈ 𝑅1
𝐻 + 𝑅1
𝑁, where 𝑅1
𝑁 is the 
longitudinal relaxation rate constant of 15N. 𝑅1
𝑁is often negligible for proteins with MW > 
30 kDa. Equations 1.40 can then be rearranged to solve for 𝑅𝑒𝑥 during the Hahn spin 
echo: 
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 To determine 𝑅𝑒𝑥, three relaxation rate constants, 𝑅2
𝛼, 𝑅2
𝛽
, and 𝑅1
2𝐻𝑧𝑁𝑧, will be 
measured experimentally using the pulse sequence reported by Wang, et al. [57] During 
the spin echo period of time 𝑇, the slow and fast relaxing components of the 15N doublet 
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relax independently if 𝑇 = 𝑛 𝐽𝐻𝑁⁄ , where 𝑛 is an integer, and 𝐽𝐻𝑁 is the scalar coupling 
constant [75]. The cross-correlation rate constant, 𝜂𝑥𝑦, is calculated from the ratio of the 
intensities of the and  spin states: 
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and 𝑅2
𝛼 −
𝑅1
2𝐻𝑧𝑁𝑧
2
⁄  is calculated from: 
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The value of 𝑅𝑒𝑥 is then calculated using equation 1.41. For non-exchanging residues, 
there is a distribution in the values of 𝑅𝑒𝑥 about 0 s
-1 due to variation in CSA throughout 
the protein. 
 
1.2.3 Picosecond-Nanosecond Timescale Dynamics 
 Protein motions in the picosecond-nanosecond (ps-ns) timescale include backbone 
and side chain bond librations and rotations. These motions are faster than molecular 
tumbling, and hence they stochastically modulate the local magnetic fields resulting in 
spin relaxation. The two dominant mechanisms that influence relaxation of spins are the 
dipole-dipole (DD) and chemical shift anisotropy (CSA). Dipole-dipole interactions 
pertain to the through-space interaction between a pair of magnetic dipoles (Figure 
1.10A). The magnitude of DD depends on the internuclear distance between the dipoles 
and their orientation with respective to the magnetic field. On the other hand, CSA refers 
to the anisotropic nature of the electronic environment surrounding the nucleus. This 
creates local magnetic fields, which also depends on the orientation of the bond vector 
relative to the static magnetic field (Figure 1.10B). Molecular tumbling and/or internal 
motions will cause the local fields created by DD and CSA to fluctuate with time. These 
oscillations contain frequency components that are equivalent to the transition 
frequencies involved in spin relaxation. The probability by which a bond vector oscillates 
at a specific frequency is given by the spectral density function, 𝐽(𝜔). The three NMR 
relaxation parameters: the longitudinal relaxation rate constant (𝑅1), the transverse 
relaxation rate constant (𝑅2), and the steady-state heteronuclear nuclear Overhauser 
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effect (HX NOE), are linear combinations of the spectral density functions at different 
transition frequencies according to the following relations: 
        2 21
1
3 6
4
H X X H X XR d J J J c J               (1.44) 
             22
1 1
4 0 3 6 6 4 0 3
8 6
H X X H H X X exR J J J J J c J J R                       
 (1.45) 
 
    2 1
1
1 6
4
H
H X H x
X
NOE d T J J

   

 
        
 
  (1.46) 
where 
 0
2 3
1
8
H X
HX
h
d
r
  

 
  
 
  (1.47) 
 
3
Xc
 
   (1.48) 
where 𝜇0 is the permeability of free space, ℎ is the Planck’s constant, 𝛾𝐻and 𝛾𝑋are the 
gyromagnetic ratios of X and 1H nuclei, respectively, 𝑟𝐻𝑋 is the length of the H-X bond 
vector, and ∆𝜎 is the chemical shift anisotropy of the X spin. 
 
 
Figure 1.10. Dominant relaxation mechanisms and the Lipari-Szabo model-free formalism. 
(A) Dipole-dipole interaction between two magnetic dipoles creates time-fluctuating local magnetic field 
affecting the neighboring spin. (B) Chemical shift anisotropy refers to the unequal electronic environment 
that shields the nucleus from the static magnetic field. Molecular motion creates an oscillating field based on 
the orientation of the bond vector relative to the static magnetic field 𝐵0. (C) The Lipari-Szabo model-free 
formalism assumes that the internal motions (𝜏𝑒) are independent of the global correlation time (𝜏𝑐). A 
generalized order parameter, 𝑆2, that indicates the degree of restriction of the bond vector can be 
determined. 
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  The three NMR relaxation parameters are measured to probe the ps-ns 
timescale dynamics of the amide (or side chain) bond vector according to the pulse 
sequence reported by Farrow, et al. [76]. Briefly, 𝑅1 is measured by inversion recovery 
experiment [77], where the return of the longitudinal magnetization back to the 
equilibrium value is monitored as a function time. The transverse relaxation rate 
constant, 𝑅2, is determined using spin echo sequences, as in CPMG, where the decay of 
transverse magnetization is followed as a function of time. The steady-state 
heteronuclear NOE measures the enhancement of the longitudinal magnetization of the 
X spin when its dipolar coupled proton is irradiated by a weak radiofrequency field. This 
is carried out by getting the ratio of the intensities (i.e. 𝑁𝑂𝐸 =
𝐼𝑠𝑎𝑡
𝐼𝑢𝑛𝑠𝑎𝑡
) from two spectra: 
one acquired with (𝐼𝑠𝑎𝑡) and one acquired without (𝐼𝑢𝑛𝑠𝑎𝑡) saturation of proton. These 
three parameters are then fitted to obtain the spectral density function, 𝐽(𝜔) using a 
variety of approaches. The most common is the Lipari-Szabo model-free formalism [78, 
79]. According to the Lipari-Szabo model free approach, the internal motions of the bond 
vectors are independent of the overall global molecular tumbling. Assuming isotropic 
tumbling, 𝐽(𝜔) can be expressed as:  
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where 𝜏𝑐 is the global correlation time of the molecule,  𝑆
2 is the generalized order 
parameter, and  
1
𝜏
=
1
𝜏𝑐
+
1
𝜏𝑒
 where 𝜏𝑒 is the effective internal correlation time of the bond 
vector. The order parameter represents the spatial restriction of motion of the bond 
vector, where a value of 1.0 denotes highly restricted motion, and a value of 0 denotes 
unrestricted motion [78, 79] (Figure 1.10C). 
 
1.3 Allostery and Cooperativity 
Allostery underlies almost all aspects of regulation of biological processes 
including signal transduction, catalysis, metabolism, and gene regulation [80, 81]. It is 
the phenomenon by which binding of a ligand at one site affects a distant site by a 
change in conformation and/or dynamics. Allostery also gives rise to cooperativity where 
a perturbation at one site can either enhance (positive cooperativity) or reduce (negative 
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cooperativity) the affinity of a binding site toward a substrate. It can either be homotropic 
(where the allosteric effector and substrate are identical) or heterotropic (where the two 
ligands are different) [82]. In the case of enzyme catalysis, allosteric ligand can either 
alter the binding interaction between the enzyme and the substrate or 𝐾𝑀 (K-type 
allostery), or the turnover kinetics of the enzyme or 𝑉𝑚𝑎𝑥 (V-type allostery). The classic 
example of allosteric cooperativity is hemoglobin [83, 84] where oxygen binding in one 
subunit increases the oxygen binding affinity of the other subunits. Since the discovery 
of allostery, people have been baffled for decades as to how allostery works at the 
atomic level. 
There were two main classical models of allostery, namely, the Monod-Wyman-
Changeux [82] (MWC, or the concerted model) and the Koshland-Nemethy-Filmer [85] 
(KNF, or the sequential model). Both models assume a conformational change 
accompanying allostery in oligomeric proteins. Each subunit can exist in either the tense 
(T) state or the relaxed (R) state, where the R state favors ligand binding. In the MWC 
model, all the subunits adopt the same state, and binding of a ligand can shift the 
equilibrium between the two states [82]. On the other hand, in the KNF model, not all 
subunits have to be in the same state, and binding of a ligand causes a local 
conformational change, which in turn induces the conformational change of nearby 
subunit [85]. This is often termed as “induced fit” mechanism. Although the two models 
prevailed for a long period time, they are phenomenological and they fail to explain at 
the atomic level how the long-range communication is transmitted between two distant 
sites [86]. 
Experimental and computational advances have reshaped the definition of 
allostery through the years. Allostery can be driven solely by dynamics, without having a 
conformational change [87-89]. Allosteric regulation is not restricted to oligomers only 
[90], but to almost all dynamic proteins [91]. One of the modern view of allostery involves 
the shift of the populations of the conformers in an ensemble [92]. A precise mechanism 
of allosteric control at the atomic level is important in understanding protein regulation. 
   
1.4 Objectives and Organization of Thesis 
 Given that protein kinases are dynamic and allosteric molecular switches, the 
overall goal of this work is to elucidate the mechanism by which allostery is propagated 
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in protein kinase A and the manner by which different ATP analogs and ATP-competitive 
inhibitors influence the kinase’s allostery and binding cooperativity. Specifically, the 
study aims to address the following questions: How do changes in hydrogen bond 
network in a protein correlate with allostery? How do different nucleotides and ATP-
competitive inhibitors influence the binding cooperativity of kinases? What are the 
dynamic effects of the binding of different ATP-competitive inhibitors? What role do 
conformational dynamics play in allosteric regulation and binding cooperativity in protein 
kinase A?  
 Mapping the chemical shift perturbation by NMR spectroscopy is one of the most 
common experimental method in tracing protein allostery. In Chapter 2, we present a 
complementary method where allosteric changes can be monitored by measuring the 
changes in the strength of the hydrogen bonds between the residues in the protein. 
 NMR spectroscopy is usually limited by the size of the protein, but with the 
development of more efficient labeling strategy, coupled with the advancement in pulse 
sequence methodology, this limitation can be circumvented and more powerful 
experiments can be performed to study the structure and dynamics of large proteins. 
Chapter 3 outlines the labeling method and the semi-automated assignment for the 
methyl groups of large proteins. 
 Recent kinase literature has introduced the dual functions of kinases, where it is 
possible to perform one function while deprived of the other. Moreover, there are ATP-
competitive inhibitors that can paradoxically activate a kinase [35]. Motivated by these 
findings, Chapter 4 dissects the effect of various nucleotides and ATP-competitive 
inhibitors in uncoupling the dual functions of kinases. 
 While structural studies are the most predominant routes in understanding ligand 
binding and inhibition of kinases, increasing number of evidences point to the crucial role 
that dynamics play in which excursion to excited states enable proteins to perform their 
function [52]. Chapter 5 probes in detail the role of conformational dynamics in 
modulating the binding cooperativity of kinases.  
 By understanding how allostery operates in protein kinase A and how the chemical 
groups of ligands in ATP-binding site can tune the binding cooperativity of protein kinase 
A, we can explore alternative ways to gain better control of the function of kinases. 
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2.1 Conspectus 
Protein kinase A is a prototypical phosphoryl transferase, sharing its catalytic core (PKA-
C) with the entire kinase family. PKA-C substrate recognition, active site organization, 
and product release depend on the enzyme’s conformational transitions from the open to 
the closed state, which regulate its allosteric cooperativity. Here, we used equilibrium 
NMR hydrogen/deuterium (H/D) fractionation factors () to probe the changes in the 
strength of hydrogen bonds within the kinase upon binding the nucleotide and a pseudo-
substrate peptide (PKI5-24). We found that the  values decrease upon binding both 
ligands, suggesting that the overall hydrogen bond networks in both the small and large 
lobes of PKA-C becomes stronger. However, we observed several important exceptions, 
with residues displaying higher  values upon ligand binding. Notably, the changes in  
values are not localized near the ligand binding pockets; rather, they are radiated 
throughout the entire enzyme. We conclude that, upon ligand and pseudo-substrate 
binding, the hydrogen bond networks undergo extensive reorganization, revealing that 
the open-to-close transitions require global rearrangements of the internal forces that 
stabilize the enzyme’s fold. 
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2.2 Introduction 
 Cyclic AMP-dependent protein kinase A (PKA) is a ubiquitous signaling enzyme 
that catalyzes the phosphoryl transfer from ATP to the serine or threonine residues of 
their protein substrates. First crystallized in 1991 [8, 9], it served as a prototype for the 
kinase family. The catalytic subunit of PKA (PKA-C) is a 350-residue protein consisting 
of a conserved bilobal core flanked by an N-terminus helical segment, known as the A-
helix, and a 50-residue C-terminal tail that wraps around the kinase [9] (Figure 2.1 A). 
The small lobe of the kinase is rich in -strands with only two short helical segments, 
while the large lobe is mostly helical. The active site cleft is positioned at the interface of 
the two lobes and harbors the nucleotide binding site. A glycine-rich loop acts as a lid, 
protecting the nucleotide’s phosphates that protrude from the binding cleft toward the 
substrate from hydrolysis. A short helix (C-helix) positioned by the activation loop 
contributes to the organization of the active site. The peptide positioning loop registers 
the substrate with respect to the nucleotide, aligning the P-site toward the -phosphate, 
with two Mg2+ ions participating in the active site organization for phosphoryl transfer. 
While the catalytic regions of PKA-C are responsible for the chemistry at the active site, 
signaling involves the core of the protein [31] with two hydrophobic spines (C- and R-
spines) that contribute to the definition of active and inactive states of the enzyme. The 
C-spine is assembled upon nucleotide binding, while the R-spine is assembled upon 
phosphorylation of the activation loop.[16, 23] Structural studies on other protein kinases 
suggest that the spines are responsible for both allosteric signaling [93] and regulation 
[94, 95].  
During the catalytic cycle, the kinase is thought to undergo extensive structural 
rearrangements. High-resolution crystal structures revealed at least three main 
conformational states: apo, intermediate (nucleotide-bound), and closed (ternary 
complex) [14]. NMR relaxation experiments have shown that the conformational 
dynamics of the enzyme drive the structural transitions from the open to closed 
conformation and play a key role in substrate recognition and turnover [40, 41]. The 
nucleotide acts as an allosteric effector, completing the catalytic spines [23, 40, 44] and 
shifting the kinase toward a structurally and dynamically committed state.[41] Reaching 
the committed state may require the rearrangement of the internal forces that stabilize 
each conformational state, such as hydrophobic, electrostatic, van der Waals, and 
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hydrogen bonding interactions. Although to a lesser extent, hydrogen bonds are thought 
to play an important role in protein stability and in fine-tuning their tertiary structure [96].  
 
Figure 2.1. Determination of fractionation factors. 
(A) Structural motifs mapped onto the ternary complex of PKA-C (PDB ID: 1ATP). (B) Representative 
portions of the [1H, 15N]-TROSY-HSQC spectra for apo PKA-C at various concentrations of D2O, highlighting 
W30 and I228 located in helical domains of the kinase. (C) Linear least-squares fit of the inverse of 
intensities for W30 and I228 versus (1-x)/x, where x is the mole fraction of H2O. 
 
In this paper, we studied the changes in the kinase hydrogen bond strengths 
across the three major conformational states. To obtain residue-specific information in 
the hydrogen-bond strengths, we measured the hydrogen/deuterium (H/D) fractionation 
factors () using solution NMR spectroscopy [97, 98]. The  values report on the 
preference of each amide site to take up deuterium over protium from a mixed H2O/D2O 
solution. Initially developed to probe hydrogen bond strengths in dicarboxylic acids [99], 
 values have been widely utilized to investigate low-barrier hydrogen bonds in enzymes 
[100] and in evaluating the contribution of hydrogen bonds to protein stability [101, 102]. 
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Recently, Cao and Bowie revisited issue of hydrogen/deuterium fractionation providing a 
revised energetic scale for the  values and underscoring the importance of analyzing 
values to determine the changes in hydrogen bond strength for ligand binding to 
proteins [103].  
Generally, a  value of unity indicates equal distribution of deuterium and protium 
between protein and bulk solvent. The amide sites involved in strong hydrogen bonds 
prefer protium over deuterium  with  < 1; whereas amides involved in weak hydrogen 
bonds have  > 1 [101]. In proteins, amide hydrogens have  values ranging from 0.3 to 
2.0, with the latter measured for very weak hydrogen bonds.[101] We measured the  
values for the backbone amides of PKA-C in three different forms: apo, ADP-bound 
(binary complex), and ADP-PKI peptide bound (ternary complex). Our results show that 
the overall  values decrease as the kinase binds ADP and a pseudo-substrate peptide 
(PKI5-24), indicating that the strength of hydrogen bonds gradually increases from the free 
to the ternary forms. Importantly, the changes in hydrogen bond strengths are not 
localized to the binding site but are pervasive throughout the entire protein. Whereas the 
majority of the hydrogen bonds increase their strengths, several other hydrogen bonds 
away from the ligand binding sites become weaker, suggesting a redistribution of the 
protein free energy. From this study,  measurements emerge as an important 
complement to other NMR parameters such as chemical shifts [104-107], H/D protection 
factors [108, 109], residual dipolar couplings [110, 111], and nuclear spin relaxation 
measurements [112-116] to characterize protein conformational dynamics and to identify 
long-range allosteric changes upon ligand binding or mutations. 
 
2.3 Experimental Procedures 
NMR sample preparation. Uniformly 15N-labeled PKA-C was expressed in E. coli 
bacteria and purified as reported previously [117]. A single protein stock solution was 
used for each set of the experiments for each form of the kinase. Each NMR sample 
contained ~200 M PKA, 20 mM KH2PO4, 90 mM KCl, 10 mM MgCl2, 10 mM MEGA-8 
(Octanoyl-N-methylglucamide), 5% Glycerol, 20 mM dithiothreitol (DTT), 1 mM NaN3. 
The pH of the buffer solutions in both protonated and deuterated water was adjusted to 
6.5 (without correction for the isotope effect). For the nucleotide-bound form, PKA-C was 
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saturated with 12 mM ADP, while for the ternary complex, the enzyme was saturated 
with 12 mM ADP and 350 M of a peptide corresponding to the recognition sequence of 
the protein kinase inhibitor (PKI5-24), and 60 mM MgCl2 was used. The samples 
containing varying concentrations of D2O (5%, 20%, 40%, and 60% by volume for the 
apo and ternary forms; 5%, 20%, 40%, 50%, and 60% by volume for the binary form) 
were prepared by mixing buffer solutions of protonated and deuterated water.  A 
maximum of 60% D2O mole fraction was chosen to minimize errors due to the increase 
of T1 values at high deuteration levels. 
Determination of H/D fractionation factors. The H/D equilibrium fractionation factor 
() is defined as the equilibrium constant of the following reaction: 
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where NH represents the weak acid and B the weak base. 
To determine the fractionation factors, a series of [1H,15N]-TROSY-HSQC[118] 
spectra were acquired using the CLEAN-TROSY version of the original pulse sequence 
[119] were recorded on all of the forms of the kinase for all of the D2O concentrations. 
The spectra were acquired on an 850 MHz Bruker spectrometer equipped with a triple 
resonance probe at 27°C with either 128 scans (for both the binary and ternary forms) or 
64 scans (for the apo form) and 60 increments and a recycle delay of 1.5 seconds. The 
spectra were processed using NMRPipe [120]. The peak intensities were determined 
using Sparky [121] with assignments previously determined for PKA-C [122]. 
Fractionation factors are obtained by the linear least-squares analysis of 
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  (2.3) 
where y is the peak intensity, x is the mole fraction of water and C is the normalization 
parameter, which is the inverse peak intensity at 100% H2O. Note that for high D2O 
concentrations, it is advisable to use non-linear fitting as the linear fitting amplifies the 
errors [123]. 
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2.4 Results 
H/D fractionation factors and structural transitions of PKA-C. Fractionation factors 
() were measured by incubating PKA-C in aqueous solutions with D2O concentrations 
ranging from 5 to 60%. Under these conditions, the intensities of the amide resonances 
in the [1H,15N]-TROSY-HSQC spectrum decrease according to their relative propensity 
to incorporate deuterium, reflecting the strength of the hydrogen bonds in which they are 
involved [97, 101]. To ensure that the exchange reached equilibrium, we incubated the 
samples and kept them at 25C for 24 hours prior to acquiring the [1H,15N]-TROSY-
HSQC spectra (Figure 2.2) [118]. Indeed, we found that the amide resonance intensities 
were unchanged after a 7 day incubation period (Figure 2.3). To calculate the  values, 
we fit the trend of the amide peak intensities as a function of the mole ratio of D2O. To 
mimic the three major conformational states of PKA-C, we performed our experiments 
on the apo, ADP-bound, and ADP/PKI5-24-bound kinase. ADP was used in place of the 
common ATP mimic, ATPN, because of the very slow hydrolysis on the timescale of 
weeks that was observed with ATPN [124]. The [1H,15N]-TROSY-HSQC spectra of 
PKA-C saturated with either ADP or ATPN are almost superimposable (Figure 2.2), 
indicating that the average conformations of the kinase are very similar. As for the binary 
complexes, the spectra of the ternary complexes formed with either ADP/PKI5-24 or 
ATPN/PKI5-24-bound are similar. Only small chemical shift perturbations are observed 
nearby the active site, reflecting the effect of the -phosphate group. Upon ligand 
binding, PKA-C undergoes linear chemical shift changes between the apo and closed 
form of the enzyme, [43, 122, 125] indicating that ligand binding shifts a pre-existing 
conformational equilibrium from open and closed state in the fast exchange regime on 
the chemical shift time scale [125]. To estimate the average conformational state of the 
kinase free and bound undergoing fast exchange equilibrium, we used CONCISE 
(COordiNated ChemIcal Shifts beHavior) [125]. As reported in Figure 2.4, the probability 
densities of the complexes with ADP and ATPN are essentially overlapped. A small but 
significant difference is observed for the probability densities for the ternary complexes, 
which reflect the differences in the observed chemical shifts (Figure 2.4 panel A). 
Nonetheless, the average positions of the distributions on the average principal 
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component (PC) score indicate that these complexes recapitulate both the intermediate 
and the closed states (Figure 2.4 panel C). 
 
 
Figure 2.2. [1H,15N]-TROSY-HSQC spectra of the three major conformational states of PKA-C used in 
this study. 
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Figure 2.3. Plots showing the correlation of the peak intensities used in the analysis of the 
fractionation factors of the amide resonances of the ternary form of PKA-C at the day of actual 
measurement (I0) and 7 days after (I). 
The linear correlation suggests that the 24-hour incubation time is enough for sufficient isotope exchange. 
 
When ADP is bound, the enzyme’s resonances undergoes significant line 
broadening originating from conformational dynamics on the s-ms timescale similar to 
those experienced with ATPN or ATP (Figure 2.5) [40, 43]. Therefore, several 
resonances in the intermediate states are not available for analysis. Overall, 211, 201, 
and 243 resonances for the apo, binary, and ternary forms of PKA-C, respectively, were 
available for the calculations of the  values (Figure 2.6). Of the calculated  values, we 
eliminated those exceeding the value of 2.0, which are affected by rapid exchange and 
T1 values [101] as well as those residues showing poor correlation coefficients (R2 < 
0.70). Note that in a few instances we measured  values slightly lower than 0.20. 
Although included in the plots, those residues are considered not exchanging with the 
solvent in the time scale we analyzed. These observation are in agreement with previous 
work by Taylor and co-workers, who found similar non-exchanging residues in the 
hydrophobic core of PKA-C using deuterium exchange mass spectrometry (DXMS) [22]. 
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The overall mean fractionation factor values for the apo, binary, and ternary complexes 
were 1.06  0.52, 1.04  0.52 and 0.96  0.55, respectively. 
 
 
Figure 2.4. Chemical shift changes upon addition of ADP and ATPN. 
A. Plots of the chemical shift changes upon addition of ADP and ATPN. B. Most significant chemical shift 
differences mapped onto the structure of PKA-C, PDB: 1ATP.  Red spheres indicate residues with  
greater than one standard deviation from the mean (i.e.  > 0.12); yellow spheres are residues with  > 
0.10. C. CONCISE analysis [125] of the amide chemical shifts showing that the average conformations of 
the binary and ternary complexes using ADP as nucleotide are similar to their ATPN counterparts. 
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Figure 2.5. Residues that are exchange-broadened in the spectrum of PKA-C/ADP. 
(A) Portions of [1H,15N]-TROSY-HSQC spectra of the three states, showing the exchange broadening in the 
binary form. (B) These residues include Gly-rich loop, B-, C-, and D-helices, DFG loop, activation loop, P+1 
loop and the acidic cluster in C-terminal tail. Gly50 and Gly55 are parts of the Gly-rich loop, Arg165 is part of 
the catalytic loop, Gly200 and Asp203 are parts of the P+1 loop. 
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Figure 2.6. . Fractionation factors of the amide resonances of PKA-C in three different states. 
Fractionation factors of the amide resonances of PKA-C in three different states: apo, binary (ADP-bound), 
and ternary (ADP- and PKI-bound) are plotted versus residue number. 
 
Although the overall strength of the hydrogen bonds increases in agreement with 
the thermostability of the protein [14], there is variability of the  values across the 
enzyme, reflecting local changes in hydrogen bond strength upon ligand binding (Figure 
2.7). In fact, the plots describing the number of occurrences versus  values for all three 
forms of PKA-C show broad distributions of  values (Figure 2.8). This contrasts with 
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the tight bell-shaped distribution of  in staphylococcal nuclease that was centered at 
0.85 [101]. The variability of  is apparent in all of the structural motifs for all of the 
states (Table 2.1). In the apo state, high  values (<> greater than 1.2) were measured 
for the N-terminus (A and 1) and C-terminal tail; while the helices in the large lobe, 
namely along E and F, display very low  values (<> less than 0.5, Table 2.1). 
These results, in qualitative agreement with the DXMS experiments, suggest that these 
hydrogen bonds make a significant contribution to the stability of the large lobe.[22] 
Unlike previous fractionation studies,[101, 126-128] there is no correlation between  
values and secondary structure in PKA-C. For instance, W30 and I228, both located in 
-helices, exhibit rather different hydrogen bond strengths (Figures 2.1B and C). We 
also observed that most residues with  values >> 2 (Figure 2.9A) are located in the 
solvent-exposed, unstructured regions of the enzyme undergoing significant motions[40, 
41, 43, 122]. Due to exchange broadening on the s-ms timescale upon ADP binding, 
we were unable to measure  in the active site, including the Gly-rich, DFG, activation, 
and peptide positioning loops. However we observed several changes in  values 
radiating away from the nucleotide binding pocket to more peripheral domains of the 
enzyme (Figures 2.8 and 2.10). In the small lobe these changes include  strands 1, 4-
5 (<binary-apo > = -0.27), the A- linker (<binary-apo > = -0.23), and A (<binary-apo > = -
0.16) (Figure 2.10). Interestingly, the loops connecting the E, F, and H helices in the 
large lobe display lower  values than in the apo state (<binary-apo >= -0.25, Table 2.1). 
Previous research has shown that the nucleotide in PKA-C functions as an allosteric 
effector [40, 44]. These results suggest that nucleotide binding may affect short- and 
long-range intermolecular forces through altering in part the hydrogen bonding network. 
Binding of PKI5-24 increases the compactness of the enzyme as it adopts a 
closed, solvent-protected conformation [14], with 54 out of 231 resonances displaying  
values around 0.3 (Figure 2.8), including residues in  strands 2 and 3, C-helix, C-4 
loop, hinge, D, E, the segment from the P+1 loop until the F helix, F, H, and the 
H-I loop. Most of these residues are buried in the interior of the kinase (Figure 2.9B). 
Overall, we observed a decrease of the average values (<ternary-binary > = -0.10  
0.38), particularly for residues localized in the large lobe and C-terminal tail (Figure 
2.10), except for a few residues in the A helix (<ternary-binary> = -0.09  0.21) and the 
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small lobe (<ternary-binary> = -0.09  0.24) (Figure 2.10). In contrast, the hinge region 
shows a positive change of < (0.35  0.30, Figure 2.10 and Table 2.1), which may 
result from a reorientation of the hinge region that enables the active site cleft to close. 
Additionally, PKI5-24 binding increases the hydrogen bond strength in the inner core of 
the kinase for helices E, F and H (Table 2.1) as well as for several residues in the 
C-terminal tail (Figure 2.10), consistent with the crystallographic data[14, 37, 129]. 
Specifically, the acidic patch (residues 330-334) has been hypothesized to recruit the 
basic substrate into the active site cleft, where Y330 is poised to interact with the 
substrate’s P-3 arginine residue [122, 130]. Substrate binding primarily strengthens the 
hydrogen bonds in the large lobe of the enzyme, and also those in the C-terminal tail, 
recruited to assemble the active site for catalysis. 
 
 
Figure 2.7. Representative least-squares fitting of residues showing different types of changes in 
hydrogen bond strengths upon binding nucleotide and pseudo-substrate. 
 
 To account for the changes in catalytically important motifs (i.e. Gly-rich, DFG 
loop, peptide positioning loops, etc.), we considered only the  values for the apo and 
ternary forms (Figure 2.11). The majority of the catalytic motifs experienced 
strengthening of hydrogen bonds, including the Gly-rich loop (<ternary-apo> = -0.61  
0.28), C (<ternary-apo> = -0.43  0.27), and the peptide positioning loop (<ternary-apo> = 
-0.39  0.24). In contrast, the only reporter of the DFG loop (Phe185) shows a higher  
value for the ternary complex (ternary-apo = 0.50). Its propensity to incorporate deuterium 
could result from the increased conformational fluctuations caused by nucleotide 
binding. Taken together, these results show that nucleotide and pseudo-substrate 
  42 
binding assembles the active site, strengthening the hydrogen bonds in the active site 
and coordinating catalysis in PKA-C. 
 
 
Figure 2.8. Distribution of the amide fractionation factors in three major states of PKA-C. 
Histogram of the occurrences vs fractionation factor values (top panel). Mapping of the fractionation factors 
on the PKA-C structure (lower panel, PDB ID: 1ATP). The amide groups are represented as spheres and 
color-coded according to the spectrum bar (Blue: strong hydrogen bonds, high  values; Red: weak 
hydrogen bonds, low  values). 
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Figure 2.9. Mapping of the residues with fractionation factors greater than 2.0 and less than 0.3 on 
the X-ray structure (1ATP). 
(A) Apo form, (B) ternary form. The H-bond strengths of several residues in the apo form are significantly 
weaker than the corresponding ternary complex.  Also, residues with  > 2.0 are mostly situated on the 
solvent-exposed, unstructured region of the kinase; while those with  < 0.3 are buried within the enzyme. 
 
 
 
Figure 2.10. Differences in the fractionation factor between states of PKA-C mapped onto the PKA-C 
structure. 
Differences in the fractionation factor between apo and binary (left), and binary and ternary complexes 
(right) of PKA-C mapped onto the PKA-C structure. 
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Motifs 
<> <> 
apo binary ternary binary - apo ternary - binary 
A-helix 1.30  0.27 1.12  0.34 0.98  0.23 -0.16  0.37 -0.08  0.21 
A- linker 1.52  0.16 1.32 0.39 1.26  0.25 -0.23  0.24 -0.13  0.20 
hinge  
(res 120-127) 
1.03  0.48 1.33  0.65 1.23  0.47 -0.03  0.06 0.35  0.30 
E-helix 0.49  0.13 0.41  0.09 0.51  0.57 -0.03  0.07 -0.16  0.23 
F-helix 0.40  0.12 0.56  0.27 0.51  0.33 0.12  0.34 -0.19   0.32 
G-helix 1.39  0.28 1.15 0.46 1.31 0.40 0.14  0.002 -0.08  0.84 
H-helix 0.86  0.60 1.36  0.57 1.00  0.88 0.06  0.05 -0.10  0.49 
C-terminal tail      
Res 298-314 1.44  0.63 1.10  0.55 1.03  0.59 -0.34  0.22 -0.11  0.33 
Res 315-345 1.51  0.39 1.65  0.27 1.32  0.37 0.28  0.08 -0.25  0.47 
Res 346-350 1.18  0.48 1.19  0.18 1.07  0.35 -0.18 0.34 -0.13  0.38 
 
 
 
 
 
 
 
 
 
Table 2.1. Average  values for the various structural motifs of PKA-C in the difference 
conformational states 
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Figure 2.11. The difference in fractionation factor between apo and ternary complexes for the 
residues that were exchange-broadened upon ADP binding. 
 
2.5 Discussion 
In recent years, PKA-C has emerged as a model system to understand both 
kinase function as well as intramolecular allosteric signaling [14, 23]. The transitions of 
PKA-C between different states involve both conformational and dynamic (protein 
flexibility) changes that propagate from the ligand binding sites to remote parts of the 
molecule [40, 44]. Therefore, a complete understanding of this allosteric signaling 
necessitates the analysis of intra- and inter-molecular interactions that hold the protein 
together.[131] Among those, hydrogen bonds play a key role in allosteric regulation[84] 
and recent reports have demonstrated their importance in enzymatic catalysis and 
inhibition.[132, 133] DXMS techniques have been used to analyze hydrogen bond 
networks of proteins to identify domains that might be involved in allosteric 
transitions.[22, 134] Unlike DXMS, NMR spectroscopy monitors H/D exchange in a site-
specific manner, making it possible to track hydrogen bonds throughout the protein at 
the atomic level. On the other hand, the NMR H/D exchange technique reports on the 
kinetic protection factors, monitoring the decay of the amide signals versus time.[108, 
109] However, this technique, with a few exceptions for selected systems,[135-140] 
usually requires the lyophilization of the protein under examination. In contrast, the 
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equilibrium  measurements can be accomplished by incubating the proteins in 
H2O/D2O solutions without lyophilization and report directly on the strength of the 
hydrogen bonds. These measurements are carried out under equilibrium conditions, 
which avoid the freezing-drying procedures required for the H/D protection factor 
measurements. This is crucial for PKA-C, an enzyme that is partially or completely 
inactivated upon lyophilization. Previous studies using H/D fractionation factors focused 
on the enzyme’s active sites [102, 141] and did not fully exploit the potential of this 
approach for identifying local and long-range changes in the hydrogen bond network and 
allosteric communication. In fact, only marginal changes were detected for the  values 
upon ligand binding to the proteins analyzed [97, 101, 128, 141]. These proteins, 
however, possess relatively rigid and compact structures with uniform values of. In 
contrast, the structure of PKA-C is highly dynamic, undergoing substantial 
conformational changes upon ligand binding.[142, 143] As a result, the  values we 
measured for PKA-C have a much broader distribution than those measured for 
staphylococcal nuclease [101], ubiquitin [126], histidine-containing proteins [127], and 
immunoglobulin G binding domain of protein G [127]. As PKA-C transitions from the 
open to closed conformations upon binding the nucleotide and the pseudo-substrate 
inhibitor, the average  values decrease, suggesting that the intramolecular hydrogen 
bonds become stronger. Globally, these results correlate well with X-ray crystallography 
[14], NMR spectroscopy [44], florescence studies [42, 144], thermodynamic [145] as well 
as DXMS analysis[22, 134] that show PKA-C’s structure becoming more compact and 
thermostable in the closed conformation. Structurally, nucleotide binding allosterically 
couples the two lobes of the kinase, causing positive binding cooperativity between the 
nucleotide and the pseudo-substrate [44, 122]. Binding of the pseudo-substrate further 
stabilizes the complex, as is also evident in the increased strengths of hydrogen bonds 
in the large lobe as measured by the fractionation factors. Overall, nucleotide binding 
affects the strength of hydrogen bonds both in the small and large lobes, while 
pseudosubstrate binding affects mostly the residues in the large lobe. This is consistent 
with the view that the nucleotide is an allosteric effector, organizing the active site, while 
the large lobe provides a docking surface for the substrate to bind [14, 44]. These 
detailed effects of the nucleotide binding went undetected in the previous DXMS 
measurements [134] either for lack of data points or intrinsic limitations of the technique. 
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Recent community maps analysis of molecular dynamics simulations [93] predicted that 
the motions of the different secondary structural elements of the small lobe are highly 
correlated. The 1, 4, 5 and the A- linker were attributed to community A 
(responsible for nucleotide binding), while the A-helix, portion of A- linker, and C-4 
linker were ascribed to community C (Figure 2.12), a central hub that controls the 
functions of the other communities [93]. The increase in the strength of the hydrogen 
bond networks in the small lobe upon nucleotide binding supports the communication 
between these communities that may act in concert for the enzyme’s closure. [93] 
Moreover, the  values show that, from the apo to the ternary complex, the hydrogen 
bonds in the C helix become stronger, indicating that perhaps strengthening these 
interactions is essential for proper organization of the active site. From the X-ray 
structure, the side chains in each turn of the C helix interact with the different domains 
of the enzyme (Figure 2.13). Specifically, Arg93 forms a cation- interaction with the 
aromatic side chains of Trp30 and Phe26 of the A helix. Glu91 forms a conserved dyad 
with Lys72 of -strand 3, while His87 forms an ion pair with the phosphate group of 
Thr197 in the closed conformation [14]. The H/D fractionation factors also show an 
extensive rigidification of the hydrophobic core in the enzyme upon ligand binding as 
previously highlighted by DXMS studies, with the E, F, and H helices involved in the 
intra-molecular communication are more resistant to deuterium exchange [22].  
Nucleotide binding also increases the hydrogen bond strengths of residues in the 
region that caps the bottom of the large lobe. The allosteric coupling between the 
catalytic loop and the large lobe was also observed using DXMS experiments [22]. In 
particular, the interactions between the conserved residues Glu208 of the APE motif and 
Arg280 are evident in our data, where these residues show lower  values upon PKI 
binding to the binary form of the enzyme. This ion pair connects the P+1 loop and the 
loop between the G and H helices. The C-terminal tail undergoes significant domain 
movement when the enzyme transitions from open to closed conformation, as observed 
in the crystal structure (Figure 2.14) [37].  While DXMS data suggest that the nucleotide 
binding increase the amide protection factors for the entire C-terminal tail [134], our data 
show that residues 315-345, which contains the gate controlling the nucleotide access, 
display hydrogen bonds weaker than in the apo form. These weak hydrogen bonds 
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concur to the increased flexibility of the intermediate state, but eventually become 
stronger upon formation of the ternary complex, with the interactions between the acidic 
cluster and the basic residues of the pseudo-substrate [130]. 
 
 
Figure 2.12. Regions showing the A and C communities. 
Regions showing the A and C communities, red and yellow, respectively. Illustration adapted from 
McClendon et al. [93] 
 
Overall, this study demonstrates that the changes in the allosteric network of the 
kinase are manifested through variations in hydrogen bond strengths. These changes 
are not unidirectional: while several hydrogen bonds become stronger upon ligand 
binding, other interactions become weaker, underscoring a redistribution of the free 
energy of binding occurring throughout the whole enzyme. As NMR methodology 
progresses toward understanding the mechanisms of allosteric transmission at the 
atomic level, the measurement of equilibrium H/D fractionation factors emerges as a 
complementary method to other NMR techniques to trace allosteric communications 
within proteins and enzymes. 
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Figure 2.13. Signal integration motifs in PKA-C. 
(A) The F-helix (red) is a central scaffold where the catalytic and regulatory spines are tethered. It also forms 
hydrophobic packing with the H-helix (blue) and catalytic loop (green). It also forms a salt bridge and 
hydrophobic packing with the P+1 loop (magenta). (B) The C-helix (dark pink) integrates the important 
catalytic elements in the active site with the small lobe and A-helix (yellow). 
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Figure 2.14. The orientations of the C-terminal tail in three different conformations of PKA as 
observed in the crystal structures. 
PDB ID: 1J3H (apo, red), 4NTT (binary, green), 1ATP (ternary, blue). 
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Figure 2.15. Fractionation factors differences for the amide resonances of PKA-C among the 
different states. 
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Residue Apo Binary (PKA:ADP) 
Ternary 
(PKA:ADP:PKI) 
3 0.58 ± 0.07 0.58 + 0.09 0.72 + 0.04 
4 1.27 ± 0.12 1.16 + 0.09 0.86 + 0.08 
5 1.48 ± 0.08 1.15 + 0.16 1.00 + 0.05 
6 1.04 ± 0.05 0.96 + 0.11 1.18 + 0.06 
7 1.29 ± 0.08 1.02 + 0.11 0.87 + 0.01 
8 1.15 ± 0.12 0.90 + 0.11 0.87 + 0.03 
9 1.30 ± 0.05 1.11 + 0.15 1.03 + 0.05 
10 1.49 ± 0.16 0.95 + 0.09 0.89 + 0.02 
11 1.27 ± 0.13 1.14 + 0.06 1.00 + 0.05 
12 1.65 ± 0.12 0.92 + 0.10 1.25 + 0.08 
13 - 1.11 + 0.09 0.99 + 0.04 
14 1.13 ± 0.12 1.10 + 0.16 0.95 + 0.02 
15 1.73 ± 0.13 - 0.44 + 0.11 
16 - 0.84 + 0.12 - 
17 0.89 ± 0.05 0.99 + 0.08 0.99 + 0.01 
18 - 1.15 + 0.11 - 
19 1.57 ± 0.04 - - 
20 1.12 ± 0.04 2.11 + 0.22 1.49 + 0.12 
21 - - 0.93 + 0.02 
24 1.33 ± 0.13 - 1.33 + 0.11 
25 1.29 ± 0.03 0.76 + 0.14 0.57 + 0.10 
26 - 0.96 + 0.07 1.03 + 0.04 
27 - 1.90 + 0.13 ND 
28 1.37 ± 0.02 - 1.06 + 0.06 
29 - 1.09 + 0.05 0.87 + 0.13 
30 1.60 ± 0.15 1.35 + 0.11 - 
31 1.49 ± 0.07 1.34 + 0.16 1.22 + 0.12 
32 1.44 ± 0.15 0.94 + 0.06 1.17 + 0.05 
34 - 1.65 + 0.20 - 
35 1.70 ± 0.13 1.62 + 0.16 1.50 + 0.04 
36 - 1.93 + 0.80 1.55 + 0.11 
37 ND 1.25 + 0.09 1.01 + 0.07 
Table 2.2. Equilibrium H/D Fractionation Factors of the Residues in Three Major States of PKA-C 
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38 - 1.37 + 0.12 1.20 + 0.03 
40 ND 0.64 + 0.10 0.82 + 0.12 
41 1.43 ± 0.09 1.33 + 0.08 1.42 + 0.05 
42 ND 1.16 + 0.12 1.40 + 0.15 
43 - 0.96 + 0.11 1.13 + 0.10 
44 - 0.57 + 0.12 - 
45 ND - 1.83 + 0.15 
46 1.09 ± 0.05 0.98 + 0.23 - 
47 - - 0.30 + 0.08 
48 - - 1.06 + 0.14 
49 1.09 ± 0.10 0.28 + 0.08 0.42 + 0.09 
50 1.26 ± 0.12 ND 0.40 + 0.05 
51 
 
- 1.52 + 0.11 
52 ND - - 
53 - - 0.89 + 0.14 
55 0.99 ± 0.05 - 0.69 + 0.08 
56 ND - - 
58 0.34 ± 0.05 0.52 + 0.11 0.21 + 0.05 
59 0.32 ± 0.05 0.47 + 0.06 0.29 + 0.10 
60 0.68 ± 0.04 0.53 + 0.06 - 
61 0.36 ± 0.11 0.45 + 0.01 - 
62 ND 1.82 + 0.52 ND 
63 1.49 ± 0.31 1.54 + 0.42 1.96 + 0.19 
64 0.96 ± 0.05 0.77 + 0.05 - 
65 - 0.61 + 0.14 0.71 + 0.16 
66 1.05 ± 0.02 1.10 + 0.06 1.18 + 0.12 
68 - 1.75 + 0.05 1.75 + 0.16 
69 0.88 ± 0.02 0.33 + 0.07 0.24 + 0.03 
70 0.45 ± 0.09 0.50 + 0.08 ND 
71 0.49 ± 0.10 0.40 + 0.04 0.21 + 0.06 
72 0.56 ± 0.08 0.44 + 0.15 0.21 + 0.05 
73 0.31 ± 0.11 - ND 
74 0.37 ± 0.07 - 0.26 + 0.02 
75 - - 1.59 + 0.26 
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76 1.74 ± 0.23 0.37 + 0.12 - 
77 1.21 ± 0.03 1.65 + 0.10 1.19 + 0.06 
78 0.83 ± 0.11 - 1.41 + 0.07 
79 - - ND 
80 - 0.16 + 0.04 - 
81 - 1.12 + 0.08 - 
82 0.79 ± 0.01 - - 
83 1.10 ± 0.05 1.30 + 0.09 1.10 + 0.11 
84 1.24 ± 0.12 - 0.36 + 0.09 
85 0.98 ± 0.17 - ND 
86 - - 1.04 + 0.02 
88 0.72 ± 0.07 - - 
89 1.81 ± 0.24 - - 
90 - 0.46 + 0.08 - 
91 - - 0.19 + 0.04 
92 - - 0.38 + 0.11 
94 1.13 ± 0.17 - 0.40 + 0.03 
95 0.54 ± 0.05 - 0.33 + 0.05 
96 - 0.39 + 0.08 0.24 + 0.09 
97 0.50 ± 0.07 - 0.16 + 0.04 
98 0.42 ± 0.04 0.36 + 0.10 0.28 + 0.03 
99 ND - - 
100 ND 1.92 + 0.14 1.27 + 0.11 
102 - 0.42 + 0.09 0.19 + 0.05 
103 0.36 ± 0.07 0.25 + 0.06 0.16 + 0.04 
104 0.89 ± 0.11 - 0.15 + 0.06 
105 1.28 ± 0.10 - - 
106 1.84 ± 0.43 1.81 + 0.17 1.72 + 0.13 
107 1.98 ± 0.34 1.46 + 0.55 1.84 + 0.12 
108 1.44 ± 0.15 ND ND 
109 1.59 ± 0.11 1.34 + 0.08 - 
110 0.80 ± 0.06 0.55 + 0.12 ND 
111 ND ND 2.07 + 0.09 
112 0.43 ± 0.06 0.42 + 0.02 0.32 + 0.04 
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113 1.46 ± 0.08 ND - 
114 1.37 ± 0.06 0.95 + 0.21 - 
115 0.23 ± 0.05 ND 0.41 + 0.04 
116 0.62 ± 0.08 0.43 + 0.08 0.37 + 0.04 
117 0.56 ± 0.03 0.50 + 0.02 0.36 + 0.05 
118 0.84 ± 0.07 - - 
119 0.49 ± 0.03 - - 
120 0.54 ± 0.11 0.57 + 0.11 1.18 + 0.04 
121 - - 1.70 + 0.08 
122 - 2.09 + 0.56 - 
123 0.81 ± 0.09 - 0.44 + 0.05 
124 1.65 ± 0.15 1.56 + 0.25 1.59 + 0.29 
125 1.13 ± 0.07 1.10 + 0.29 1.51 + 0.21 
126 - - ND 
127 - - 0.97 + 0.11 
128 - - 0.18 + 0.05 
129 - - ND 
130 - - 1.82 + 0.25 
131 - - 1.20 + 0.09 
132 - - 0.27 + 0.06 
133 1.79 ± 0.09 - 0.47 + 0.13 
134 0.99 ± 0.06 - 1.44 + 0.06 
136 - ND 1.27 + 0.03 
137 - ND ND 
138 2.09 ± 0.58 - 0.23 + 0.07 
139 ND 2.19 + 0.49 1.90 + 0.23 
140 ND ND ND 
142 ND ND 1.82 + 0.04 
143 0.43 ± 0.04 ND - 
144 0.33 ± 0.06 0.29 + 0.06 0.33 + 0.08 
145 0.56 ± 0.08 - - 
146 - - 0.25 + 0.03 
147 0.46 ± 0.08 0.50 + 0.07 ND 
148 0.56 ± 0.02 0.43 + 0.07 - 
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149 ND 0.47 + 0.04 0.16 + 0.06 
150 0.75 ± 0.03 ND 0.23 + 0.07 
151 0.35 ± 0.03 0.33 + 0.07 - 
155 0.50 ± 0.12 ND 0.29 + 0.07 
156 - - 0.81 + 0.10 
157 - - 0.17 + 0.03 
160 ND - - 
161 ND - 1.67 + 0.10 
162 1.03 ± 0.11 0.24 + 0.05 - 
163 - 0.58 + 0.07 - 
165 ND - 1.93 + 0.48 
166 1.37 ± 0.18 1.00 + 0.14 0.16 + 0.07 
170 - - 0.53 + 0.16 
174 - 0.67 + 0.05 0.26 + 0.03 
175 0.29 ± 0.03 0.41 + 0.06 0.30 + 0.04 
176 ND ND 1.34 + 0.19 
177 - 1.58 + 0.10 1.83 + 0.06 
178 ND ND - 
179 0.33 ± 0.09 ND 0.20 + 0.03 
180 0.47 ± 0.12 ND 0.21 + 0.08 
181 - 0.50 + 0.09 - 
182 0.34 ± 0.05 - 0.34 + 0.02 
184 - - ND 
185 1.53 ± 0.32 - 2.03 + 0.24 
186 0.86 ± 0.05 - ND 
187 1.11 ± 0.07 - ND 
188 0.96 ± 0.02 ND ND 
189 2.00 ± 0.38 - - 
190 ND 1.58 + 0.24 1.69 + 0.24 
191 ND 1.92 + 0.23 0.92 + 0.18 
192 1.11 ± 0.03 - 1.32 + 0.03 
193 1.22 ± 0.09 1.03 + 0.11 1.18 + 0.04 
194 - 1.69 + 0.07 1.44 + 0.10 
195 1.60 ± 0.20 - 1.51 + 0.03 
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196 - 0.77 + 0.06 0.95 + 0.03 
197 1.16 ± 0.15 0.71 + 0.11 - 
198 1.55 ± 0.11 ND 1.41 + 0.28 
199 ND - 0.21 + 0.05 
200 1.76 ± 0.09 - 1.14 + 0.34 
201 ND - 0.46 + 0.12 
203 ND - 0.43 + 0.15 
205 0.71 ± 0.01 - 0.30 + 0.07 
206 0.94 ± 0.05 0.50 + 0.08 0.23 + 0.07 
208 0.70 ± 0.14 1.63 + 0.09 0.16 + 0.07 
209 0.25 ± 0.08 - 0.30 + 0.11 
210 0.30 ± 0.05 ND 0.29 + 0.05 
211 - - 1.02 + 0.12 
212 1.58 ± 0.03 1.10 + 0.07 - 
213 - 0.98 + 0.09 1.11 + 0.04 
214 1.43 ± 0.06 1.09 + 0.12 1.15 + 0.08 
215 - 1.45 + 0.07 0.42 + 0.10 
216 1.15 ± 0.25 0.72 + 0.07 1.93 + 0.13 
218 - - 1.19 + 0.12 
219 0.51 ± 0.04 - - 
220 - 1.04 + 0.23 0.29 + 0.10 
221 0.33 ± 0.02 0.30 + 0.03 0.26 + 0.03 
222 0.42 ± 0.10 - - 
225 0.61 ± 0.07 0.29 + 0.08 0.36 + 0.06 
226 0.33 ± 0.05 0.39 + 0.06 - 
227 - 0.41 + 0.08 0.38 + 0.11 
228 0.29 ± 0.03 0.60 + 0.08 - 
230 - 0.37 + 0.07 - 
231 - 0.45 + 0.07 0.44 + 0.03 
232 - 0.85 + 0.12 0.84 + 0.09 
233 0.32 ± 0.01 0.89 + 0.24 0.34 + 0.05 
235 - - 0.88 + 0.08 
238 - 0.54 + 0.14 - 
239 - - ND 
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240 ND ND ND 
241 2.13 ± 0.16 1.47 + 0.16 1.54 + 0.04 
242 1.24 ± 0.09 ND 1.55 + 0.07 
244 ND ND 1.60 + 0.03 
245 1.04 ± 0.09 1.19 + 0.04 1.26 + 0.04 
246 1.63 ± 0.12 1.77 + 0.57 0.59 + 0.05 
247 - 0.54 + 0.05 1.38 + 0.11 
248 - 1.32 + 0.77 1.27 + 0.04 
249 1.27 ± 0.08 - 1.73 + 0.09 
250 1.62 ± 0.15 - - 
251 ND - - 
252 - 0.91 + 0.04 - 
253 1.10 ± 0.03 1.18 + 0.06 1.04 + 0.09 
254 0.95 ± 0.02 ND 1.26 + 0.03 
255 1.73 ± 0.07 1.04 + 0.05 1.05 + 0.07 
256 ND ND 1.78 + 0.13 
257 - - 1.25 + 0.09 
261 1.25 ± 0.05 ND 1.58 + 0.15 
262 1.45 ± 0.03 ND ND 
263 1.74 ± 0.17 1.83 + 0.20 2.08 + 0.28 
264 - 1.80 + 0.02 1.35 + 0.05 
265 0.41 ± 0.01 ND ND 
266 - 
 
0.27 + 0.08 
267 - 1.17 + 0.12 0.30 + 0.06 
268 - - - 
269 0.61 ± 0.05 0.64 + 0.04 - 
272 0.67 ± 0.07 - - 
273 0.64 ± 0.03 - - 
274 0.26 ± 0.05 0.22 + 0.04 0.26 + 0.07 
275 1.95 ± 0.10 ND 1.27 + 0.09 
276 0.58 ± 0.05 1.71 + 0.22 - 
277 1.28 ± 0.20 1.25 + 0.19 1.55 + 0.18 
278 0.58 ± 0.03 0.52 + 0.07 0.51 + 0.04 
279 0.92 ± 0.09 0.55 + 0.03 0.73 + 0.02 
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280 0.73 ± 0.06 0.98 + 0.08 0.28 + 0.04 
281 1.68 ± 0.57 ND 0.55 + 0.16 
282 - - 1.18 + 0.55 
283 - - 0.37 + 0.03 
284 0.53 ± 0.06 - 0.29 + 0.07 
286 - 0.98 + 0.05 1.16 + 0.02 
287 1.10 ± 0.08 1.08 + 0.10 1.42 + 0.04 
288 - - 0.75 + 0.13 
289 1.17 ± 0.06 - 1.05 + 0.04 
290 1.40 ± 0.09 1.04 + 0.03 0.79 + 0.02 
291 ND 1.25 + 0.22 ND 
292 0.24 ± 0.03 0.23 + 0.02 - 
293 0.51 ± 0.07 - ND 
294 0.27 ± 0.03 0.27 + 0.04 0.16 + 0.06 
295 1.60 ± 0.22 1.80 + 0.05 1.60 + 0.01 
296 ND 1.65 + 0.05 ND 
297 ND ND ND 
298 2.05 ± 0.21 1.64 + 0.20 1.63 + 0.14 
299 1.10 ± 0.16 0.65 + 0.09 0.59 + 0.01 
300 - 0.88 + 0.06 0.94 + 0.02 
301 1.94 ± 0.24 1.35 + 0.13 1.98 + 0.09 
302 ND 1.83 + 0.14 1.66 + 0.04 
303 1.42 ± 0.15 - 0.75 + 0.08 
304 1.15 ± 0.11 0.80 + 0.07 0.91 + 0.13 
305 - 1.50 + 0.14 - 
307 1.57 ± 0.19 ND - 
308 - 0.36 + 0.06 0.28 + 0.04 
309 0.28 ± 0.04 0.24 + 0.03 0.18 + 0.08 
310 0.70 ± 0.03 0.77 + 0.18 0.42 + 0.08 
311 ND ND 1.64 + 0.01 
312 2.07 ± 0.06 1.63 + 0.19 1.48 + 0.18 
314 2.11 ± 0.15 1.56 + 0.06 0.93 + 0.13 
315 ND 1.91 + 0.22 ND 
317 - ND 1.27 + 0.05 
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318 1.57 ± 0.23 1.90 + 0.12 1.30 + 0.13 
319 - - 1.58 + 0.04 
320 - - 1.13 + 0.07 
322 2.13 ± 0.24 ND 1.94 + 0.08 
323 - - 1.31 + 0.06 
324 - - 0.72 + 0.02 
325 0.96 ± 0.02 - 0.61 + 0.02 
326 - - 0.68 + 0.05 
327 1.87 ± 0.18 - ND 
328 1.05 ± 0.09 - 1.09 + 0.01 
329 - - 1.02 + 0.02 
330 ND - ND 
331 1.43 ± 0.12 1.80 + 0.18 1.52 + 0.04 
332 - 1.99 + 0.14 1.16 + 0.13 
333 - 1.35 + 0.08 1.66 + 0.08 
334 ND 1.70 + 0.06 - 
335 - 1.86 + 0.07 1.38 + 0.64 
336 1.65 ± 0.07 1.84 + 0.19 1.47 + 0.04 
337 ND - 1.59 + 0.10 
338 - 1.47 + 0.11 1.35 + 0.19 
339 - 1.61 + 0.11 - 
341 ND ND 1.74 + 0.11 
342 ND 1.22 + 0.45 1.85 + 0.21 
343 ND ND 1.79 + 0.14 
344 1.42 ± 0.06 1.67 + 0.04 1.21 + 0.10 
345 - 1.16 + 0.05 1.02 + 0.02 
346 1.75 ± 0.18 1.23 + 0.19 0.98 + 0.04 
347 0.58 ± 0.03 - ND 
348 1.16 ± 0.07 0.97 + 0.02 0.81 + 0.02 
349 1.23 ± 0.07 1.39 + 0.08 0.89 + 0.06 
350 - 1.18 + 0.12 1.58 + 0.05 
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3.1 Conspectus 
The developments of biosynthetic specific labeling strategies for side-chain methyl 
groups have allowed structural and dynamic characterization of very large proteins and 
protein complexes. However, the assignment of the methyl-group resonances remains 
an Achilles’ heel for NMR, as the experiments designed to correlate side chains to the 
protein backbone become rather insensitive with the increase of the transverse 
relaxation rates. In this chapter, we outline a semi-empirical approach to assign the 
resonances of methyl group side chains in large proteins. This method requires a crystal 
structure or an NMR ensemble of conformers as an input, together with NMR data sets 
such as NOEs and PREs, to be implemented in a computational protocol that provides a 
probabilistic assignment of methyl group resonances. As an example, we report the 
protocol used in our laboratory to assign the side chains of the 42-kDa catalytic subunit 
of the cAMP-dependent protein kinase A. Although we emphasize the labeling of 
isoleucine, leucine, and valine residues, this method is applicable to other methyl group 
side chains such as those of alanine, methionine, and threonine, as well as reductively-
methylated cysteine side chains. 
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3.2 Introduction 
Isotopic labeling is at the heart of NMR spectroscopy. After the pioneering work 
in the early ‘60s by several research groups [146-149], more complex labeling schemes 
have been used to attenuate transverse relaxation and push the boundaries of NMR 
analysis of large macromolecular complexes [150-152]. A significant step forward was 
made when non-labile protons in proteins were substituted by deuterons, ameliorating 
the dipolar relaxation due to 1H-13C, 1H-15N, and 1H-1H interactions, increasing sensitivity 
and resolution, thereby rendering proteins larger than 20 kDa amenable to structural 
NMR studies [153, 154]. Although complete deuteration has been used for backbone 
assignments in conjunction with transverse relaxation optimized spectroscopy (TROSY) 
[118], NOESY-based experiments benefit from incomplete (or fractional) deuteration, 
which preserves some protons for distance measurements [154]. Another quantum leap 
in the NMR structure determination of large complexes was made by Kay and co-
workers, who developed a biosynthetic strategy for 1H,13C methyl group labeling in a 
highly deuterated background [155, 156]. Since then, this labeling strategy has 
expanded to include selective methyl group labeling such as isoleucine, valine, leucine, 
methionine [157], threonine [158], and alanine [159]. Although selective labeling 
schemes for aromatic side chains will certainly have an impact both in structure 
determination and dynamic characterization of large proteins [152], here we will focus on 
the use of methyl groups for the spectroscopy of large systems [160] akin to the TROSY 
method developed for backbone amides [118]. Following these methyl labeling 
schemes, quantitative studies on binding, structure, and conformational dynamics of 
proteins that are several hundred kDa are emerging, such as large molecular machinery 
[161-163], allosteric enzymes [164], chaperones [165], and protein thermodynamics 
[112]. 
The first methyl labeling scheme was published in 1997 by Gardner and Kay 
[156], who obtained a selective protonation of amino acids in which the direct 
biosynthetic precursor to isoleucine, 2-ketobutyrate, was enzymatically and chemically 
prepared with selective 13CH3 labeling in a highly deuterated background. Exploiting the 
Escherichia coli (E. coli) biosynthetic pathway, this protocol enables the specific 13CH3 
labeling of the C of Ile, while the remaining non-labile protons are replaced by 
deuterons. The incorporation of 2-ketoisovalerate, in a similar fashion, leads to selective 
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labeling on the C and C of leucine and valine, respectively [155], resulting in the so-
called “ILV labeling” scheme (Figure 3.1). Nowadays, these biosynthetic precursors are 
commercially available in a variety of labeling schemes for assignment, structure 
determination, and dynamics studies. Selective labeling of the C methyl of isoleucine 
has also been devised [166], but is uncommon due to the superior spectral qualities of 
the C methyl group. Usually, selective labeling of other amino acids is achieved through 
direct addition of the amino acid to the growth medium during cell growth. For alanine 
and methionine, this is most commonly accomplished by directly incorporating the amino 
acid prior to induction (30 minutes to 1 hour) at final concentrations of 100-250 mg/L 
[112, 165] for Met and from 100-800 mg/L for alanine [112, 159]. An alternate approach 
is to engineer cysteine and react with 13C-methyl-methanethiosulfonate (13C-MMTS) to 
produce a methionine mimic [167]. Kay and coworkers have also developed an in vitro 
biosynthetic method to produce U-[2H],Thr-2[13CH3] (13CH3 labeled threonine in a 
deuterated background) [158]. Threonine is a direct biosynthetic precursor to 2-
ketobutyrate, leading to isoleucine methyl (C) labeling. Since threonine is converted to 
glycine either from threonine aldolase or threonine dehydrogenase/2-amino-3-
ketobutyrate ligase, the authors used 100 mg/L of d5-glycine along with 50 mg/L of U-
[2H] Thr-2[13CH3] and 50 mg/L of 2-ketobutyrate for specific threonine and isoleucine 
labeling (Figure 3.1).  
 
3.3 Methyl labeling protocol for the cAMP-dependent Protein 
Kinase A (PKA-C) 
In this outline, we highlight a method to label the 13C isoleucine (C), leucine, and valine 
methyl groups for the catalytic subunit of cAMP-dependent Protein Kinase A (PKA-C) 
(Figure 3.2). Specific labeling of side-chain methyl groups is achieved using the M9 
minimal medium typically used for 15N labeling of proteins with the addition of 
appropriate amounts of methyl labeling precursors. As the protocols for overexpression 
and purification of PKA-C have been described extensively [28, 168, 169], here we 
report only the main steps of the protocol (Figure 3.3). Note that for binding titrations 
studies we used fully protonated kinase and 2D NMR experiments; however, for methyl 
group assignment experiments (i.e., 3D [13C,13C]-methyl NOESY experiments) we 
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utilized fractionally deuterated kinase expressed in 80% D2O. In our hands, the utilization 
of fully perdeuterated media resulted in a scarce expression of the kinase. Nonetheless, 
for larger proteins with molecular weights greater than 100 kDa, high levels of 
deuteration are often necessary. In the latter case, over-expression of proteins in 100% 
D2O is highly strain-, vector-, and protein-dependent and requires optimization for each 
of these variables. Several tips for the optimization of perdeuterated growths have been 
provided by Gardner et al. [170]. 
Materials 
Note: All stocks should be sterile before usage. 
LB Media (1L) 
 10.0 g Tryptone 
 5.0 g Bacto-Yeast 
 10.0 g NaCl 
M9 Media (1L) 
3.0 g KH2PO4   
12.8 g Na2HPO4·7H2O 
1.0 g NH4Cl (for 15N labeling use 15NH4Cl) 
0.5 g NaCl  
Vitamins (50mL) 
5.0 mg Ca D(+)-panthothenate 
5.0 mg Biotin 
5.0 mg Folic Acid 
5.0 mg Niacinamide USP 
5.0 mg Pyridoxal 5-phosphate monohydrate 
1000 mg Thiamin 
Trace Metals (1x, 100mL) 
50 mM FeCl3   
20 mM CaCl2   
10 mM MnCl2   
10 mM ZnSO4  
2 mM CoCl2   
2 mM CuCl2      
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2 mM NiCl2      
2 mM Na2MoO4    
2 mM Na2SeO3     
2 mM H3BO3  
Note: More details in the preparation of Trace Metal solution is provided at 
Studier et. al.[171]  
Keto-acid Stock (10 mL, water) 
2-ketobutyric acid-4-13C sodium salt (70mg/L of media) 
2-keto-3-(methyl-13C)-butyric acid-4-13C sodium salt (90mg/L of media)   
Calcium Chloride 
Magnesium Sulfate 
D-glucose 
Ampicillin 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) 
 
1. Place 500 mL of M9 media into baffled flasks and autoclave.   
2. Grow BL21 (DE3) cells containing the pRSET plasmid with PKA-C overnight in 
LB media (with Ampicillin). 
3. In the morning the culture should be in log phase growth. Then pellet the BL21 
(DE3) cells under 2200xg for 10 minutes. During this time prepare add the 
following per 500 mL flask containing M9 media:  
a. 10 ml of 20% w/v glucose  
b. 5 mL of Vitamin stock 
c. 1 mL of 1 M MgSO4. 
d. 1 mL of 50 mM CaCl2 
e. 500 L of 1000x Trace Metals  
f. 500 L of 10% w/v Ampicillin stock 
4. Resuspend the cell pellet in M9 media and allow to grow for at least an hour to 
allow for the culture to adapt to the adjusted metabolism. We usually have an 
initial OD600 of ~0.8. 
5. Once the cells reach log phase growth, lower the temperature to 24°C and add in 
the appropriate concentration of keto-acids into each flask (70 mg/L of 2-
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ketobutyric acid-4-13C sodium salt and 90 mg/L of 2-keto-3-(methyl-13C)-butyric 
acid-4-13C sodium salt). 
6. After one hour, induce with 0.4 mM IPTG for at least 5 hours. Harvest under 
8000xg for 25 minutes at 4°C. 
Purification of PKA-C 
 Buffer A (1L) 
- 30 mM MOPS (3-(N-morpholino)propanesulfonic acid)  (6.28g) 
- 15 mM MgCl2        (3.05g) 
- 5 mM -mercaptoethanol      (352l/L of 
buffer) 
- pH 8.0 
 Buffer B (1L) 
- 30 mM MOPS        (6.28g) 
- 15 mM MgCl2        (3.05g) 
- 25 mM KCl        (1.86g) 
- 5 mM -mercaptoethanol      (352l/L of 
buffer) 
- pH 8.0 
Elution Buffer (100mL) 
- 30 mM MOPS       (628 mg) 
- 15 mM MgCl2       (305 mg) 
- 25 mM KCl       (186 mg) 
- 1 mM cAMP       (33 mg) 
- 5 mM -mercaptoethanol     (35.2l/100 mL of 
buffer) 
- pH 8.0 
 
Cell Lysis 
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1) Re-suspend PKA and the His6-RII(R213K) overexpressed cells in Buffer A. 
Make sure the pellet containing RII was grown in at least 1/3 of the volume of 
your PKA. 
2) Grind the cells in ice for approximately 10 minutes then lyse using a French 
press using 1000 psi of pressure. 
3) Spin down the solution at 20,000 rpm for 40 minutes at 4C. Mix with 10 mL of 
NiNTA slurry and batch bind at 4C for a minimum of 3 hours. 
Elution 
1) Run the slurry through the column (make sure the resin does not dry). 
2) Wash with Buffer B (~200 mL). If preferred the wash buffer can also include 20 
mM Imidazole to remove some non-specific binding proteins. This will not affect 
the PKA:RIIα interaction. 
3) Elute PKA-C using 150 mL of elution buffer.  
To remove RII wash with ~50 mL of Buffer B with 250 mM imidazole. 
 
Although mass spectrometry is a viable method to assess the labeling of proteins with 
stable isotopes, the most straightforward way to determine the correct isotopic 
incorporation is to acquire the [1H,13C]-HMQC spectra of the system of interest. The 
characteristic chemical shift patterns allow one to easily identify isoleucine (C), leucine, 
and valine methyl groups as they resonate in distinct regions of the 1H/13C correlated 
spectra. Due to the high sensitivity of methyl groups, 2D spectra of large proteins (~40 
kDa) with reasonable sensitivity (S/N ratio 200-400) can be measured with modern 
spectrometers (700-900 MHz) with relatively modest concentrations (~200 M). A 
[1H,13C]-HMQC spectrum of apo PKA-C shows the labeling and spectral quality of ILV-
methyl groups labeling (Figure 3.4). Below, we outline the NMR sample preparation that 
we use for apo form of PKA-C:  
Materials 
Potassium Phosphate Monobasic 
Potassium Chloride 
Dithiothreitol 
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Magnesium Chloride 
Sodium Azide 
10kDa Centrifugal Concentrator 
99+% Deuterium Oxide 
Long-tip Pipet, 13-1/4”  
5 mm Shigemi Tube 
1. Dialyze purified PKA-C under NMR buffer (20 mM KH2PO4, 90 mM KCl, 10 mM 
DTT, 10 mM MgCl2, 1mM NaN3 at pH 6.5) overnight at 4°C. Initial concentration 
of PKA-C should < 5 M.  
2. Concentrate PKA-C at 2400xg using a 10kDa cutoff centrifugal concentrator at 
4°C until the enzyme is concentrated to ~200 M. The protein concentration can 
reliably be measured by absorbance measurement at 280 nm using an extinction 
coefficient of 52060 M-1cm-1. 
3. Pipette 250 L (for Agilent spectrometers) or 300 L (for Bruker spectrometers) 
and add 12.5 or 15 μL of D2O (~5% v/v), respectively. Transfer the protein 
solution into a shigemi tube using a long-tip pipet. Place the plunger inside the 
tube until the plunger is evenly covered with no visible bubbles in the solution. 
After spectrometer set up (spectrometer details are dependent on model and 
spectrometer) acquire an [1H,13C]-HMQC spectrum. 
 
3.4 Semi-Automated Methyl Group Resonance Assignment 
Strategies 
 For backbone studies, the assignment is carried out by walking through the 
peptide backbone through a series of triple resonance NMR experiments [172-175]. For 
the assignment of methyl groups resonances, the classical approach requires TOCSY-
based spectroscopy with the magnetization starting on the methyl groups and 
transferred via 13C-13C couplings to the protein backbone [176]. This approach, however, 
is not applicable to methyl group side-chains of large proteins, such as the 82 kDa 
malate synthase G with a correlation time of ~46 ns [177]. In the latter case, the 
branched amino acids present a bifurcation of the magnetization pathways with a 
significant loss of transfer. Although several experiments have been tailored to correlate 
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backbone C, C and C’ chemical shifts to methyl groups [178-180], the relatively fast 
transverse relaxation rates of these nuclei for larger proteins or conformational exchange 
phenomena (see the case of PKA-C [43]) do not allow to carry out sequential backbone 
assignments. A possible solution is to use a divide and conquer approach in which 
proteins are dissected into several smaller domains and the assignments are pieced 
together [165, 181]. However, there are many large monomeric proteins that are 
unamenable to this approach. An alternative strategy is to use site-specific mutations to 
exchange amino acids with methylated side chains for glycine or other amino acids. The 
latter method, however, is very cumbersome and time-consuming, particularly for very 
large systems. In response to this need, Matthews and co-workers proposed an 
automatic method that uses both NMR and X-ray structural data to back calculate methyl 
side chain assignments [182]. This automated procedure was designed to rapidly assign 
methyl groups using full-length proteins and without mutagenesis [182]. This approach 
requires a crystal structure as a starting point to calculate methyl group chemical shifts 
and synthetic NOEs. An algorithm is then used to rank the scores of the initial (seed) 
assignment against the experimental NMR data. The latest version of this method 
features an improved algorithm with no manual intervention in NOESY spectra peak 
picking.  
Inspired by this work, we developed an approach that uses a similar philosophy, 
but utilizes a probabilistic method to tackle assignment problem. Specifically, we 
improved the efficiency of the phase space search using fuzzy logic coupled with Monte 
Carlo sampling. This approach, named FLAMEnGO (Fuzzy Logic Assignment of Methyl 
Groups), utilizes NOESY data as the primary input in concert with other data sets, such 
as methine-methyl TOCSY data, as well as paramagnetic relaxation enhancements 
(PREs). In our newer version of this software, FLAMEnGO 2.0 [183], we introduced a 
graphic interface that enables the interactive assignment of the methyl group 
resonances with the option of including secondary constraints, such as mutagenesis or 
supplemental NMR data.  
In the following synopsis, we describe the construction and usage of FLAMEnGO 
2.0, as well as its application to the side-chain methyl groups of PKA-C. 
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3.5 Semi-Automated Assignment Protocol using FLAMEnGO 2.0 
All of the available methyl auto-assignment algorithms share the same philosophy: 
searching for the best assignments by comparing experimental NOE connectivities and 
chemical shifts to back-calculated data from the X-ray coordinates [182-186]. Starting 
from the available crystal structure or NMR structural bundle, FLAMEnGO 2.0 back-
calculates a 3D/4D NOESY spectrum from the internuclear methyl-methyl distances and 
compares synthetic data to an experimental NOESY spectrum (Figure 3.5). The 
algorithm iteratively swaps the resonance assignments until the scoring function is 
maximized. This process is repeated iteratively for an array of different simulated NOE 
distances until no further improvement is found. Given the probabilistic nature of this 
algorithm, multiple runs are performed in parallel to provide a statistical weight to the 
resonance assignments. Although FLAMEnGO is designed to handle sparse NOE data 
sets, sufficient coverage of the NOE network and other restraints (i.e., methine-methyl 
TOCSY or methyl-HN COSY, PREs or site-directed mutagenesis) are required for a 
confident assignment. The outline of the procedure for using FLAMEnGO GUI is shown 
in Figure 3.6. 
Below, we detail the experimental data and data formatting, as well as brief 
instructions on usage of FLAMEnGO 2.0 
Materials 
 3D C,C,H 13C-HMQC NOESY 13C-HMQC data set (These pulse sequences are 
part of the TOPSPIN release for Bruker spectrometers, and are downloadable 
from the NMRFAM website 
http://pine.nmrfam.wisc.edu/download_pulseprogs.html for Agilent 
spectrometers).  
 2D [1H,13C]-HMQC data set (required) 
 Predicted chemical shift table (required, sources listed below) 
 Paramagnetic Relaxation enhancement data (optional) 
 Methine-methyl TOCSY data (optional) 
 Assigned amide chemical shifts (optional, if amide-methyl NOESY data are 
incorporated) 
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 PDB file for protein. Note that hydrogen atoms need to be added to the PDB. 
Molprobity (http://molprobity.biochem.duke.edu/) is a resource to perform this 
function. 
 
System Requirements and Specifications 
The python-based FLAMEnGO 2.0 program includes two main components: 1) 
the frontend GUI program flame.py, and 2) the backend engine FLAMEnGO.py. The 
former provides a convenient interface for configuring the setup and displaying the 
results, while the latter is the driver for a Monte-Carlo search.  The software is ready to 
run under Python 2.7, and requires wxPython and matplotlib modules for GUI and 
plotting. An integrated scientific python package, such as Enthought Canopy 
(https://www.enthought.com/products/canopy/) or Anaconda Python 
(https://store.continuum.io/cshop/anaconda/) are needed for full functionality.     
 
Input File Formats  
FLAMEnGO 2.0 uses a Monte Carlo search algorithm to swap resonance 
assignments from given input data and computes the fitness of the resonance 
assignments based on a score function. The details of the scoring function are 
discussed in Chao et al. [183, 186]. 
  
Initial Random Assignment  
The algorithm needs an arbitrary initial assignment to start the swapping process 
associated with the Monte Carlo algorithm. This seed assignment must be consistent 
with PDB numbering and included in all input data. The data are formatted in a series of 
columns by <assignment #> <amino acid type> <resonance atom ID> -> <assignment 
#> <amino acid type> <resonance atom ID>. Note that there is no change in residue, 
rather this indicates to the program which residues to assign. To constrain a specific 
resonance assignment (e.g., found using site-directed mutagenesis), the user should 
place an asterisk at the beginning of the line: 
 
296 VAL HG2 -> 296 VAL HG2 
* 301 ILE HD1 -> 301 ILE HD1 
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321 ILE HD1 -> 321 ILE HD1 
323 VAL HG1 -> 323 VAL HG1 
323 VAL HG2 -> 323 VAL HG2 
325 ILE HD1 -> 325 ILE HD1 
 
3D C,C,H 13C-HMQC-NOESY-13C-HMQC  
The 3D C,C,H 13C-HMQC-NOESY-13C-HMQC data need to be formatted in a 
series of columns in the following order: <13C (2) chemical shift> <1H (3) chemical 
shift> <13C (1) chemical shift> <13C (2) linewidth>  <1H (3) linewidth> <13C (1) 
linewidth> 
18.32 1.28 27.41 0.4 0.025 0.4 
22.76 0.88 19.53 0.4 0.025 0.4 
22.76 0.88 15.69 0.4 0.025 0.4 
22.76 0.88 21.55 0.4 0.025 0.4 
22.76 0.88 18.66 0.4 0.025 0.4 
20.97 0.78 17.77 0.4 0.025 0.4 
25.05 0.68 23.33 0.4 0.025 0.4 
 
[1H,13C]-HMQC/15N Amide 
The data is formatted in a series of columns by <assignment #> <amino acid 
type> <resonance atom ID> <chemical shift value>. Note that the assignment reported in 
this file at the beginning of the calculation is arbitrary for the [1H,13C]-HMQC. The amide 
chemical shifts are optional and only required if one is using amide to methyl NOE data. 
The amide chemical shifts must be assigned based on previous experiments. 
  7 LEU HD1     0.34  
  7 LEU HD2     0.56  
  7 LEU CD1    25.39  
  7 LEU CD2    24.56  
 20 LEU HD1     0.88  
 20 LEU HD2     0.64  
 20 LEU CD1    25.10  
 20 LEU CD2    27.22 
 
Paramagnetic Relaxation Enhancement Data (PREs) 
Although the PRE data are listed as an option, we demonstrated that the 
inclusion of these constraints in the computation dramatically increases both the speed 
and accuracy of the resonance assignments [183, 186]. In particular, PRE data are 
crucial to solve the ambiguities caused by partial peak overlap (Figure 3.7). PRE data 
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are included as distances using the semi-quantitative approach described by Battiste 
and Wagner [187], in which the ratios of the peak intensities in the presence of the 
oxidized versus the reduced spin label are converted into three different categories: 
weakly affected (< 20% of signal is lost through the PRE effect), moderately affected 
(20-80% of the signal is lost) or strongly effected (<20% of the signal is lost). These 
categories are flagged as W, M, and S in the input file. If a resonance is unobserved 
regardless of the PRE effect, then a flag of 999 is used in the 4th column of the input file. 
The data are formatted in four columns, including <assignment #> <amino acid type> 
<resonance atom ID> <Flag (W, M, S, 999)>: 
 
 89  HD1  LEU 999 
 92  HD2  LEU 999 
102  HD1  LEU M 
102  HD2  LEU M 
 71  HD1  ILE S 
 92  HD1  LEU S 
138  HD1  LEU W 
 13  HD1  LEU W 
 
Prediction of Methyl group chemical shifts from the PDB file 
Various algorithms are used to predict the side chain chemical shift values. 
Output from any commonly used program, such as CH3SHIFT [188]  (http://www-
sidechain.ch.cam.ac.uk/CH3Shift/), SHIFTX2 [189], (http://www.shiftx2.ca/) and PPM 
[190] (http://spin.ccic.ohio-state.edu/index.php/ppm) can be implemented in FLAMEnGO 
2.0. Since the output is not uniform between programs, data must be reformatted as 
follows: <residue #> <amino acid type> resonance atom ID> <predicted chemical shift 
value> <error of prediction> 
 
1 VAL CG2 19.992 1.128 
1 VAL HG2 0.828 0.173 
5 LEU CD1 25.747 1.412 
5 LEU HD1 0.969 0.176 
 
Residue Type  
  75 
Amino acid-type assignments can be included as constraints in the search 
algorithm. The data format is identical to that of the initial assignment file. 
 
Instructions to run FLAMEnGO 2.0 GUI 
1. Open FLAMEnGO 
“python flame.py” 
2. Specify the location of each input file on the main window. 
3. To set up FLAMEnGO go under File > SetUp (Figure 3.8A). Set the NOE 
range between 5.0-10.0 with step size of 0.5. The sampling number is the 
number of Monte Carlo calculations run at each point and should be over 100k 
(Figure 3.8B). 
4. Select the Run button. Please note that calculations take a considerable 
amount of time. 
5. Once the runs are finished a plot of the score with respect to the NOE 
distance will appear (Figure 3.8C). To minimize the uncertainty of the 
assignment, click on the point where the NOE value with the maximum score 
is first reached. 
6. Select the number of calculations you wish to run (≥10). The final output will 
give the assignment and the statistical weight of each assignment. 
Output Files 
FLAMEnGO provides two types of output files. The first is the assignment file, which 
provides the calculated assignment at each given calculation at a specified NOE cutoff 
distance. Once the aggregate calculations are performed at a cutoff distance, the 
probability of each assignment is calculated. The probability of each assignment from 
the calculations is what is used to determine the fitness of the assignment. 
 
Score and Assignment 
The output file provides the user with the percent of the residues assigned, the 
assignment score and the assignment from the single calculation. The assignment is 
provided as the following <initial assignment> -> <calculated assignment. On the first 
line the first two columns provide the <final scoring value> <% of residues assigned>. 
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 (205.2936878260806, 93.079554272662747, 193, 17.844744345905379) 
############################# 
158   LEU   HD1 ->    148   LEU   HD1 
     237   VAL   HG1 ->     90   VAL   HG2 
     321   ILE   HD1 ->    196   ILE   HD1 
     259   LEU   HD2 ->    191   LEU   HD2 
     197   LEU   HD1 ->     75   LEU   HD1 
 
Summary 
The summary file will provide the assignment, as well as the number of times the 
particular assignment was made across all the calculations. A confident assignment is 
defined in this case as one that is consistent through all calculations at least 80% of the 
time; a reliable statistic for this assessment requires ≥10 calculations.  For each 
assignment the output is as follows: <initial assignment> -> <calculated assignment> 
<number of times the assignment was calculated>. 
 
   105   VAL   HG1 ->    137   VAL   HG1    10 
   254   LEU   HD1 ->     68   LEU   HD1    10 
    75   LEU   HD2 ->    263   LEU   HD2     6 
   143   LEU   HD2 ->     45   LEU   HD2     7 
    13   LEU   HD1 ->    259   LEU   HD1    10 
   241   VAL   HG2 ->    137   VAL   HG2    10 
 
3.6 Conclusions and Perspectives 
 Selective labeling of the methyl group side-chains has extended the application 
of NMR methods to the analysis of both structure and dynamics of proteins up to 1 MDa. 
However, as the systems become larger, classical methods for resonance assignments 
fail. In this chapter, we reported a semi-empirical approach that enables the assignment 
of methyl group resonances in large proteins. This structure-based approach requires 
the X-ray or the NMR ensemble of structures to generate a probability-based 
assignment. Inclusion of NOEs, PRE, site-specific mutagenesis data, methine-methyl 
TOCSY, and partial assignment from methyl-HN COSY data dramatically improves both 
the accuracy and the speed of the assignment procedure. This method promises to 
extend biomolecular NMR studies beyond the MDa limit. 
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Figure 3.1. Biosynthetic pathways for the specific labeling of A) isoleucine, B) leucine and valine, C) 
alanine, D) methionine and E) threonine. 
Note the off-pathway dilution of alanine and threonine amino acids. 
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Figure 3.2. General growth scheme used to express 15N 13C-ILV labeled PKA-C. 
All cultures are grown in 32°C with induction occurring at 24°C. This is to prevent the formation of inclusion 
bodies during expression [169]. In M9 media, 15NH4Cl (1 g/L) and D-glucose (4 g/L) are used as the only 
nitrogen and carbon sources respectively. 
 
 
 
 
Figure 3.3. SDS-PAGE of the purification of PKA-C using a His6-RII immobilized construct. 
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Figure 3.4. [1H,13C]-HMQC of Apo PKA-C acquired with a 220 M sample on an Avance III 900 MHz 
Bruker spectrometer. 
The spectrum was acquired with 2048 x 200 complex points and 16 transients at 27°C for a total acquisition 
time of approximately 1 ½ hours. 
 
 
Figure 3.5. Overview of the FLAMEnGO algorithm. 
An input structure and the [1H,13C]-HMQC spectrum are used to simulate a NOE spectrum. This spectrum is 
compared with the experimental NOE data, the assignments swapped and the process is repeated until a 
best match is found. Other experimental restraints, such as PRE data, are used. Figure adapted from Chao, 
et al. [186] 
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Figure 3.6. Outline for running FLAMEnGO GUI. 
 
 
 
Figure 3.7. Spectra of oxidized (green) and reduced (red) PKA-C with a spin label on residue 244. 
Note the spectrum should be nearly identical before and after the reduction of the spin label. 
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Figure 3.8. Graphical Interface for FLAMEnGO. 
(A) Main menu of FLAMEnGO. Input files are directly placed inside the selection. (B) Parameter set up for 
the NOE distances, amino acid types you wish to assign, and the number of Monte Carlo steps. (C) Output 
from the run. Note that the program performs the calculation at each NOE distance. (D) Once the score has 
plateaued from increasing the NOE distance, select the point and repeat the calculation at this distance to 
provide a statistical assignment of each residue. Figure adapted from [183] 
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4.1 Conspectus 
The canonical function of kinases is to transfer a phosphoryl group to substrates, 
initiating a signaling cascade; while their non-canonical role is to bind other kinases or 
substrates, acting as scaffolds, competitors, and signal integrators. Here, we show how 
to uncouple kinases dual function by tuning the binding cooperativity between nucleotide 
(or inhibitors) and substrate allosterically. We demonstrate this new concept for the C-
subunit of protein kinase A (PKA-C). Using thermocalorimetry and NMR, we found a 
linear correlation between the degree of cooperativity and the population PKA-C’s closed 
state. The non-hydrolysable ATP analog (ATPC) does not follow this correlation, 
suggesting that changing the chemical groups around the phosphoester bond can 
uncouple kinases dual function. Remarkably, this uncoupling was also found for two 
ATP-competitive inhibitors, H89 and balanol. Since the mechanism for allosteric 
cooperativity is not conserved in different kinases, these results may suggest new 
approaches for designing selective kinase inhibitors. 
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4.2 Introduction 
Protein kinases are ubiquitous phosphoryl transferases that regulate many cellular 
signaling processes [191]. Due to their primary role in cell physiology and pathology, 
protein kinases have become major drug targets to counteract human diseases, such as 
heart failure and cancer [192, 193]. Kinases canonical function is to transfer the -
phosphate of ATP to Ser/Thr/Tyr residues of substrates, thereby activating or 
deactivating various signaling pathways [3, 193-195]. About a decade ago, Manning and 
co-workers identified a non-canonical function for kinases that, in several instances, do 
not carry out any catalytic function; rather they provide binding scaffolds to modulate, 
integrate, or compete in signaling cascades, the so-called pseudo-kinases [194]. While 
kinases mediate signaling through phosphoryl transfer and scaffolding (dual function), 
pseudo-kinases’ function is independent from catalysis [33, 196]. To date, approximately 
10% of the 518 members of the mammalian kinases have been identified as pseudo-
kinases, with reduced or completely obliterated ability to catalyze phoshoryl transfer [32, 
33]. Recent site-directed mutagenesis studies suggest that it is possible to uncouple the 
canonical from the non-canonical function of kinases [36, 95, 197]. Also, it has been 
found that small molecules that inhibit kinase phosphorylation in vitro are able to activate 
kinase pathways in cell [35, 198, 199]. The latter suggests that kinases depleted of their 
catalytic functions still work as scaffolds and play an active role in cell signaling. 
Therefore, uncoupling canonical and non-canonical functions of protein kinases with 
small molecules would enable one to achieve a higher level of control over the kinase-
mediated signaling pathways [32].  
Although substantial progress has been made for the development of allosteric 
inhibitors [200-202], small molecules that bind the ATP binding site (ATP-competitive 
inhibitors) remain the most common kinase inhibitors [203]. However, none of these 
drugs have been engineered to uncouple the dual functions of kinases, rendering them 
either pseudo-kinases (devoid of catalytic activity) or dead kinases (non-catalytic and 
non-scaffolding). So, how can we uncouple canonical and non-canonical kinase 
functions? Since allosteric binding cooperativity (K-type cooperativity, i.e., nucleotide 
binding affects substrate affinity) is a hallmark for several kinases [44, 143], we 
reasoned that by modulating the chemical moieties of nucleotides and nucleotide-
analogs it would be possible to control allosteric binding cooperativity. The latter will 
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make it possible to design inhibitors able to steer kinases’ function toward pseudo-
kinases or dead kinases.  
As a model system, we chose the catalytic subunit of the cAMP-dependent protein 
kinase A (PKA-C). This enzyme is one of the most studied and has represented the 
benchmark for the entire kinase family [14]. PKA-C is organized into two lobes, an N-
terminal small lobe with 5 -strands and one helix (C helix), and a C-terminal large lobe 
mostly helical that harbors the substrate binding cleft [8] (Figure 4.1A). The nucleotide 
(ATP) binds at a critical junction of the kinase core, which is embedded between the 
small and large lobes [8]. Through coordination of two Mg2+ ions, the nucleotide 
positions several amino acids from various catalytic motifs such as the DFG loop, 
glycine-rich loop, and catalytic loop for phosphoryl transfer (Figure 4.1C) [93]. 
Structurally, the nucleotide’s adenine ring completes the architecture of the catalytic 
spine (C-spine), an array of hydrophobic residues that play a key role in intramolecular 
allosteric signaling and kinase activation [23]. The substrate binds the C-lobe, laying on 
the peptide positioning loop, which provides high-binding affinity for registering the 
recognition sequence. It has been hypothesized that ATP acts as an allosteric effector 
priming the kinase structure for substrate binding [23, 41, 204]. The dynamic apo 
enzyme toggles between three major conformational states along the free energy 
reaction coordinate (open, intermediate, and closed, Figure 4.1B). ATP binding shifts 
the enzyme conformational ensemble from an open to an intermediate state, increasing 
substrate affinity through a K-type binding cooperativity [205-207]. Binding of substrate 
further shifts the ensemble toward the enzyme’s closed state. In spite of a plethora of 
structural [14] and biophysical data [208], it is still unclear how the different chemical 
moieties of ATP confer positive K-type cooperativity for substrates. 
By combining isothermal titration calorimetry (ITC) with NMR spectroscopy we 
show how small molecules (nucleotides or small molecule inhibitors, Figure 4.1D) are 
able to modulate the degree of the binding cooperativity for the pseudo-substrate 
peptide derived from the endogenous protein kinase inhibitor (PKI5-24). For the nucleotide 
analogs, we found a linear correlation between the degree of cooperativity and the 
population of the closed state of the enzyme. The highest degree of cooperativity is 
reached with ATP, where the phosphate groups pre-organize the active site for 
phosphoryl transfer and prime the substrate binding site for high binding affinity 
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(catalytically competent state). The degree of cooperativity is substantially reduced for 
ATPN and completely abrogated for ATPC. In addition, ATPC drastically decreases 
the binding affinity of PKA-C for phospholamban, a natural substrate of this kinase in the 
heart muscle. For H89 and balanol, two chemically different ATP-competitive inhibitors 
of PKA-C, we found negative and positive binding cooperativity, respectively. These 
results demonstrate that it is possible to modulate substrate binding cooperativity by 
changing the chemical nature of small molecule inhibitors that can decouple the dual 
functions of kinases, opening new directions for manipulating protein kinases functions 
in a specific manner. 
 
 
Figure 4.1. Three-dimensional fold and conformational states of PKA-C. 
(A) Ribbon diagram of the catalytic subunit of protein kinase A (PDB: 1ATP) shown with the C-spine scaffold 
(yellow surface), sandwiching the adenine moiety of ATP, and the peptide fragment of the heat stable 
protein kinase inhibitor (PKI5-24). (B) Overlay of the glycine-rich loop of the open (PDB: 1J3H), intermediate 
(PDB:1BKX) and closed (PDB:1ATP) forms of PKA-C. (C). Electrostatic and hydrophobic contacts with ATP 
deduced from the 1ATP structure of PKA-C. (D) Chemical structures of the nucleotide analogues used in 
this study. 
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4.3 Results  
Different nucleotides provide varying degree of binding cooperativity.  
To measure substrate binding cooperativity of PKA-C, we utilized ITC to measure 
the binding affinity of PKA-C for the heat stable protein kinase A inhibitor peptide (PKI5-
24). Since PKI5-24 contains the substrate recognition motif for PKA-C (with Arg residues 
on the P-2 and P-3 positions and an Ala instead of a Ser at the P-site), it is considered a 
pseudo-substrate[14], recapitulating the high binding affinity of the R-subunits[8, 9, 41, 
209]. The degree of binding cooperativity between PKI5-24 and the nucleotide was 
assessed by saturating the kinase with a series of nucleotide analogs: adenine, 
adenosine, AMP, ADP, ATPγN, ATPγC, and ATP (Figure 4.2-4.4). Under the time scale 
of our experiments, we did not detect any hydrolysis of ATPN, which has been detected 
in the crystallized PKA-C/ATPN/SP20 complex (SP20 is a substrate peptide derived 
from PKI5-24 with Asn20Ala and Ala21Ser mutations [124]). The different nucleotides 
were chosen to dissect the contribution of each chemical moiety (i.e., adenine ring, 
ribose, and phosphates) to the K-type cooperativity. All of these nucleotides display very 
similar binding affinities for the enzyme [43, 210, 211], with Kd values between 20-50 
M. Note that under our experimental conditions, two Mg2+ ions occupy the binding site, 
which are required for the high binding affinity of PKI5-24 [212]. To quantify the extent of 
cooperativity, the binding thermodynamics were interpreted using a classical 
heterotropic linkage model (Figure 4.2A), where the binding of one ligand enhances or 
reduces the affinity of the second ligand. The degree of cooperativity (σ), which is 
independent of the order of ligand binding, quantifies the extent of K-type cooperativity 
[44, 213]. Saturation with most nucleotides increases the binding affinity toward PKI5-24. 
The highest affinity and degree of cooperativity (= 400) was measured for ATP. 
Specifically, we found a gradual increase of affinity of PKI5-24 and binding cooperativity 
for the following series: adenine < adenosine < ADP < ATPN << ATP (Figure 4.2B). 
These data indicate that the adenine ring, the ribose and the three phosphates 
contribute incrementally to the enzyme’s binding affinity for PKI5-24. As previously 
observed [210], the adenine moiety (Figures 4.2-4.4, and Table 4.1) is especially 
important for the binding affinity, since its ring, sandwiched between residues Val57 in 
the N-Lobe and Leu173 in the C-Lobe, is stabilized by hydrophobic interactions. The 
  89 
ribose moiety and phosphate groups further increase PKI5-24 binding affinity, with a 
significant increase in cooperativity correlated with the number of phosphate groups. 
Notice that the affinity of the pseudo-substrate peptide is much greater when the enzyme 
is bound to ATP than ADP, indicating that ADP facilitates the exit of the enzymatic 
product. An anomalous behavior is observed for AMP, which has been shown to have a 
lower binding affinity for PKA compared to other nucleotide analogs [210]. In agreement 
with these previous data, we found a substantially weaker affinity with AMP (Kd ~ 250 
M). These binding experiments were repeated at higher AMP concentrations to 
saturate the kinase; however, we did not observe significant changes in the pseudo-
substrate affinity (Figure 4.5). Since the structure of the kinase in complex with AMP is 
not available, we speculate that the absence of the  and  phosphates prevents the 
closure of the binding cleft, reducing the affinity for the substrate. Interestingly, two non-
hydrolysable nucleotide mimics that are commonly used for structural studies, ATPN 
and ATPC, show a decrease in PKI5-24 binding cooperativity. In fact, the presence of a 
nitrogen atom in place of oxygen at the  position of the ATP phosphoester dramatically 
reduces the binding cooperativity (σ = 53). This phenomenon is accentuated for ATPγC, 
where a methylene group replaces the bridging oxygen. In this case, the binding 
cooperativity between the non-hydrolysable nucleotide and pseudo-substrate is 
completely abolished (σ = 1.0).  
 
 
Figure 4.2. Binding cooperativity between nucleotide and pseudo-substrate. 
(A) Two-state heterotropic linkage model for nucleotide and pseudo-substrate binding. CB) Plot of the Kd of 
PKI5-24 to PKA-C in the presence of various nucleotides (See also Figures 4.9-4.12). 
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Figure 4.3.  The ITC isotherms and their fits of PKI5-24 titrating to PKA-C under different nucleotide 
saturating conditions (2 mM). 
(related to Figure 4.2) 
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Figure 4.4. Full thermodynamic profile of PKI5-24 binding in the presence of various nucleotides. 
The entropic contribution was calculated as described in the methods section. (related to Figure 4.2) 
 
 
 
Figure 4.5. ITC isotherm of AMP binding to PKA-C and PKI5-24 binding at 6 mM AMP. 
(A) ITC isotherm of AMP binding to PKA-C. A Kd value of 250 ± 57 M was found. (B) ITC isotherm of 
PKI5-24 binding at 6 mM AMP. Fit to a single-site binding model gave a Kd value of 6.2 M (related to 
Figure 4.2). 
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Note that some of the binding isotherms (See also Figure 4.3, 4.14) do not have a sharp inflection point and 
the H and S terms are less reliable. 
 
 Kd (M)  ΔG 
(kcal/mol) 
ΔH 
(kcal/mol) 
TΔS 
(kcal/mol) 
Apo 6.4 ± 0.56 1 -7.14 ± 0.05 -22.03 ± 0.63 -14.90 ± 0.68 
ATPC 6.1 ± 0.27 1.0 -7.17 ± 0.02 -13.61 ± 0.36 -6.43 ± 0.38 
AMP 5.7 ± 0.18 1.1 -7.20 ± 0.02 -20.17 ± 0.07 -12.97 ± 0.08 
Adenine 1.5 ± 0.03 4.3 -8.00 ± 0.01 -19.43 ± 0.16 -11.43 ± 0.18 
Adenosine 0.53 ± 0.02 12 -8.63 ± 0.02 -21.32 ± 0.18 -12.69 ± 0.20 
ADP 0.23 ± 0.0097 29 -9.13 ± 0.03 -17.67 ± 0.35 -8.54 ± 0.37 
ATPN 0.12 ± 0.0050 53 -9.49 ± 0.02 -18.12 ± 0.27 -8.64 ± 0.30 
ATP 0.016 ± 
0.0019 
400 -10.72 ± 0.07 -11.90 ± 0.34 -1.17 ± 0.38 
 
 
ATPC prevents substrate binding. 
To further understand the role of the bridging oxygen of the  and  phosphates 
on the binding cooperativity of more realistic substrates that display much lower affinity 
than the pseudo-substrate, we utilized a 19-amino acid peptide corresponding to the 
cytoplasmic domain of phospholamban (PLN1-19), a signaling target for PKA-C that 
regulates cardiac contractility [40, 214, 215]. Although phospholamban contains a 
transmembrane domain, the cytoplasmic domain alone is recognized and 
phosphorylated by PKA-C [214]. Remarkably, the binding titrations carried out in the 
presence of saturating concentration of ATPC showed a dramatic reduction of the 
binding affinity. Previous binding studies show that the dissociation constant of PLN1-19 in 
the ternary complex PKA-C/ATPN/ PLN1-19 is approximately 28 μM [122]. In stark 
contrast, for the PKA-C/ATPC complex the PLN1-19 peptide has a Kd > 1 mM (Figure 
4.6A). Accordingly, NMR titrations of the PLN1-19 peptide on the PKA-C/ATPC complex 
do not show any detectable chemical shift changes in both the amide and methyl group 
Table 4.1. The affinity, degree of cooperativity (), and thermodynamics of PKI5-24 binding with 
respect to the kinase saturated with the nucleotide determined from ITC. 
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fingerprints (Figure 4.6B). Although PLN1-19 and PKI5-24 share the same recognition 
sequence, PKI5-24 contains a high affinity region [209] that is not found in other 
substrates. Both ITC and NMR titrations indicate that the loss of binding affinity by 
ATPC observed in the pseudo-substrate is not only confirmed using PLN1-19, but is 
accentuated with natural substrates. 
 
 
Figure 4.6.  ATPC abrogates native substrate binding. 
(A) ITC isotherm of PLN1-19 binding to ATPC saturated PKA-C. (B) Overlay of [1H,15N]-TROSY-HSQC 
spectra of the complexes PKA-C/ATPγC (green) and PKA-C/ATPγC/PLN1-19 (red) showing no detectable 
chemical shift changes (related to Figure 4.2). 
 
Linkage between structural transitions and binding cooperativity. 
To probe the conformational transitions of the enzyme with the different 
nucleotides, we mapped the enzyme’s amide fingerprint using [1H,15N]-TROSY-HSQC 
experiments [118] as the amide chemical shifts are sensitive reporters of allosteric 
transitions (Figure 4.7) [104, 125, 216]. Although previous crystallographic structures of 
these complexes were reported to be identical [14], small changes in chemical shifts 
have been demonstrated to report on subtle changes in conformation and allostery [105, 
106, 217]. Resonance assignments for the different free and ligated states of the kinase 
were previously obtained using triple-resonance experiments [122] and transferred to the 
spectra of the kinase saturated with the different nucleotides, as well as in the ternary 
complexes. We found that the addition of the pseudo-substrate to nucleotide-saturated 
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PKA-C shifts the amide resonances of the enzyme along linear chemical shift 
trajectories (Figure 4.8A). This indicates that the enzyme predominately interconverts 
between two states and pseudo-substrate binding shifts the populations of the enzyme 
toward the closed state to different extents. 
 
 
Figure 4.7. 1H-15N TROSY-HSQC of all the binary (PKA-C and PKI5-24) and ternary complexes of PKA-
C with PKI5-24. 
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Figure 4.8. CONCISE analysis of the chemical shift changes with nucleotide. 
(A) [1H,15N]-TROSY-HSQC spectra showing the backbone amide chemical shift changes of PKA-C 
saturated with different nucleotides upon binding PKI5-24 (See also Figures 4.13, 4.14 and 4.16) (B) Residues 
following linear trajectories (blue spheres) plotted on the cartoon representation of the PKA-C crystal 
structure (PDB: 1ATP). 
 
A succinct view of the process is offered by the analysis of the amide chemical 
shifts using CONCISE [125], a statistical approach that utilizes principal component 
analysis to quantify the global coordinated response of the amide chemical shifts upon 
ligand binding. This method identifies the predominant linear trajectory of all the 
chemical shifts and the aggregate amide chemical shifts for each state is grouped 
together by their average position along the linear trajectory (PC score). These changes 
are displayed as probability density distributions defining a specific conformational state 
of the kinase along the conformational equilibrium [125]. The chemical shifts of each of 
the three major conformational states (open, intermediate, and closed) were previously 
defined by performing triple resonance experiments to assign the backbone chemical 
shifts or the apo, nucleotide bound and PKI bound forms of the enzyme [122]. Addition 
of PKI5-24 to all of the nucleotide-bound forms of the kinase shifts the conformational 
equilibrium toward the closed state (Figures 4.8, 4.9, and Table 4.2 and 4.3), reflected 
in the higher PC score from CONCISE, but to different degrees (Figure 4.10). In 
particular, a gradual shift of the probability density distributions of the amide chemical 
shifts is apparent going from adenine, adenosine, and ADP up to ATP, indicating that the 
presence of the ribose and the increased number of phosphates gradually shifts the 
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conformational equilibrium toward the kinase closed state. To link the binding 
thermodynamics of PKI5-24 with the conformational transition, we first compared the free 
energy of binding of PKI5-24 under saturating conditions of nucleotide with the PC score 
(Figure 4.11) and did not find a firm correlation. However, a comparison between the 
free energy of binding for PKI5-24 and the PC score of the enzyme’s ternary complexes 
with PKI5-24 (Figure 4.12B) shows a linear correlation between the extent of the closed 
state and the free energy of binding (|R| = 0.95, Figure 4.12B), indicating that the 
degree of cooperativity of substrate binding strongly depends on the extent of the closed 
state. 
 
 
Figure 4.9.  Linear chemical shift trajectories of PKA-C. 
(A) Linear chemical shift trajectories that either have some states missing or demonstrate some deviation 
around the linear trajectory due to local chemical changes. (B) Trajectory for the Open, Intermediate and 
Closed state in PKA-C (related to Figure 4.3 and 4.5). 
 
  
8 16 17 35 37 44 58 62 97 117 
143 144 155 177 191 192 193 206 208 213 
214 220 226 241 245 249 256 265 274 315 
322 323 331 337 338 348     
 
  
Table 4.2. List of residues that defined linear trajectories for the 12 states analyzed with CONCISE. 
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Figure 4.10. CONCISE analysis of the 1H-15N TROSY-HSQC of all the binary (PKA-C and PKI5-24) and 
ternary complexes of PKA-C with PKI5-24. 
 
Table 4.3. PCA and standard deviation of the CONCISE analysis of all ten structural states.  
  
PCA 1 
 
Standard Deviation 
Apo 
 
-2.14 
 
0.68 
ATPγN 
 
-0.96 
 
0.81 
AMP/PKI5-24  -0.01  0.48 
ATPγC/PKI5-24  0.19  0.43 
Apo/PKI5-24 
 
0.03 
 
0.49 
Adenine/PKI5-24 
 
0.38 
 
0.48 
Adenosine/PKI5-24  0.48  0.62 
ADP/PKI5-24  0.52  0.49 
ATPγN/PKI5-24  0.64  0.59 
ATP/PKI5-24  0.77  0.66 
H89/PKI5-24  0.05  0.96 
Balanol/PKI5-24  0.04  0.78 
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Figure 4.11.  CONCISE analysis performed on the nucleotide bound states of PKA-C (without PKI5-24) 
and a comparison of the PC score of the nucleotide bound states with the cooperativity of PKI5-24 
binding. 
 
 
 
Figure 4.12. Chemical Shift Trajectories with Nucleotides and ATP-competitive inhibitors. 
(A) [1H,15N]-TROSY-HSQC spectra showing the backbone amide chemical shift changes of PKA-C 
saturated with different ATP-competitive inhibits and nucleotides upon binding PKI5-24. (B) Linear correlation 
between PC1 score and degree of cooperativity of the aggregate chemical shifts including the ATP-
competitive inhibitors (see also Figures 4.7, 4.9-4.11 and Table 4.2-4.3). 
 
The CONCISE analysis yields insights into the global opening and closing 
transitions following only those residues with linear trajectories. Therefore, we followed 
the chemical shift trajectories of the Ile, Val, and Leu methyl groups. Methyl group 
chemical shifts also report on allosteric networks particularly in large proteins [164, 218, 
219]. Upon ligand binding most of the methyl group chemical shifts follow predominately 
linear trajectories along the open to close conformational states, reporting on a two state 
equilibrium in the fast exchange regime (Figure 4.13). However, several methyl groups 
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in the PKA-C/ATPC/PKI5-24 complex located near the binding site as well as in distal 
regions follow non-linear chemical shift trajectories, with many resonances exhibiting 
substantial line broadening even at ligand saturation conditions. These features suggest 
that ATPC shifts the enzyme into another conformational state that is outside the open-
to-closed reaction coordinates traceable with the other nucleotides and that binds 
substrates with lower affinity. 
 
 
Figure 4.13. Effects of the ligand binding on the kinase side chains. 
Methyl-TROSY spectra of 13C methyl-labeled PKA-C saturated with different nucleotides. Most of the 
resonances follow linear chemical shift trajectories. Several resonances for ATPC do not lay the shared 
linear trajectory 
 
ATP-competitive inhibitors exhibit positive and negative cooperativity. 
To understand the allosteric response of commonly used high affinity ATP-
competitive inhibitors, we analyzed the binding cooperativity of H89 and balanol (Table 
4.4 and Figure 4.14). H89 is an isoquinoline sulfonamide-based inhibitor designed to 
achieve higher selectivity for PKA-C and is commonly used to block PKA-C activity in 
cells [220]. Balanol is a natural occurring small molecule isolated from Verticillium 
balanoides with high inhibitory potency for PKC [221] and PKA-C [222]. We found that 
balanol displays a positive cooperativity ( = 7.0) for PKI5-24. In contrast, H89, displays 
negative binding cooperativity ( = 0.55). Our ITC results reveal that high affinity ATP-
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competitive inhibitors can modulate allosteric binding cooperativity in a manner similar to 
the nucleotides. 
 
 
Figure 4.14. Binding cooperativity between ATP-competitive inhibitors and pseudo-substrate. 
(A) ITC isotherms for PKI5-24 binding to PKA-C saturated with Balanol (left), and H89 (right). (B) Plot of the 
Kd of PKI5-24 to PKA-C in the presence and absence of ATP-competitive inhibitors. (C) Structure of PKA-C 
with balanol (PDB:1BX6, orange) and H89 (PDB: 1YDT, blue) with key electrostatic interactions. 
 
 Kd (M)  ΔG 
(kcal/mol) 
ΔH 
(kcal/mol) 
TΔS 
(kcal/mol) 
Balanol 0.92 ± 0.13 7.0 -8.30 ± 0.09 -16.14 ± 0.56 -7.83 ± 0.65 
H89 11.2 ± 0.75 0.57 -6.81 ± 0.04 -18.46 ± 0.62 -11.65 ± 0.60 
 
 
Table 4.4. The affinity, degree of cooperativity (), and thermodynamics of PKI5-24 binding with 
respect to the kinase saturated with the ATP-competitive inhibitor determined from ITC. 
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To map the conformational state of PKA-C complexes with H89 or balanol and 
the pseudo-substrate PKI5-24, we used [1H,15N]-TROSY-HSQC experiments and 
performed similar analysis (Figure 4.12). Several residues of the amide backbone 
followed linear trajectories along the two-state equilibrium. Several other residues, 
however, showed marked deviations from these trends and were excluded from the 
CONCISE analysis (Figures 4.12 and 4.17). Many of these non-linear trajectories result 
in the unique chemical environment around each ligand and not accurately report on the 
global conformational transition [106]. The probability distribution curves show that these 
ternary complexes are only partially closed and occupy intermediate position in the 
conformational equilibrium. When plotted as a function of the degree of binding 
cooperativity, the ternary complex with H89 falls within the linear correlation, displaying 
negative cooperativity, while the ternary complex with balanol, which shows a positive 
binding cooperativity, deviates from this relationship (Figure 4.12B).  Although balanol 
shows cooperativity with pseudo-substrate binding, it fails to drive the entire enzyme 
toward a substrate competent state as in the case of ATP.  
Analysis of the crystal structures and the NMR spectral signatures of the binary 
complexes with H89 and balanol explain the differences between their cooperative 
behaviors. The hydroxybenzophenone moiety together with the ester linkage of balanol 
form several hydrogen bonds with residues in the Gly-rich loop, i.e., Val57, Gly55, 
Phe54, Ser53, and Gly52, as well as the side chain groups of the conserved ion pair 
Lys72 and Glu91, and Asp184 (a residue in the DFG loop), while the bromocinnamoyl 
group of H89 does not make such electrostatic interactions (Figure 4.14C). This 
electrostatic interactions from balanol enable the Gly-rich loop to be clamped down and 
be coupled to the residues in the C-helix and large lobe. The NMR spectra show that, 
while both inhibitors caused apparent chemical shift changes in the small lobe, hinge 
and C-terminal residues, balanol perturbs the chemical shifts of the residues in the 
catalytically important motifs more significantly than H89 (Figures 4.15 and 4.16). These 
residues include Gly186, Ala188 (DFG loop), Thr197 (activation loop) and Glu203 
(residue in the peptide positioning loop which interacts with the P-6 Arg). This allosteric 
interaction between the residues in the small lobe and substrate binding site may be 
responsible for the observed contrasting cooperativity effect with the two ATP-
competitive inhibitors. 
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Figure 4.15. Chemical Shift Changes in the Active Site. 
(A) [1H,15N]-TROSY-HSQC spectra of the backbone chemical shifts of active site residues in PKA-C. In the 
ATPN bound state, many of these resonances experience exchange so they are unobservable (dotted 
circle). (B) Significant chemical shift changes upon binding of balanol and H89. Note that balanol induces 
more significant chemical shift changes in the active site compared to H89. 
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Figure 4.16.  Chemical shift perturbation of PKA upon balanol or H89 binding. 
 
 
 
Figure 4.17.  Residues of PKA-C that do not follow the open to closed linear trajectory upon ATP-
competitive inhibitor binding.  
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4.4 Discussion 
Although it has been known that PKA-C exhibits K-type allosteric cooperativity [44, 
223], this work illuminates the structural basis for this phenomenon. The correlation we 
found between the conformational state of the ternary complex and the free energy of 
binding for the pseudo-substrate has many implications for kinase substrate recognition 
and function. The nucleotide emerges not only as carrier of the phosphate group for 
chemistry at the active site, but also having a structural role for mediating allosteric 
binding cooperativity. Importantly, high binding affinity of the substrate and pseudo-
substrate can only be achieved when the appropriate nucleotide brings together the 
small and the large lobes, shifting the population of the enzyme toward the intermediate 
state [125], pre-organizing the active site such that it is complementary for substrate 
binding and enabling the ternary complex to reach a catalytically competent state [224, 
225]. This conformational transition is most closely obtained with native substrates and 
ATP, leading to the most favorable free energy of binding. Removal of the β- and -
phosphate or ribose does not significantly alter the nucleotide binding affinity, but results 
in an enzyme conformation progressively less complementary for substrate binding.  
Interestingly, for both AMP and ATPγC, they did not fall within the linear 
relationship between free energy of pseudo-substrate binding and extent of the closed 
state, showing that these nucleotides do not exhibit positive K-type cooperativity 
(Figures 4.2B and 4.12). Not only AMP has a lower binding affinity, but it is also unable 
to drive the conformation of the glycine-rich loop in a competent state, abrogating 
binding cooperativity. Interestingly, the non-hydrolysable nucleotide mimic ATPC has a 
similar effect (Figure 4.2). Our data could be explained by comparing the crystal 
structures of the kinase in the presence of SP20 and ATPC (PDB entry 4IAC[226]) with 
that in complex with PKI5-24 and ATP (PDB entry 1ATP). Overall, the backbone 
structures of the two complexes are identical. However, in the 4IAC structure ATPC 
does not interact with the backbone amide groups of Phe54 and Gly55, preventing the 
glycine-rich loop from closing and resulting in a more open conformation (Figure 4.18). 
Furthermore, in the presence of ATPγC, the second Mg2+ ion adopts a bi-pyramidal 
coordination geometry rather than the octahedral geometry found with both ATP and 
ATPγN [226]. Therefore, the coordination of the metal ion plays a key role in positioning 
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the -phosphate and the substrate for productive phosphoryl transfer. Moreover, the 
chemical shifts of the methyl groups suggest that the ternary complex PKA-
C/ATPC/PKI5-24 occupies a different state in the conformational landscape of the 
enzyme, with a loss of binding cooperativity for the pseudosubstrate and complete 
obliteration of binding for phospholamban. Although all chemical moieties are important 
for binding cooperativity, our data underscore the central role of the oxygen atom 
bridging the  and  phosphate. Structurally, this atom provides the coordination 
geometry for the second Mg2+ ion, clamping down the glycine-rich loop and shifting the 
conformational equilibria for the formation of a productive ternary complex with 
substrates. In fact, the degree of cooperativity is significantly attenuated when nitrogen 
replaces the oxygen (ATPN). The latter was also predicted but not proven in the 
published work by Walsh and coworkers [227]. If the degree of cooperativity is 
attenuated by the substitution of the oxygen with nitrogen (ATPN), it is completely lost 
with ATPγC, a widely used non-hydrolysable ATP analog for both kinases and ATPases 
[228]. In the case of PKA-C, this compound appears to prevent the formation of a 
catalytically competent complex with endogenous substrates. 
  
 
Figure 4.18.  Structure of the glycine rich loop of PKA-C/ATP/PKI5-24 and PKA-C/ATPγC/PKS5-24. 
PKA-C/ATP/PKI5-24 (PDB:1ATP, white) and PKA-C/ATPγC/PKS5-24 (PDB: 4IAC, blue) 
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Based on the above considerations, we conclude that the oxygen bridging the  
and  phosphate is a hot spot for modulating binding cooperativity. By changing the 
chemistry around this hot spot, it is possible to convert a kinase into a completely dead 
kinase abrogating both its canonical and non-canonical functions. These results may 
have important implications in the design of new inhibitors of kinases. It is possible to 
anticipate that newly designed inhibitors may be directed to either the catalytic function 
(i.e., phosphoryl transfer) or both catalytic and binding functions. In the former case, the 
kinase would still function as a pseudo-kinase preserving its signaling role as scaffolds, 
anchors, spatial modulators, traps, and ligand-driven regulators of canonical kinases [36, 
196]. In fact this case has previously been observed with small molecular inhibitors of 
RAF kinase, activating kinase signaling pathways in a dose dependent manner [35, 199] 
or in the more recent finding that ATP-competitive inhibitors can block protein kinase 
recruitments to the Hsp90-Cdc37 system[229]. In the latter case, the kinase would be 
totally dead and removed from its signaling pathways (Figure 4.19). Mutations have 
been reported to convert active kinases into pseudo-kinases, preserving their non-
catalytic functions [95, 197]. In the case of PKA-C, residual catalytic activity enables 
yeast to survive[230]. On the other hand, a catalytically dead PKA-C fails to be 
autophosphorylated, but it can still bind ATP as well as the regulatory subunits and is 
recognized and phosphorylated by PDK-1 [197]. Another notable case is with a mutation 
that fuses the C-spine, blocks ATP binding and allows for dimerization of RAF kinase 
domains [36]. ATPC renders the kinase dead, abolishing both catalysis and binding of 
substrates, despite assembly of the C-spine.  
In fact, widely used ATP-competitive inhibitors such as balanol and H89 are able 
to render PKA-C a pseudo-kinase and a dead kinase, respectively. Although both 
inhibitors contain aromatic rings that intercalate with the C spine residues, balanol 
possesses several polar groups that form hydrogen bonds with side-chain groups critical 
for substrate recognition and catalysis, including the conserved Lys72 and Glu91 in the 
active site [231], the conserved Asp184 in the DFG loop, and the Gly-rich loop. H89 
lacks these hydrophilic groups and the interaction within the binding site is almost 
exclusively through hydrophobic contacts. The polar interactions in balanol bring down 
the Gly-rich loop in a quasi-competent state. This is further supported by the crystal 
structure where the Gly-rich loop in the H89-bound complex is directed away from the 
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catalytic loop, resulting in the loss of interaction between the pseudosubstrate and the 
Gly-rich loop, resulting in a negative cooperativity. In the committed complex, the 
movement of the Gly-rich loop coordinated by the nucleotide corresponds to allosteric 
rearrangements of the residues in the substrate binding site [40, 44]. Interestingly, both 
balanol and H89’s electrostatic interactions with the critical Mg2+ ion are not observed in 
the X-ray structures. Future design of inhibitors exploiting the hot spot for binding 
cooperativity may lead to greater control of kinase function in vivo and tune the kinase 
binding cooperativity. 
In a recent work on Src kinase, Foda et al. show a negative binding cooperativity 
between ATP and substrates [232]; while a positive cooperativity was measured for ADP 
and phosphorylated substrate. These authors found that the negative cooperativity is 
mediated by an allosteric network of contacts initiated by a protonation event occurring 
at the DFG loop [232]. This contrasts the positive K-type binding cooperativity found for 
PKA-C [44], where a high degree of cooperativity was observed for ATP with the 
endogenous protein kinase inhibitor (PKI), regulatory subunits (R-subunits) [46], and 
substrates [122]. These findings suggest that the mechanism for cooperativity is not 
uniform throughout the kinome and that cooperativity hot spots may become a target for 
designing inhibitors able to fine-tune specific signaling pathways. 
In conclusion, our study identifies a hot spot for tuning binding cooperativity and 
decoupling canonical and non-canonical functions in kinases, introducing the concept of 
a possible higher level of control achievable by high affinity competitive inhibitors. By 
modulating the extent of closure of the Gly-rich loop, newly designed kinase inhibitors 
would then be able to convert a kinase into a pseudokinase, i.e., creating a scaffold that 
it is still involved in signaling, or alternatively, subtract kinases from their signaling 
pathways altogether, impairing both enzymatic activity and substrate binding (dead 
kinases) [32, 196]. 
 
 
 
 
 
  108 
 
Figure 4.19. Uncoupling canonical and non-canonical function of kinases. 
The apo enzyme (blue) displays both disassembled C spine and disengaged Gly-loop. Binding of non-
hydrolyzable ATP analogs or good ATP mimic drug inhibitors (i.e., able to engage Gly-rich loop via 
coordination of Mg2+ ion) produce a pseudokinase that is unable to carry out phosphoryl transfer but is able 
to bind substrates cooperatively (yellow). Binding of drug inhibitors that are unable to properly coordinate the 
Mg2+ ion to engage the Gly-loop (i.e., ATPC, H89, see also Figure 4.19) obliterates both catalytic and 
scaffolding function (dead kinase). 
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4.5 Experimental Procedures 
Adenosine 5’-triphosphate (ATP), adenosine 5’-monophosphate (AMP), γ-β-
methyleneadenosine 5’-triphosphate (ATPγC), adenine, and N-[2-(p-
bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H89) were purchased from 
Sigma Aldrich (St. Louis, MO, USA). Adenosine 5’-diphosphate (ADP) and adenosine 
were purchased from Research Products International (Mt. Prospect, IL, USA). 
Adenosine 5’-(β,γ-imido)triphosphate (ATPγN) was purchased from Roche Diagnostics 
(Indianapolis, IN, USA). Balanol was purchased from AnalytiCon Discovery, LLC 
(Rockville, MD, USA). 
 
Sample Preparation. Recombinant catalytic subunit of PKA was expressed in BL21 
(DE3) cells as previously described by Studier[171] at 24 °C. Purification of PKA-C was 
performed as previously described using the His6-RIIα(R213K)[168] subunit and a 
second purification step was performed using the HiTrap SP cation exchange column as 
previously described[183]. The most abundant isoform, corresponding to 
phosphorylation at S338, T197 and S10, was used for all experiments. Peptide synthesis 
was performed on a CEM Liberty microwave synthesizer as described previously[41]. 
Kinase activity was tested with a gel shift assay and quantified using A280 = 52060 M-
1cm-1. 
 
ITC measurements. All ITC measurements were performed with a Microcal VP-ITC 
instrument or TA NanoITC instrument at 300K. Samples were buffer exchanged into 20 
mM MOPS, 90 mM KCl, 10 mM DTT, 10 mM MgCl2, 1 mM NaN3, pH 6.5. Approximately 
1.7 mL of 11.4-32μM of PKA-C was used for each experiment and 280 µL of 140-350μM 
of PKI5-24 in the titrant syringe. For the AMP binding experiment 300 L of 238M of 
PKA-C was used with 50 L of 3.3mM of AMP. Final concentration of 2mM of nucleotide 
was used for nucleotide saturated experiments and a concentration of 50 M for the 
inhibitor saturated experiments. All experiments were performed in triplicate. The heat of 
dilution of the ligand to the buffer was taken into account by measuring the heat of 
dilution of the ligand to the buffer and was subtracted from the experiment accordingly. 
Binding was assumed to be 1:1 and was analyzed using the NanoAnalyze software (TA 
instruments New Castle, DE, USA),  with the Wiseman Isotherm [233]: 
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where the change of the total complex, d[MX] with respect to the change of the ligand 
concentration, d[Xtot] is dependent on r, the ratio of the Kd with respect to the total protein 
concentration, and Rm, the ratio between the total ligand and total protein concentration. 
The free energy of binding was determined using the following: 
 ln dG RT K    (4.2) 
where R is the universal gas constant and T is the temperature at measurement (300 K). 
The entropic contribution to binding was calculated using the following: 
   T S H G     (4.3) 
Calculations for the cooperativity constant (σ) were calculated as follows: 
 
,
, ,   
d Apo
d nucleotide d inhibitor
K
K or K
    (4.4) 
where Kd,Apo is the Kd of PKI5-24 binding to the apo enzyme and Kd,nucleotide or Kd,inhibitor is 
the Kd of PKI5-24 to the nucleotide- or inhibitor-bound enzyme, respectively. 
NMR Experiments. Samples for 13C IVL 15N labeled PKA-C were expressed and purified 
as previously described[44, 183]. Effective final sample concentrations were 0.2-0.25 
mM in 20 mM KH2PO4, 90 mM KCl, 10 mM DTT, 10 mM MgCl2 1 mM NaN3 at pH 6.5 
with 12 mM of nucleotide. Adenosine and adenine lack solubility in aqueous solution and 
concentrations of 10 mM and 6mM respectively were used. For ATP-competitive 
inhibitors concentrations of 0.8 mM of Balanol and 3 mM of H89 were used. Samples 
with ATP and ATPN were performed with 60 mM MgCl2 for MgATP. Additions of 4, 8, 
12, 18, 24, and 32 μL of 4.0 mM of PKI5-24 were used for a minimum final two fold molar 
excess of ligand. NMR assignments on the apo, nucleotide bound (ATPγN) and ternary 
(ATPγN and PKI5-24) were carried out on an 850 MHz Bruker Avance III spectrometer 
and described elsewhere [234]. 1H-15N TROSY-HSQC experiments and 1H-13C HMQC 
experiments for nucleotide-bound PKA-C were carried out on a Varian Inova 600 MHz 
spectrometer equipped with a Cold HCN probe operating at 300 K. [1H-15N] TROSY-
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HSQC experiments of PKA-C with ATP-competitive inhibitors were performed on a 
Bruker Avance 700 MHz spectrometer equipped with a TXI probe. 
 
Analysis of Chemical Shift Perturbations. We employed the COordiNate ChemIcal 
Shift bEhavior (CONCISE)[125] method to monitor trajectories of chemical shifts and 
measure the change in equilibrium position associated with each PKA-C construct (apo, 
ATPγN, adenosine/PKI5-24, adenine/PKI5-24, Apo/PKI5-24, AMP/PKI5-24, ADP/PKI5-24, 
ATPγC/PKI5-24, ATPγN/PKI5-24, balanol/PKI5-24 and H89/PKI=). In short, through Principal 
Component Analysis (PCA), the method identifies a set of residues whose chemical 
shifts respond linearly to the conformational transition. Each one of these residues 
provides a measure of the equilibrium position for every PKA-C construct in form of 
scores along the first principal component. The equilibrium position for a given construct 
is given by the average of the PC-scores over all linear residues. To identify the residues 
whose chemical shifts follow a linear pattern, a threshold of 1.0 to 3.0 for the ratio of the 
standard deviations of PC1 over PC2 was used, and residues that were affected by 
chemical shifts perturbations below 0.05 ppm were also discarded (see [125]for details 
on the threshold calibration). After this threshold was applied, a total of 36 residues 
formed the subset that was used to trace the equilibrium position of each state (see 
Table 4.3-4.4). 
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5.1 Conspectus  
ATP-competitive compounds are the most potent drugs developed for protein kinases, 
and to date constitute the only clinically approved kinase inhibitors. By targeting the ATP 
binding pocket, these molecules block the catalytic or canonical function of kinases, 
preventing substrate phosphorylation. Paradoxically, a few ATP-competitive inhibitors 
activate down-stream kinase pathways in vivo through poorly understood mechanisms. 
Here, we utilized the catalytic subunit of cyclic AMP-dependent protein kinase (PKA-C) 
as a benchmark to determine how its inhibited forms recognize substrates. As the X-ray 
structures of the inhibited kinases are very similar, we analyzed the dynamic response of 
PKA-C upon binding to two high-affinity ATP competitive inhibitors, balanol and H89, 
and compared it with the nucleotide mimic, ATPN. When bound to either inhibitor, PKA-
C is still able to recognize the pseudo-substrate, PKI5-24, although with opposite K-type 
allosteric cooperativity. Multi-timescale NMR relaxation experiments show that balanol 
and H89 differentially alter the conformational landscape of the kinase, shifting the 
timescale of its motions and influencing the allosteric binding cooperativity. While both 
inhibitors attenuate the microsecond-millisecond timescale dynamics of the enzyme, 
balanol engages the two lobes, preserving the coordinated motions. Our results provide 
a new paradigm for exploring the chemical nature of ATP-competitive inhibitors, showing 
how they can differently modulate allosteric binding cooperativity and other non-catalytic 
functions. 
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5.2 Introduction 
 Eukaryotic protein kinases (EPKs) populate ~2% of the genome and control vital 
cellular processes such as development and differentiation, metabolism, and stress 
response by catalyzing the transfer of the -phosphate from ATP to serine, threonine, or 
tyrosine residues in their protein substrates[2].  Aberrant phosphorylation is linked to 
diseases such as cancer [235], autoimmune disorders [236], cardiac disease [6], and 
diabetes [7]. To date, there are at least 60 diseases associated with kinases, and this 
number is likely to increase, making protein kinases major drug targets [237-239]. 
Although allosteric drugs for kinases have been discovered [240], the majority of small 
molecules targeting kinases are ATP-competitive inhibitors (Type I or II). These 
molecules abolish the canonical or catalytic function of kinases by blocking the ATP-
binding site, and thus prevent phosphorylation of substrates [240]. Interestingly, several 
ATP-competitive inhibitors display paradoxical activation of kinase pathways in vivo 
[241]. Although inhibited, kinases can still participate in signaling pathways, suggesting 
these competitive inhibitors may induce alternative ways to control kinases’ signaling 
[32, 33, 196].  Specifically, how ATP-competitive inhibitors influence the substrate 
binding affinity remains unexplored. 
ATP-competitive inhibitors bind in a pocket located between the two lobes of the 
structurally conserved catalytic cores. This bilobal fold is preserved among EPKs and 
was first revealed when the structure of the catalytic subunit of PKA (PKA-C) was solved 
[8]. The small N-lobe includes a 5-stranded -sheet that controls nucleotide-binding and 
a highly conserved C-helix, whose positioning is dynamically regulated and crucial for 
active kinases [242]. The larger C-lobe is mostly -helical and includes the substrate-
binding site and the catalytic residues that are essential for phosphoryl transfer [14, 243]. 
Two stacks of hydrophobic residues, referred to as Regulatory (R)- and Catalytic (C)- 
spines, span the two lobes of the kinase core and are docked onto the F-helix in the C-
lobe [23, 31]. Other conserved structural elements include the linker region  and four 
loops (the Gly-rich, DFG, activation, and catalytic loops)[14]. ATP binding connects all of 
these elements and couples both lobes structurally and dynamically (Figure 5.1)[40, 41]. 
While phosphorylation of the activation loop typically contributes to assembly of the R-
spine, the adenine ring of ATP is necessary to complete the C-spine, intercalating 
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between A70 and Val57 in the N-lobe and L173 in the C-lobe, synchronizing the motions 
in the hydrophobic core, and linking the two lobes[244].  
 
 
Figure 5.1.  Architecture of the catalytic subunit of cAMP-dependent protein kinase A (PKA-C). 
A. The canonical kinase subdomains as identified by Hanks and Hunter [245] mapped onto the structure of 
PKA-C (PDB: 1ATP) B. The conserved hydrophobic core architecture of protein kinases as described by 
Kornev and Taylor [23] mapped onto the structure of PKA-C highlighting the C- spine (yellow), R-spine (red) 
and Shell (teal) residues (PDB ID: 1ATP) 
 
To understand how ATP-competitive inhibitors modulate the substrate binding 
cooperativity of kinases, we chose PKA-C as a benchmark and analyzed its binding 
response to balanol and H89, two high affinity ATP-competitive inhibitors widely used for 
studying both PKA and PKC signaling pathways [222, 246]. Balanol is a fungal 
metabolite from Verticillium balanoides [247], while H89 (or N-[2-(p-
bromocinnamylamino)ethyl]-5-isoquinoline sulfonamide) is a synthetic, H-series inhibitor 
used to study PKA signaling in cardiac and smooth muscle [248](Figure 5.2A).  Both 
balanol and H89 inhibit PKA-C with low nM affinity, i.e., Ki ~ 4 [247] and 48 nM [220], 
respectively, but surprisingly, they display opposite K-type cooperativity (𝜎 =
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𝐾𝐷𝑜𝑓 𝑃𝐾𝐼5−24𝑏𝑖𝑛𝑑𝑖𝑛𝑔 𝑡𝑜 𝐴𝑝𝑜𝑒𝑛𝑧𝑦𝑚𝑒
𝐾𝐷𝑜𝑓 𝑃𝐾𝐼5−24𝑏𝑖𝑛𝑑𝑖𝑛𝑔 𝑡𝑜 𝑖𝑛ℎ𝑖𝑏𝑖𝑡𝑜𝑟−𝑏𝑜𝑢𝑛𝑑 𝑒𝑛𝑧𝑦𝑚𝑒
) with respect to the pseudo-substrate, protein 
kinase inhibitor (PKI5-24), with a cooperativity value () of 7 for balanol, and 0.6 for H89 
[249]. As the X-ray structures of PKA-C/balanol and PKA-C/H89 are very similar (overall 
RMSD < 0.7 Å, Figure 5.2B) with significant differences only in the ATP binding pocket, 
we reasoned that the divergent cooperative behavior might correlate with the different 
conformational dynamics of the two complexes and the existence of alternate high-
energy conformational states. To test this hypothesis, we used multi-timescale NMR 
relaxation measurements (from ps to ms timescale) and compared the dynamic 
response of PKA-C to both balanol and H89 binding with that of the nucleotide. We 
found that these inhibitors alter the structural coupling between the two lobes of the 
kinase in a completely different manner. Notably, they differentially alter the kinase’s 
conformationally excited states responsible for the allosteric binding cooperativity, 
shifting the timescale of the enzyme’s motions. While in the previous paper, we reported 
the thermodynamics for the binding of pseudosubstrate to the inhibitor-bound kinase, 
here we present the underlying mechanism for the observed opposite K-type 
cooperativity. We conclude that the divergent cooperativity observed for these ATP-
competitive inhibitors is due to their different ability to steer the enzyme through energy 
basins of the conformational landscape that can be more or less committed to substrate 
binding. Our results suggest that it is possible to modulate the binding cooperativity of 
the kinases by tuning the chemical nature of the ATP-competitive inhibitor, introducing a 
new way to fine-tune kinase function. 
 
5.3 Results 
ATP-competitive inhibitors alter the structural coupling between the kinase’s 
lobes.  
To monitor the kinase’s structural response to the binding of balanol and H89, we 
mapped both the amide and methyl group fingerprints (Figure 5.3), obtaining the distinct 
signatures for competent and incompetent states of PKA-C [41]. A hallmark for the 
kinase’s competent (or committed) state (ATP-bound) is the dramatic broadening of the 
amide resonances associated with catalytically important loops such as the Gly-rich, 
DFG, activation and peptide-positioning loops, and the C-helix [43]. This is correlated 
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with increased conformational dynamics in the intermediate timescale[43, 44]. In 
contrast, we found that binding either balanol or H89 to the kinase did not cause any line 
broadening in the amide or methyl fingerprint resonances; rather they induce distinct 
chemical shift perturbations (CSPs) throughout the enzyme (Figures 5.4 and 5.5). While 
both inhibitors cause substantial CSPs involving amide residues in the Gly-rich loop, 
linker region, and C-terminal tail, balanolcaused appreciable chemical shift changes that 
are localized within the catalytically important loops: DFG (G186, A188), activation 
(T197), and P+1 loop (E203) (Figure 5.5). Balanol binding also affects the resonances in 
the methyl fingerprint, with pronounced changes throughout the hydrophobic core 
(Leu173, Leu95 and Val104) and the hydrophobic PIF binding pocket where the C-
terminal tail docks (Leu116, Val80). On the other hand, H89 binding perturbs mostly the 
side chains of the N-lobe and linker that line the binding site (I46, Val104, Leu106, 
Val123), with sparse long-range effects involving mostly L132 and I150 (Figures 5.5 
and 5.6). The CSPs for both inhibitors follow linear trajectories along the open-to-closed 
conformational equilibrium of the kinase, with the exception of a few resonances for the 
balanol-bound complex. To quantify the structural transitions of PKA-C/inhibitor 
complexes, we analyzed the coordinated behavior of the chemical shifts along the open-
to-closed conformational transition using apo, ADP-bound, ATPN/PLN1-19-bound and 
ATPN/PKI5-24-bound as reference states [125]. We found that on average the probability 
density of the fingerprint resonances for both balanol- and H89-bound complexes shifts 
toward an intermediate or nucleotide-bound state (Figure 5.7). This behavior is similar 
for both amide and methyl side chain resonances, indicating that the two lobes of the 
enzyme are close together upon binding these inhibitors in agreement with the X-ray 
structures [231, 250, 251]. To dissect the allosteric intramolecular network of 
communication, we performed covariance analysis on the CSPs [104]. Indeed, we 
noticed dramatic differences in the coordinated chemical shift changes of both amide 
and methyl resonances between nucleotide and inhibitors that report on the open-to-
closed transition of the kinase. In fact, ATPN binding causes globally coordinated 
changes of chemical shifts, with highly correlated residues across the N- and C- lobes 
(Figures 5.8 and 5.9). Specifically, the chemical shifts of the resonances associated 
with the A (residues 17-30), A-1 linker (residues 31-41), 4 and 5 (residues 107-
112, 117-119), activation loop (residues 190-96), APE motif (residues 206-210), E helix 
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(residues 142, 147-152), and the C-terminal tail (residues 314, 318, 322, 323, 331, 332, 
337, 348-350) show highly correlated changes (coefficients |rij | > 0.98). Interestingly, 
several correlations can also be observed between the N-lobe and the substrate binding 
cleft (activation loop, P+1, and APE) with both the F and G helices. The correlations 
found for the G helix are especially important, as this motif constitutes a docking site for 
many substrates and regulatory subunits. The extent of the network of correlated 
chemical shifts observed for the ATPN-bound kinase is largely underestimated, since 
several residues in the Gly-rich, C helix, activation loop etc. are broadened beyond 
detection and cannot be monitored. A similar scenario is found for the methyl groups 
resonances in the ATPN-bound, where extensive correlations cross the core of the 
enzyme, involving the C helix, activation loop, peptide-positioning loop, C-terminal tail, 
E, F, G, and H helices (Figures 5.8C-D, 5.12). However, the methyl groups of the 
ATPN-bound kinase are less affected by exchange broadening. The correlations found 
for the F helix support the structural role of this element in anchoring the hydrophobic 
spines to the large lobe, constituting a signaling conduit that couples the two lobes 
structurally [23]. Overall, we observe a remarkable number of correlations between the 
N- lobe and the activation loop, suggesting cross talk between the ATP binding pocket 
and the activation loop of the kinase, an allosteric communication recently identified for 
Src kinase as well [252]. In contrast, the number and the extent of the correlations are 
much lower in the inhibitor-bound complexes (Figures 5.8, 5.10-5.11). Although the 
activation loop in the balanol-bound complex preserves most of its correlations with the 
A helix, A-1 loop, and E helix, these correlations are no longer present in the H89-
bound complex (Figure 5.15). Analogously, in the inhibitor-bound complexes both the 
extent and the number of correlations for the methyl-bearing side chains from the ATP-
binding pocket to the peripheral regions of the kinase are dramatically attenuated, with 
H89 displaying the least number of correlations (Figures 5.8C-D, 5.13-5.14). These 
coordinated changes in the CSPs caused by the nucleotide binding between the 
hydrophobic core of the enzyme and peripheral catalytic motifs of the kinase emphasize 
the central role that both the C- and R- spines, and their neighboring residues[244], have 
in reaching a catalytically committed state with higher binding affinity for the substrate. 
While binding either ATP-competitive inhibitor disrupts this allosteric network, they do so 
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in different manner, with balanol having more persisting allosteric communication 
between the two lobes. 
 
 
Figure 5.2.  X-ray structure of PKA-C with ATP-competitive inhibitors. 
A. Chemical structures of balanol, H89, and ATP. The p-hydroxybenzamide group in balanol (or isoquinoline 
ring in H89) mimics the adenine moiety of ATP, the perhydroazepane ring in balanol (or sulfonamide in H89) 
occupies the ribose subsite, while the benzophenone group in balanol (or bromocinnamoyl group in H89) 
takes the place of the triphosphate of ATP. B. Overlay of the crystal structures of PKA-C when bound to 
balanol (green, PDB: 1BX6) or H89 and PKI5-24 (orange, PDB:1YDT) with an RMSD < 0.7 Å. C. Architecture 
of the hydrophobic core of PKA-C is identical when bound to balanol or H89: the C- and R- spines are 
rendered in yellow and red, respectively, the shell residues are reported in teal. 
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Figure 5.3.  Backbone and methyl side chain fingerprints of the inhibited kinase. 
(A) [1H,15N]-TROSY-HSQC spectrum of the amide fingerprints of PKA-C bound to balanol (green) or H89 
(gold). (B) [1H,13C]-TROSY-HMQC spectra showing of the corresponding methyl fingerprint of the Ile, Leu, 
and Val residues. 
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Figure 5.4.  Inhibitor bound complexes do not adopt a dynamically committed state. 
(A) Portions of the [1H,15N] TROSY-HSQC spectra showing the line broadening of several amide groups in 
the PKA-C/ATPN complex (bottom) and corresponding narrow resonances in the balanol (top) and H89 
(middle) complexes. (B) Corresponding portions of the [1H,13C] TROSY-HMQC spectra showing the methyl 
resonance fingerprints. As for the amide, several methyl resonances broaden out in the PKA-C/ATPN, but 
they are sharp for inhibitor bound complexes. (C) Mapping of the exchange broadened residues in the 1ATP 
structures. All of these residues become sharper in the inhibitor bound complex and include the A- linker, 
Gly-rich loop, hinge, catalytic loop, DFG loop, activation loop, P+1 loop, and C-terminal tail. 
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Figure 5.5.  Chemical shift perturbations of of PKA-C upon binding balanol and H89.  
Combined CSPs for (A) amide backbone and (B) methyl side chain resonances of PKA-C versus residue 
upon binding of balanol (green) or H89 (orange). The dashed line represents one standard deviation from 
the mean CSP. 
 
  123 
 
Figure 5.6.  Mapping of the 1H/13C combined CSPs of the balanol, H89, and ATPN states. 
 
 
Figure 5.7.  Probability densities of Inhibited states along the open to closed equilibrium. 
Comparison of the probability distributions for the different states of PKA-C analyzed with CONCISE using 
the chemical shifts of (A) amide backbone and (B) methyl side chains. The reference states used in all of 
these analyses are apo (blue), ADP-bound (cyan), ATPN/PLN-bound (magenta) and ATPN/PKI5-24 bound 
(red). 
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Figure 5.8.  Allosteric network of communication as mapped by the chemical shift covariance 
analysis (CHESCA). 
(A) CHESCA maps for the amide residues upon binding ATPN, balanol, and H89. The different colors 
indicate the extent of correlations. (B) Allosteric network of the correlations among amide groups mapped 
onto the X-ray structure of PKA-C using  the Xpyder utility [253]. Only correlations with 𝑟𝑖𝑗 > 0.98 are 
mapped for clarity.  (C) CHESCA maps for the methyl groups of ILV side chains. (D) Allosteric correlations 
among methyl groups mapped onto the X-ray structures of the kinase. Only correlations with 𝑟𝑖𝑗 > 0.90 are 
indicated. The ATPN-bound complex has the highest degree of correlation involving residues between the 
two lobes. The number and extent of correlation were lower in the inhibitor-bound complexes, with H89 
showing the least number of correlations. 
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Figure 5.9.  Correlated backbone chemical shift changes upon ATPN binding. 
CHESCA correlation matrix for the backbone amide resonances for the PKA-C/ATPN complex (see also 
Figure 5.2). The backbone residues that were exchange-broadened (gly-rich, C-helix, DFG, P+1 loop, etc.) 
are indicated by black lines in the secondary structure plot. 
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Figure 5.10.  Correlated backbone chemical shift changes upon balanol binding. 
CHESCA correlation matrix for the backbone amide resonances of the PKA-C/balanol complex (see also 
Figure 5.8). 
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Figure 5.11.  Correlated backbone chemical shift changes upon H89 binding. 
CHESCA correlation matrix for the backbone amide resonances for the PKA-C/H89 complex (see also 
Figure 5.8). 
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Figure 5.12. Correlated methyl side-chain chemical shift changes upon ATPN binding. 
CHESCA correlation matrix for the methyl side chain resonances for the PKA-C/ATPN (see also Figure 
5.2). 
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Figure 5.13. Correlated methyl side-chain chemical shift changes upon balanol binding. 
CHESCA correlation matrix for the methyl side chain resonances for the PKA-C/balanol complex (see also 
Figure 5.2). 
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Figure 5.14. Correlated methyl side-chain chemical shift changes upon H89 binding. 
CHESCA correlation matrix for the methyl side chain resonances of PKA-C/H89 complex (see also Figure 
5.2). 
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Figure 5.15. Allosteric communications between V191 and other residues in three different states. 
The number of correlations (rij > 0.98) between the amide resonance of V191 and the other residues of the 
protein decreases from  ATPN-bound to balanol-bound to H89-bound. 
 
 
ATPN, balanol and H89 differentially alter the microsecond-millisecond timescale 
dynamics of the kinase. 
The coordinated CSPs suggest that changes in the conformational landscape 
and the dynamic state of the enzyme may lead to differences in its substrate binding 
cooperativity. To monitor the effects of the nucleotide and inhibitor binding on the 
conformational dynamics in the s-ms timescale, responsible for changes in free energy 
landscape, we quantified the exchange contribution to the transverse relaxation rate 
(𝑅𝑒𝑥) using Carr-Purcell-Meiboom-Gill (CPMG) relaxation dispersion experiments [58, 
254]. We found that the apo kinase is the most malleable state [40, 255], with several 
backbone amide residues exhibiting significant conformational exchange (Figure 
5.16A). The most dynamic regions include the linker (residues 124-125), the A-1 
(T37) and the D-E (residues 138-139) loop, 8 (residues 180-182), D (residues 133-
134), the catalytic loop (residues 165-166), and C-terminal tail (residues 314-315). 
Nucleotide binding further increases the s-ms dynamics of these residues with the 
exception of the D-E loop (Figure 5.17A). In addition, the Gly-loop (L49, M58, L59), 
activation loop (W196), peptide-positioning loop (L198), portions of F (residues 216-
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221) as well as the acidic cluster (residues 331-334) displayed significant conformational 
exchange (i.e., high 𝑅𝑒𝑥values). In contrast, upon binding either balanol or H89, the 
average s-ms timescale conformational exchange is dramatically diminished across the 
entire enzyme (Figure 5.17A). However, there are significant differences in the dynamic 
behavior of PKA-C in complex with the two inhibitors. Specifically, the vast majority of 
the residues in the PKA-C/H89 complex show almost no conformational exchange for 
the amide resonances (𝑅𝑒𝑥 ≤ 4 s
-1). In contrast, we found significant conformational 
exchange in the PKA-C/balanol complex for the Gly-rich, DFG, and activation loops, as 
well as the C-terminal tail (Figure 5.17A).  
 
 
Figure 5.16. Multi-timescale conformational dynamics of apo PKA-C amide backbone. 
Mapping of the (A) conformational exchange, 𝑅𝑒𝑥
𝐶𝑃𝑀𝐺, measured using CPMG relaxation dispersion, (B) 
conformational exchange, 𝑅𝑒𝑥
𝑇𝑅−𝐻𝐸 , measured using TROSY Hahn-Echo experiments, and (C)  HX-NOE, on 
the X-ray structure of PKA-C all measured on a 850 MHz spectrometer for the apo form of the kinase. 
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Figure 5.17.  Multi-timescale conformational dynamics of PKA-C amide backbone upon binding ATP-
competitive inhibitors. 
(A) Mapping of the conformational exchange, 𝑅𝑒𝑥
𝐶𝑃𝑀𝐺, on the X-ray structure of PKA-C measured using 
CPMG relaxation dispersion on a 850 MHz spectrometer for the ATPN-bound, balanol-bound, and H89-
bound forms of the kinase. (B) Corresponding mapping of the conformational exchange, 𝑅𝑒𝑥
𝑇𝑅−𝐻𝐸 , measured 
using TROSY Hahn-Echo experiments on a 850 MHz spectrometer. For comparison, the previously 
published data for the dynamics of ATPN-bound state are shown[250]. (C) HX-NOE measured on a 900 
MHz spectrometer of backbone amide residues as proxy for the fast timescale conformational dynamics (ps-
ns). 
 
 
To monitor the conformational dynamics of the highly conserved hydrophobic 
core, i.e., the C- and R-spines, we analyzed the 13C CPMG relaxation dispersion [255] of 
the methyl bearing side chains of Val, Ile, and Leu, with 125 total probes interspersed 
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throughout the enzyme. The apo PKA-C displays a wide range of conformational 
dynamics throughout the hydrophobic core that extend through the peripheral side 
chains. Binding of nucleotide dynamically activates many methyl side chain residues, 
particularly those lining the active site (C-spine, R-spine, shell, and allosteric hotspot 
(I150)). These motions are attenuated upon binding balanol and completely quenched 
with H89 (Figure 5.18). The only residues exhibiting significant 𝑅𝑒𝑥 in both inhibited 
complexes are located in the hydrophobic core in the ATP binding cleft (L49, V57, L95, 
L103, V104, L160). In general, the 𝑅𝑒𝑥 values found for the balanol-bound kinase are 
higher than those of the PKA-C/H89 complex. In addition to the core, the PKA-C/balanol 
complex displays substantial s-ms motions for the methyl side chains located in the B 
(V80), C (I85, L89, and I94) helices, as well as in the peptide positioning loop (L198) 
(Figures 5.18, 5.19, and 5.21). Upon fitting the CPMG dispersion curves with a two-
state model, we obtained the kinetic (𝑘𝑒𝑥) and thermodynamic (𝑝𝐴) parameters of the 
exchange process [256]. For the ATPN-bound kinase, several residues in the C-spine 
(L172, L173), R-spine (L106) and surrounding bridging residues (I150, I180, V182) fit to 
a single global two-state exchange process with a rate constant (𝑘𝑒𝑥) of 2400 ± 200 s
-1 
and a ground-state population (𝑝𝐴) of 92.8 ± 0.4% (Figures 5.19, 5.20 and Table 5.5). 
The rate and residues which undergo synchronous motions are consistent with other 
studies with nucleotide bound to PKA-C, suggesting these synchronous motions are 
critical for catalysis[255]. Meanwhile, a number of residues in the hydrophobic core and 
B and C helices of the balanol-bound kinase also fit into a global two-state exchange 
process, but in a much slower exchange regime (kex = 90 ± 50 s-1 and pA = 90.9 ± 3.9%, 
Figure 5.19 and Table 5.6). In contrast, we were unable to perform group fitting for the 
H89-bound complex due to the limited number of side chains showing 𝑅𝑒𝑥 > 2 s
-1 and 
the relatively low 𝑘𝑒𝑥 values obtained from the fit of individual residues. Moreover, a 𝑘𝑒𝑥 
< 200 s-1 obtained from the CPMG experiments suggests that the ground state of the 
kinase is in slow conformational exchange with its conformationally excited state. 
Therefore, to better characterize these slow chemical exchange process, we used 13C 
CEST experiments on methyl group resonances, which are able to detect states 
exchanging in the range of 20-200 s-1 [56, 257]. For the apo kinase, we found that three 
residues in the conserved hydrophobic core, L95, V104 and I150, exhibit slowly-
exchanging excited states with significant chemical shift difference () from the ground 
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state (Figure 5.22A). The exchange kinetics (kex), population (pA), and chemical shift 
difference () obtained from CEST are in close agreement with those obtained from 
fitting the CPMG dispersion curves [244]. Remarkably, binding of either ATPN or ATP-
competitive inhibitor suppresses the excited state of L95 (broadened upon ATPN 
binding), V104, and I150 (peak overlapped in the balanol complex), which are positioned 
in the hydrophobic core of the kinase. Their motions become coordinated and move at a 
faster timescale for ATPN-bound complex. Furthermore, both nucleotide and inhibitors 
generate new slowly-exchanging excited states with significant  for selected residues. 
Remarkably, both the ATPN-bound and balanol-bound kinase displays new slowly-
exchanging excited states for V80 and I85 (Figure 5.22B) with comparable chemical 
shift difference values () that are outside the trajectories delineating the open-to-
closed conformational equilibrium (Figure 5.23). This demonstrates that balanol 
preserves similar slow millisecond dynamics of the B-helix residues (V80 and I85) 
exhibited by ATPN-bound kinase. In addition, L173 also exhibits slower exchange 
kinetics in the balanol-bound kinase (faster in the corresponding nucleotide-bound 
kinase, Figure 5.22B). L173 is located in the C-spine and is buried in the core of the 
enzyme, interacting with the adenine ring in the 1ATP structure and with the 
hydroxybenzamide moiety in the 1BX6 structure [231]. Two residues, L49 and L172, 
also show alternate states for the H89-bound kinase (Figure 5.23), with L172 being an 
integral part of the C-spine. Fitting the CEST profiles obtained for the inhibited kinases 
into a two-site exchange equation, we found that residues in the PKA-C/balanol complex 
interconvert with a 𝑘𝑒𝑥 spanning from 40 to 200 s
-1 (Table 5.7), while slower exchange 
kinetics were found for the PKA-C/H89 complex (𝑘𝑒𝑥 = 40-50 s
-1, Table 5.7). The 
differential suppression of s-ms timescale dynamics, the formation of new alternate 
conformations, and the difference in exchange kinetics suggest that these ATP-
competitive inhibitors exert different effects on the enzyme’s populations. These 
molecules shift the enzyme to conformational states that are poised (committed) for 
substrate binding (as manifested by positive cooperativity) in the case of balanol, and 
less poised for substrate binding in the case of H89. 
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Figure 5.18. Slow conformational dynamics of the hydrophobic core measured by CPMG 
experiments. 
Mapping of the 𝑅𝑒𝑥 of the methyl groups from ILV measured by 
13C SQ CPMG relaxation dispersion for the 
PKA-C/ATPN, PKA-C/Balanol, and PKA-C/H89 complexes. The spheres are color-coded according to the 
spectrum bar on the right. White spheres denote side chains that did not exhibit chemical exchange. For 
comparison the previously published data for the apo form are shown [244]. All data were measured at 850 
MHz spectrometer and 27C. 
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Figure 5.19.  Dynamic response of the core residues of PKA-C upon binding ATPN or ATP-
competitive inhibitors. 
(A) Relaxation dispersion curves of the methyl side chain groups measured on a 700 MHz (black) and 850 
MHz (red) spectrometer, showing significant exchange in the PKA-C/ATPN complex and no exchange in 
the inhibitor-bound complexes. (B) Relaxation dispersion curves of the methyl side chain groups (same as in 
A) that show significant exchange in both PKA-C/ATPN and PKA-C/balanol complexes, but no exchange in 
PKA-C/H89. Duplicate measurements were carried out at 𝜈𝐶𝑃𝑀𝐺values of 50, 500 and 1000 Hz. Errors were 
propagated and reported as error bars. The methyl groups of PKA-C/ATPN (C) and PKA-C/balanol (D) 
fitting a two-state exchange process are mapped into their respective structures. 
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Figure 5.20. 13C Dispersion curves of PKA-C bound to ATPN under high Mg2+ conditions. 
Dispersion curves (𝑅𝑒𝑥  > 2 s
-1) for the PKA-C/ATPN complex as measured using 13C SQ CPMG relaxation 
dispersion at 850 (blue) and 700 MHz (green). The curves are fitted using the GUARDD[258] program. 
Errors were propagated from duplicate measurements at 𝜈𝐶𝑃𝑀𝐺 values of 50, 500, and 1000 Hz. 
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Figure 5.21. 13C CPMG dispersion curves for the side chain methyl groups in PKA-C bound to ATP-
competitive inhibitors. 
Dispersion curves (𝑅𝑒𝑥  > 2 s
-1) for the (A) PKA-C/balanol complex and (B) PKA-C/H89 complex as 
measured using 13C SQ CPMG relaxation dispersion at 850 (blue) and 700 MHz (green). The curves are 
fitted using the GUARDD[258] program. Errors were propagated from duplicate measurements at 𝜈𝐶𝑃𝑀𝐺 
values of 50, 500 and 1000 Hz. 
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Figure 5.22.  Differential suppression and formation of conformationally excited states of PKA-C 
upon binding of nucleotide and ATP-competitive Inhibitors. 
(A) 13C CEST measured on a 900 MHz spectrometer using a B1 field of 15 MHz (red) and 30 Hz (blue). The 
side chain methyl groups for L95 (R-spine), V104 (shell), and I150 (allosteric hot spot) show distinct 
conformationally excited states in the apo form. Binding of ATPN, balanol or H89 suppresses the 
conformationally excited states for these core residues. (B) Formation of new excited states for V80 and I85 
(B helix) for both ATPN-bound and balanol-bound complex, and L173 (C-spine) for balanol-bound 
complex. The CEST profiles, as well as the chemical shift difference, for V80 and I85 for the ATPN-bound 
and balanol-bound complexes are very similar. C. Hydrophobic and hydrogen bond interactions within the 
adenine and phosphate binding sites of PKA in the apo form, and when bound to ATP, balanol, and H89. 
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Figure 5.23. 13C CEST profiles for the different PKA-C complexes. 
(A) 13C CEST profiles measured at 900 MHz using a B1 field of 15 Hz (red) and 30 Hz (blue) that shows the 
formation of new excited states for L49 and L172 in H89-bound complex that were not observed in either 
ATPN- or balanol-bound complexes. (B) Comparison of the chemical shift difference obtained from the 
CEST experiments () with the chemical shift difference between the nucleotide-bound or inhibitor-bound 
complex and the apo or the nucleotide-bound or inhibitor-bound complexes and the corresponding ternary 
complex.  
Circle:∆𝛿 =  𝛿𝑛𝑢𝑐𝑙𝑒𝑜𝑡𝑖𝑑𝑒−𝑏𝑜𝑢𝑛𝑑 − 𝛿𝑎𝑝𝑜(𝑜𝑟 𝛿𝑖𝑛ℎ𝑖𝑏𝑖𝑡𝑜𝑟−𝑏𝑜𝑢𝑛𝑑 − 𝛿𝑎𝑝𝑜);  
Square: 𝛿 = 𝛿𝑛𝑢𝑐𝑙𝑒𝑜𝑡𝑖𝑑𝑒−𝑏𝑜𝑢𝑛𝑑 − 𝛿𝑛𝑢𝑐𝑙𝑒𝑜𝑡𝑖𝑑𝑒  𝑎𝑛𝑑 𝑃𝐾𝐼−𝑏𝑜𝑢𝑛𝑑  (𝑜𝑟 𝛿𝑖𝑛ℎ𝑖𝑏𝑖𝑡𝑜𝑟−𝑏𝑜𝑢𝑛𝑑 − 𝛿𝑖𝑛ℎ𝑖𝑏𝑖𝑡𝑜𝑟 𝑎𝑛𝑑 𝑃𝐾𝐼−𝑏𝑜𝑢𝑛𝑑). The 
diagonal line shows the 1:1 correlation. The chemical shift difference from the CEST experiment does not 
correlate with the chemical shift difference between the binary and either apo or ternary forms. 
 
 
ATP-competitive inhibitors shift the timescale of the kinase motions. 
To monitor the conformational exchange on a faster time scale, we carried out 
[1H,15N]-TROSY Hahn echo (TR-HE) experiments on the different kinase forms [57]. This 
experiment is complementary to CPMG and is able detect conformational dynamics 
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closer to the s timescale [259]. The dynamically uncommitted apo kinase displays 
extensive conformational exchange ( ), located in residues of the linker, the A-1 
and D-E linkers, 3, 8, Gly-rich, catalytic, DFG and activation loop, as well as in the 
APE motif (Figures 5.17B and 24). Although the binding of the inhibitors causes an 
overall attenuation of the across most residues, both inhibited complexes show 
several regions with significant , an effect that is more accentuated for the PKA-
C/H89 complex (Figures 5.17B and 24). In the H89-bound complex, the A- linker, 
gly-rich loop, 3 and 5 strands, catalytic loop, E and H helices, the APE motif, and 
the acidic cluster in the C-terminal tail displayed higher values than those of the 
PKA-C/balanol complex. This suggests that these motions are shifted in a faster 
timescale, and probably preventing the kinase from sampling conformations that 
possess high binding affinity for the pseudo-substrate. Finally, we measured [1H,15N] 
heteronuclear NOEs as a proxy for backbone amide motions occurring in the ps-ns time 
scale. Upon inhibitor binding, we did not observe a significant change in overall 
backbone flexibility (average HX-NOE changed from 0.84 ± 0.14 to 0.86 ± 0.14 or 
0.870.13 in going from apo to inhibitor-bound) (Figures 5.17C and 25). Except for a 
few residues, we did not observe significant differences in the ps-ns timescale dynamics 
between the two inhibitor-bound complexes (Figure 5.25). Overall, these data suggest 
that the backbone ps-ns dynamics did not change significantly upon ligand binding and it 
does not play a major role in allosteric binding cooperativity. 
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Figure 5.24. Slow conformational dynamics of the backbone as measured by TROSY Hahn-Echo 
experiments. 
𝑅𝑒𝑥 values versus residue for apo PKA-C, PKA-C/ATPN, PKA-C/balanol, and PKA-C/H89 complexes as 
measured by 15N TROSY Hahn-Echo experiments at 27C on a 850 MHz spectrometer. The trimmed mean 
and a standard deviation from the trimmed mean are indicated by dashed line and dash dotted line, 
respectively. The uncertainties were calculated using error propagation of the root mean square noise of the 
spectra. For comparison, the previously published data for the ATPN-bound state were shown [122]. 
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Figure 5.25. Fast backbone dynamics as measured by HX-NOE experiments. 
HX-NOE values versus residue for (from top to bottom) apo PKA-C, PKA-C/ATPN, PKA-C/Balanol , PKA-
C/H89 complexes measured at 27C and 900 MHz. The trimmed mean HX-NOE (indicated by dashed line) 
for apo PKA-C, PKA-C/ATPN, PKA-C/Balanol, and PKA-C/H89 were 0.84  0.14, 0.85  0.29, 0.86 0.14, 
and 0.87  0.13, respectively. The uncertainties were calculated using error propagation of the root mean 
square noise of the spectra. 
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5.4 Discussion 
The majority of the kinase literature focuses on the optimization of both potency 
and selectivity of ATP-competitive inhibitors. To the best of our knowledge, there are no 
publications reporting on the effects of these inhibitors on the binding cooperativity for 
substrate that is preserved when the ATP-binding pocket is occupied. Yet, it is emerging 
that both canonical and non-canonical functions of kinases are essential to cellular 
signaling [32, 33, 260]. Pseudo-kinases, for instance, are devoid of catalytic function, but 
they are still pivotal for the regulation of several cellular events by acting as scaffolds or 
substrates for binding other kinases [33]. As for the pseudo-kinases, inhibited kinases 
that are unable to phosphorylate substrates may still act as scaffolds or substrates for 
other kinases. A notable example is the activation of the RAF kinase in vivo using the 
ATP-competitive inhibitor PLX4270 [35, 238].  In this case, PLX4270 under sub-
saturating conditions converts B-RAF into a pseudo-kinase, catalyzing dimerization and 
activation of C-RAF [261]. More recently, conformation-selective ATP-competitive 
inhibitors have been shown to control the regulatory interactions and non-canonical 
function of MAP kinases [262]. These examples support the wide spread phenomenon 
of paradoxical activation or off-target effects elicited by several kinase inhibitors [241, 
263], and at the same time, generate a growing interest toward manipulating catalytic 
and non-catalytic kinase functions using small molecules [260].  
Our data show that two chemically distinct inhibitors with comparable potency 
modulate the K-type cooperativity of PKA-C differently. The backbone of the inhibited 
complexes are very similar and do not explain the differential behavior of these 
compounds. In contrast, NMR reveals a direct correspondence between the extent of 
coordinated behavior of the chemical shifts and allosteric cooperativity in ATPN, 
balanol, and H89. Specifically, we found that the gradual loss of cooperativity (degree of 
cooperativity, , going from 53 for ATPN to 7 for balanol, and 0.6 for H89 [249]) is 
concomitant with the loss of chemical shift correlation throughout the entire enzyme. 
This indicates that small, but functionally significant, structural rearrangements must 
occur to allosterically couple the nucleotide pocket with the substrate binding site for 
cooperativity. The two inhibitors also exemplify the bivalent nature of the ATP binding 
site. Both share the hydrophobic adenine binding pocket as do almost all kinase 
inhibitors, however the way in which these two inhibitors complement the phosphate 
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binding part of the ATP binding pocket is completely different, and reveal dramatic 
differences in the dynamic features of the kinase Moreover, relaxation dispersion and 
CEST measurements show that the opposite binding cooperativity displayed by these 
ATP-competitive inhibitors is linked to the differential alteration and formation of lowly 
populated conformational states, or excited states, suggesting that they might be 
responsible for substrate recognition.  
In fact, the ATPN-bound, or intermediate, state of PKA-C is quite dynamic with 
synchronous motions for catalytically important loops [43] and the hydrophobic core 
[244].  The C- and R-spines, thought to be inert scaffolding for the enzyme’s catalytic 
loops, are indeed highly dynamic and play a key role for propagating allostery and 
render the kinase committed to catalysis [244]. The PKA-C/balanol complex retains 
some of the correlated motions in the catalytic loops, the B-helix (I85, V80), R-spine 
(L95), and C-spine (L173) found in the intermediate state, indicating that dynamics in the 
hydrophobic core contributes to allosteric control of positive cooperativity. H89 binding, 
on the other hand, quenches the dynamics in the majority of these residues, reflecting its 
negative K-type cooperativity due to the lack of the hydrophilic interactions with the 
active site eliminating the bi-valent nature of the ATP-binding pocket (Figure 5.22C). 
While both inhibitors attenuate the overall s-ms timescale dynamics, balanol was able 
to engage the two lobes of the enzyme as a result of the interactions in the bivalent ATP-
binding site. In addition to the hydrophobic interaction between the C spine residues, 
when balanol is bound, the benzophenone moiety forms a number of polar interactions 
with the Gly-rich loop of PKA-C, as well as with Asp184 of the conserved DFG loop 
[231], driving the kinase toward an intermediate-like state, displaying coordinated 
chemical shift behavior similar to the ATP-bound form (Figure 5.22C). Though balanol is 
not as cooperative as the natural ligand ATP, the opening and closing of the enzyme is 
still synchronous for some of the residues in the hydrophobic core and the kinase 
explores high-energy conformations that have enhanced binding affinity for the 
substrate. One notable finding we found is that, aside from the fast timescale dynamics, 
the ATPN-bound kinase also exhibited slow ms dynamics in the B-helix, exchanging 
with an excited state conformation that has a chemical shift significantly different from 
the ground state. This slow dynamics was preserved in the balanol-bound kinase. The 
synchronous motions, together with the slow ms dynamics in B-helix, allow the key 
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elements in the kinase (B, C, DFG, activation, as well as peptide positioning loops) to 
orient properly for substrate recognition. This contrast with the H89-bound complex, 
where the bromocinnamoyl moiety is unable to couple the two lobes structurally as 
manifested by the absence of polar interactions between the bromocinnamoyl moiety 
and the residues lining the phosphate binding site (Figure 5.22C), thus severing the 
allosteric communication between the ATP and substrate binding sites, and abrogating 
the allosteric cooperativity. Interestingly, motions along B helix are absent with ATPC, 
an ATP-mimic which lacks K-type cooperativity[249], but remains dynamic along the 
hydrophobic spines [255]. In addition, the disruption of allosteric network and 
desynchronization of motions of the two lobes are also responsible for the Y204A mutant 
to exhibit negative cooperativity toward the pseudosubstrate[43, 44]. The totality of our 
observations indicates that the propagation of dynamically driven allostery through 
hydrophobic motifs is multifarious, with different timescales of motion within distinct 
regions of the kinase to modulate cooperativity and substrate binding.  
Understanding the relationship between excited states and protein function has 
been a subject of study in recent years [254, 264].  Dynamic studies on CAP[113] and 
DHFR[265] suggest that conformationally excited states are required for protein function, 
inhibition, and substrate recognition [214, 266, 267]. Single-site allosteric mutants that 
disrupt the transition to competent excited states ablate binding and catalysis [43, 265]. 
Small molecules also have been shown to suppress excited states in several proteins, 
including DHFR [268], RAS [269], the R-subunit of PKA [270], and IGPS [271]. Ligand 
binding does not necessarily suppress excited states, but depending on their context, 
may increase or decrease the population of specific states, affecting the kinase’s activity. 
This behavior is manifested in PKA-C where, binding of ATP enhances the population of 
the excited state that is competent for catalysis, priming the kinase for substrate binding. 
On the other hand, ATP-competitive inhibitors suppress the committed states for 
catalysis, reducing affinity for substrates, and abrogating both canonical and non-
canonical function of the kinase.   
In conclusion, we used PKA-C as a proof-of-concept to demonstrate that it is 
possible to control the binding affinity for substrates by using different ATP-competitive 
inhibitors. These results suggest a new way to modulate the substrate binding ability of 
kinases to activate or de-activate signaling irrespective of the catalytic (canonical) 
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activity, prospecting a new way to control kinase function in vivo.  Future design of 
kinase inhibitors must take into account the dual activity of ATP-competitive inhibitors to 
fine-tune both catalytic and binding functions of kinases. 
 
5.5 Materials and Methods 
Materials. All reagents used were analytical grade or higher. N-[2-(p-
bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H89) was purchased from 
Sigma Aldrich (St. Louis, MO, USA). Balanol was a gift of Dr. M. Walters (Department of 
Medicinal Chemistry, Institute for Therapeutics Discovery and Development, University 
of Minnesota). Adenosine 5’-(β,γ-imido)triphosphate (ATPγN) was purchased from 
Roche Diagnostics (Indianapolis, IN, USA). 
 
Sample Preparation. Uniformly-2H ,15N, 13CH3 ILV-labeled murine PKA-C in a pRSETb 
vector was expressed recombinantly in E. coli  BL21 (DE3) cells using M9 minimal 
media enriched with 15NH4Cl and [2H]-D-glucose in 85% D2O at 24C as described 
previously [117]. Induction was carried out at OD600 ~ 1.2 with 0.4 mM IPTG. PKA-C was 
expressed for 12 hours overnight. The 13C labeling of the methyl groups of ILV residues 
was achieved by adding 2-ketobutyric acid-4-13C-3,3-d2 and 2-keto-3-(methyl-d3)-butyric 
acid-4-13C-3-d sodium salts one hour prior to IPTG induction with final concentrations of 
70 mg/L and 90 mg/L, respectively[155, 272]. PKA-C was purified by affinity 
chromatography using the His6-RIIα(R213K) subunit as previously described [168]. PKA-
C was subsequently dialyzed in a buffer containing 20 mM KH2PO4, 25 mM KCl, and 5 
mM -mercaptoethanol at pH 6.5. The different isoforms were separated by cation 
exchange using HiTrap SP column using a linear gradient of Buffer A (20 mM KH2PO4, 
pH 6.5) to Buffer B (20 mM KH2PO4, 1 M KCl, pH 6.5). PKA-C was quantified using  UV 
absorbance at 280nm ( = 52060 M-1cm-1). The NMR samples consisted of 0.20-0.42 
mM PKA-C solubilized in buffer containing 20 mM KH2PO4, 90 mM KCl, 10 mM MgCl2, 
10 mM DTT, 1 mM NaN3 at pH 6.5, except for CPMG relaxation dispersion and CEST 
experiments of PKA/ATPN where 60 mM MgCl2 was used to avoid ATPN hydrolysis. 
The nucleotide-bound complex was prepared by saturating the PKA-C with 12 mM 
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ATPN while the inhibitor-bound complexes were prepared by saturating the enzyme 
with 1.35 mM balanol and 2 mM H89, respectively. 
 
NMR Spectroscopy. The assignment of the backbone[122] and side-chain methyl[183] 
groups has been determined previously. The combined chemical shifts were calculated 
according to the formula: 
 
2 2
H Xa         (5.1) 
where ∆𝛿𝐻 and ∆𝛿𝑋 are the proton and hetereonuclei chemical shift changes, 
respectively, 𝑎 is a scaling factor for the chemical shift of the heteronuclei, which is equal 
to 0.154 for 15N and 0.25 for 13C, respectively. The 2D backbone amide spectrum was 
acquired using the CLEAN-TROSY[119] version of the original TROSY-HSQC pulse 
sequence, while the methyl side chain spectrum was acquired using the methyl TROSY- 
experiment[273] at 850.3 MHz. The data were acquired as 120 (t1) x 2048 (t2) complex 
points (for backbone amide) and 200 (t1) x 2048 (t2) complex points (for methyl side 
chain) using 16 scans and a recycle delay of 2.0 seconds. 
The s-ms timescale conformational dynamics of backbone amides and methyl 
groups from ILV of apo PKA-C, PKA-C/ATPN, PKA-C/balanol, and PKA-C/H89 were 
measured using Carr-Purcell-Meiboom Gill (CPMG) relaxation dispersion experiments 
[58, 254]. The 15N CPMG relaxation dispersion experiments were performed using the 
relaxation-compensated version of the CPMG experiment [68], with improved phase 
cycle according to Long et al. [274]. The 13C SQ CPMG pulse sequence by Lundstrom et 
al. [275] was used for the methyl group relaxation dispersion experiments. Both 15N and 
13C relaxation dispersion experiments were performed in an interleaved mode with 𝜐𝐶𝑃𝑀𝐺 
values of 0, 50, 100, 150, 200, 250, 300, 400, 500, 600, 800, and 1000 Hz. Effective 
transverse relaxation rate constant, 𝑅2,𝑒𝑓𝑓, were determined at each 𝜐𝐶𝑃𝑀𝐺 value using 
the peak intensities with and without relaxation period according to the equation[276]: 
 
0
2, 
ln
 eff
I
I
R
T
 
 
    (5.2) 
where I0 and I are the peak intensities of the resonances in the 2D spectra acquired in 
the absence and presence of a relaxation period, respectively, and T is the total CPMG 
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time [277] which was 40 ms. Duplicate measurements were carried out at 𝜐𝐶𝑃𝑀𝐺 values 
of 50, 500, and 1000 Hz for error estimation and errors were indicated as standard 
deviations. The backbone 15N CPMG data were acquired on Bruker AVANCE III 
operating at 850.3 MHz; while the 13C CPMG data were acquired at two different fields 
using Bruker AVANCE III spectrometers operating at 700.1 and 850.3 MHz, respectively. 
The 15N CPMG spectra were acquired as 120 (t1) x 2048 (t2) complex points for apo and 
ATPN-bound, 102 (t1) x 2048 (t2) complex points for balanol-bound, and 98 (t1) x 2048 
(t2) complex points for H89-bound using 96 (for apo), 64 (for ATPN-bound) and 128 (for 
inhibitor-bound) scans with a recycle delay ranging of 2.50 seconds. All 13C CPMG 
spectra were acquired as 160 (t1) x 2048 (t2) complex points using 48 scans and a 
recycle delay of 2.50 seconds. 
The TROSY Hahn-Echo experiments [57] were performed on the backbone 
residues using a Hahn-echo period corresponding to 2/JNH (10.8 ms).  The peak 
intensities of the , , zz spin states were used to calculate the 𝑅𝑒𝑥
𝑇𝑅−𝐻𝐸 according to the 
following equation [76, 278]: 
      ln  lnTR HEex zz zzR C C       (5.3) 
where 𝐶𝑧𝑧 = (2𝜏)
−1, 𝐶𝛽 = (<  > −1)(4𝜏)
−1,  = 1 − 2 ln 𝜌𝑧𝑧 / ln 𝜌𝛽, 𝜌𝑧𝑧 = 𝐼𝑧𝑧/𝐼𝛼, and 
𝜌𝛽 = 𝐼𝛽/𝐼𝛼. <> is the trimmed mean of the  value for the amide resonances not 
showing chemical exchange [57]. All spectra were acquired in an interleaved mode with 
120 (t1) x 2048 (t2) complex points using 240 (for apo) or 256 (for inhibitor-bound) scans 
and a recycle delay of 2.0 seconds. The uncertainties on the  𝑅𝑒𝑥
𝑇𝑅−𝐻𝐸 values were 
calculated from propagating the errors using the root mean square noise from the 
spectra.  
All 13C methyl CEST experiments were recorded on a Bruker 900.21 MHz 
spectrometer equipped with a TCI cryoprobe using the pulse sequence by Bouvignies 
and Kay[257]. The CEST datasets were acquired using an exchange time of 400 ms and 
two different B1 field strengths ~15 Hz and ~30 Hz. A series of 79 2D HSQC spectra 
were acquired with 144 (t1) x 2048 (t2) complex points with the 13C carrier offsets 
between 8.73 and 28.71 ppm at 58 Hz (0.256 ppm) intervals. Each 2D spectrum was 
acquired with 16 scans and 70 increments, using a recycle delay of 2.0 s. To construct 
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the CEST profiles, the ratio of peak intensities with (I) and without (I0) the exchange 
delay, Tex, as a function B1 offset was used [257].  
The 1HX-NOE values [76] were calculated from the ratio of signal intensities of the 
TROSY-select experiments with and without a 1H saturation of 5 s [118]. The datasets 
were acquired as 120 (t1) x 2048 (t2) complex points using 184-196 scans and a recycle 
delay of 5.0 seconds. The uncertainties on the HX-NOE values were calculated using 
error propagation of the root mean square noise [279]. 
 
Data Processing and Analysis.  
All data were processed using NMRPipe [120] and peak intensities were quantified using 
FuDA (http://pound.med.utoronto.ca/~flemming/fuda/) and Sparky [121]. Gaussian 
window function with a line broadening of -12 Hz was applied in the direct dimension 
while sine bell window function with an offset of 0.5 was applied in the indirect 
dimension. The data were zero-filled to the nearest power of 2. Twenty and nine side 
chains showed significant dispersion (𝑅𝑒𝑥 > 2 s
-1) in the balanol-bound and H89-bound 
complex, respectively, and were subsequently fitted individually using a two-state 
exchange model using the GUARDD software [258] with 𝑘𝑒𝑥, 𝑝𝐵, ∆𝜔, and 𝑅2
0 as the 
fitting parameters. Among the side chains that showed chemical exchange, group fitting 
into a two-state exchange process were carried out for residues that satisfy: 
𝜒𝑔𝑟𝑜𝑢𝑝
2
𝜒𝑖𝑛𝑑𝑖𝑣𝑖𝑑𝑢𝑎𝑙
2 <
1.20. We were able to group fit twelve and seven side chains in the ATPN-bound and 
balanol-bound complex, respectively, into a single two-state exchange process and 
extracted the group 𝑘𝑒𝑥 and 𝑝𝐵, as well as the individual ∆𝜔, and 𝑅2
0.  On the other hand, 
the CEST profiles were analyzed using a two-state exchange model included in the 
ChemEx software [56], with 𝑘𝑒𝑥, 𝑝𝐵, and ∆𝜔 as the main fitting parameters. Among the 
side chains analyzed, three, two, three, and two side chains showed pronounced excited 
states in the CEST profiles for the apo, ATPN-bound, balanol-bound, and H89-bound 
PKA-C, respectively. 
 
Analysis of Chemical Shift Trajectories 
The allosteric network of the backbone amide or methyl side chain residues in 
the nucleotide or inhibitor-bound PKA-C that report the open to close transition was 
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determined using the COordiNate ChemIcal Shift bEhavior(CONCISE)[125] to monitor 
the change in the equilibrium position associated with each PKA-C state. The reference 
states used were apo, ADP-bound, ATPN/PLN1-19-bound, and ATPN/PKI5-24-bound to 
measure the change of the equilibrium position along the open to closed conformational 
states. CONCISE uses Principal Component Analysis (PCA) to identify a set of residues 
whose chemical shifts respond linearly to the conformational transition. Each residue 
provides a measure of the equilibrium position for every state of PKA-C in form of scores 
along the first principal component. The equilibrium position for a given construct is 
given by the average of the PC-scores over all linear residues. To identify the residues 
whose chemical shifts follow a linear pattern, a threshold of 1.0 to 3.0 for the ratio of the 
standard deviations of PC1 over PC2 was used, and residues that were affected by 
chemical shifts perturbations below 0.05 ppm were also discarded. 
To identify which residues respond in a correlated fashion to ligand binding, an 
adapted version of the chemical shift covariance analysis [104](CHESCA) method was 
applied to the cluster of linear residues identified using CONCISE. The correlation 
matrices between the linear residues identified from CONCISE were constructed from 
correlation coefficients (𝑟𝑖𝑗 ) that exceed 0.9. The correlations were mapped into the 
structure using the xPyder plugin [253] with a cutoff value of 0.98 for backbone amide 
groups for clarity and 0.90 for side-chain methyl groups. 
 
Data Availability 
All generated and processed data during this study are available from the authors upon 
request. 
 
Code Availability 
The script for CONCISE with CHESCA is available from the corresponding author upon 
request; while xPyder is a free PyMol plugin that can be accessed here: 
http://xpyder.sourceforge.net/. The programs used to extract peak intensities can be 
downloaded online: FuDA (http://pound.med.utoronto.ca/~flemming/fuda/) and Sparky 
(http://www.cgl.ucsf.edu/home/sparky/). The GUARDD software used to fit the CPMG 
relaxation dispersion data can be downloaded here: 
https://code.google.com/archive/p/guardd/downloads, while the ChemEx 0.6.0 software 
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used to fit the CEST profiles can be obtained here: 
https://github.com/gbouvignies/chemex/releases. 
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Residue 
Rex (s-1) 
apo ATPN-bound 
Balanol-
bound 
H89-bound 
3 no exchange no exchange 2.2 ± 0.5 0.4 ± 0.4 
4 no exchange no exchange no exchange no exchange 
5 no exchange no exchange no exchange no exchange 
6 ND no exchange no exchange 0.7 ± 0.1 
7 0.4 ± 0.2 no exchange 0.2 ± 0.1 0.1 ± 0.1 
8 0.6 ± 0.1 no exchange no exchange no exchange 
9 no exchange no exchange no exchange no exchange 
10 no exchange 0.3 ± 0.2 0.2 ± 0.2 no exchange 
11 no exchange 1.6 ± 0.5 0.2 ± 0.2 no exchange 
12 0.2 ± 0.1 1.2 ± 0.2 1.6 ± 0.2 0.3 ± 0.1 
13 ND 1.3 ± 0.3 1.8 ± 0.3 no exchange 
14 0.9 ± 0.3 1.3 ± 0.6 1.5 ± 0.3 ND 
15 ND ND ND no exchange 
16 ND 3.5 ± 0.9 ND 0.5 ± 0.2 
17 ND 1.7 ± 0.5 0.3 ± 0.5 no exchange 
18 0.8 ± 0.4 no exchange 0.9 ± 0.5 0.2 ± 0.2 
19 ND 5.5 ± 2.4 0.9 ± 0.3 2.1 ± 0.3 
20 0.3 ± 1.2 ND no exchange ND 
21 ND 8.2 ± 2.8 2.1 ± 0.4 no exchange 
24 ND no exchange 0.6 ± 0.6 no exchange 
25 ND no exchange 0.5 ± 0.4 1.2 ± 0.3 
26 ND ND 0.6 ± 0.5 0.6 ± 0.6 
27 2.3 ± 0.7 10.4 ± 2.2 1.1 ± 0.3 no exchange 
28 1.0 ± 0.6 ND no exchange 2.0 ± 0.5 
29 ND 5.9 ± 2.8 ND ND 
30 no exchange 7.0 ± 3.2 0.9 ± 0.3 4.0 ± 0.4 
31 1.1 ± 1.3 ND 2.4 ± 1.3 0.1 ± 1.1 
32 1.7 ± 0.6 2.8 ± 1.3 ND 1.4 ± 0.8 
34 ND 4.1 ± 1.4 no exchange ND 
35 0.7 ± 0.2 3.5 ± 0.9 no exchange no exchange 
36 ND ND no exchange 0.5 ± 0.5 
37 21.1 ± 5.2 59.3 ± 22.3 1.7 ± 0.6 3.5 ± 0.6 
38 ND 14.6 ± 3.3 12.5 ± 0.8 1.6 ± 0.4 
39 0.1 ± 0.3 no exchange ND 0.4 ± 0.3 
40 no exchange ND ND ND 
41 0.2 ± 0.4 no exchange 0.3 ± 0.4 ND 
42 no exchange ND no exchange no exchange 
43 ND ND 1.3 ± 0.6 ND 
44 ND ND no exchange 0.1 ± 0.5 
45 0.2 ± 0.3 no exchange no exchange 0.7 ± 0.2 
Table 5.1. 𝑹𝒆𝒙 values of the backbone amide residues of the different states of PKA-C (apo, ATPN-
bound, balanol-bound, and H89 bound) measured using 15N CPMG relaxation dispersion at 850 MHz 
and 27C. 
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46 0.7 ± 0.4 4.2 ± 1.2 5.9 ± 1.1 ND 
48 ND ND no exchange no exchange 
49 no exchange 43.9 ± 8.6 ND 1.6 ± 1.4 
50 2.7 ± 1.9 ND ND ND 
52 4.3 ± 0.6 ND 0.7 ± 0.6 2.7 ± 0.6 
55 1.9 ± 0.5 ND 4.6 ± 0.7 2.5 ± 0.7 
56 11.9 ± 0.6 ND ND ND 
58 no exchange 17.7 ± 11.6 no exchange 1.0 ± 0.7 
59 6.5 ± 0.9 11.2 ± 2.1 no exchange 2.3 ± 0.8 
60 0.9 ± 0.8 3.9 ± 3.3 no exchange 0.3 ± 0.7 
61 no exchange ND 0.8 ± 0.2 0.2 ± 0.6 
62 no exchange no exchange no exchange 0.3 ± 0.5 
63 no exchange no exchange no exchange no exchange 
64 no exchange 1.8 ± 0.6 0.4 ± 0.4 no exchange 
65 ND 1.9 ± 2.5 1.0 ± 0.9 2.7 ± 0.4 
66 no exchange no exchange ND no exchange 
67 6.1 ± 0.2 3.6 ± 1.3 ND ND 
68 0.4 ± 0.4 ND no exchange no exchange 
69 2.3 ± 0.6 ND 0.2 ± 0.4 1.5 ± 1.0 
70 2.0 ± 0.7 ND 0.1 ± 0.4 2.8 ± 0.6 
71 no exchange ND no exchange 0.7 ± 0.5 
72 5.7 ± 0.9 ND 2.5 ± 0.8 3.8 ± 0.9 
73 9.5 ± 1.0 ND ND no exchange 
74 0.5 ± 0.5 8.1 ± 3.7 no exchange 1.8 ± 0.6 
76 1.3 ± 0.5 ND 0.7 ± 0.3 1.1 ± 0.7 
77 2.6 ± 0.6 4.1 ± 1.1 3.9 ± 0.7 ND 
78 ND ND ND no exchange 
79 ND ND ND no exchange 
80 0.9 ± 0.7 8.5 ± 3.1 2.7 ± 0.9 0.8 ± 0.5 
81 2.6 ± 0.8 no exchange ND ND 
82 ND 9.1 ± 1.5 0.1 ± 0.3 no exchange 
83 no exchange 8.4 ± 3.4 ND 2.2 ± 0.7 
84 2.0 ± 1.0 ND ND ND 
85 0.2 ± 0.7 ND ND ND 
90 1.0 ± 0.5 10.1 ± 6.2 ND ND 
94 18.6 ± 3.4 ND ND ND 
95 0.7 ± 0.9 ND ND ND 
96 5.6 ± 0.5 ND 0.5 ± 0.7 0.4 ± 0.4 
97 no exchange ND no exchange no exchange 
98 1.5 ± 0.9 no exchange no exchange no exchange 
99 1.5 ± 0.7 ND 1.0 ± 0.5 ND 
100 0.9 ± 0.4 2.5 ± 0.9 0.3 ± 0.4 ND 
103 6.3 ± 0.6 no exchange 2.2 ± 0.7 0.2 ± 0.7 
106 6.7 ± 0.5 4.1 ± 2.0 0.6 ± 0.3 ND 
107 2.9 ± 1.1 ND no exchange 1.8 ± 1.2 
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108 2.1 ± 0.7 3.3 ± 1.0 5.5 ± 1.7 ND 
109 no exchange ND no exchange ND 
110 2.8 ± 0.6 6 ± 5.1 0.9 ± 0.5 0.8 ± 0.5 
111 no exchange no exchange 1.6 ± 1.0 0.5 ± 0.4 
112 1.5 ± 0.5 2.3 ± 2.3 no exchange no exchange 
113 no exchange ND 0.3 ± 0.6 ND 
114 no exchange no exchange 0.9 ± 0.4 ND 
115 no exchange 10.1 ± 9.0 2.5 ± 1.2 no exchange 
116 no exchange ND 1.8 ± 0.7 no exchange 
117 no exchange 2.5 ± 2.4 3.6 ± 1.0 1.3 ± 0.6 
118 2.5 ± 0.6 11.6 ± 1.8 ND 0.5 ± 0.6 
119 0.8 ± 0.8 no exchange no exchange 1.5 ± 0.7 
120 5.4 ± 1.1 ND no exchange 2.2 ± 0.9 
124 25.7 ± 2.9 15.9 ± 19.7 ND 1.0 ± 0.5 
125 19.3 ± 2.2 ND no exchange 2.1 ± 0.9 
126 ND ND no exchange 3.9 ± 0.9 
128 ND ND no exchange 2 ± 1.2 
133 8.5 ± 0.9 ND ND ND 
134 7.3 ± 1.0 ND no exchange 1.2 ± 0.8 
136 ND ND 0.8 ± 1.0 ND 
137 ND 7.2 ± 4.3 1.6 ± 0.4 1.8 ± 0.4 
138 22.2 ± 1.1 ND ND ND 
139 6.6 ± 0.5 3.7 ± 1.7 0.6 ± 0.5 0.4 ± 0.5 
140 1.3 ± 0.4 2.0 ± 1.2 1.0 ± 0.5 ND 
142 2.4 ± 0.7 5.6 ± 2.8 no exchange 1.0 ± 0.6 
143 4.6 ± 0.9 no exchange no exchange 0.6 ± 0.8 
144 0.2 ± 1.6 no exchange ND no exchange 
145 1.1 ± 0.7 ND 0.6 ± 1.0 ND 
147 ND ND ND ND 
148 no exchange no exchange 2.7 ± 2.7 no exchange 
149 0.2 ± 1.6 no exchange no exchange no exchange 
150 ND 17.7 ± 8.7 3.9 ± 3.2 ND 
151 ND ND no exchange 1.4 ± 0.3 
155 0.4 ± 1.0 ND no exchange no exchange 
160 2.7 ± 1.1 ND ND ND 
161 1.3 ± 0.4 7.4 ± 5.8 no exchange 0.5 ± 0.4 
162 2.1 ± 0.5 8.8 ± 5.5 ND no exchange 
163 ND 15.4 ± 3.5 ND ND 
164 6.9 ± 1.7 ND ND 0.5 ± 2.1 
165 14.8 ± 4.3 ND no exchange ND 
166 4.2 ± 0.7 38.0 ± 21.8 1.1 ± 0.6 1.3 ± 0.7 
174 ND no exchange 1.6 ± 0.4 ND 
175 9.5 ± 0.7 ND no exchange 1.1 ± 0.6 
176 no exchange no exchange no exchange 2.2 ± 0.7 
177 ND 10.6 ± 4 ND 0.1 ± 0.5 
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178 no exchange ND no exchange 1.1 ± 1.7 
179 no exchange 4.2 ± 3.5 no exchange no exchange 
180 15.9 ± 1.6 13.7 ± 14.8 ND 1.0 ± 0.9 
181 ND 17.5 ± 5.5 ND ND 
182 17.2 ± 1.2 8.0 ± 5.4 no exchange ND 
186 3.9 ± 1.4 ND 5.6 ± 1.7 2.8 ± 0.8 
187 2.2 ± 1.0 ND ND ND 
188 3.3 ± 0.9 ND 6.4 ± 0.9 1.2 ± 0.6 
189 2.5 ± 0.6 ND ND ND 
190 4.2 ± 0.8 10.2 ± 3.4 2.9 ± 0.5 1.0 ± 0.4 
191 1.6 ± 0.5 7.1 ± 1.4 6.0 ± 0.5 1.9 ± 0.4 
192 no exchange ND no exchange ND 
193 0.9 ± 0.5 no exchange no exchange ND 
194 ND ND 1.5 ± 0.2 ND 
195 2.2 ± 0.5 ND 1.5 ± 0.5 ND 
196 2.7 ± 0.7 15.6 ± 4.4 0.9 ± 0.5 ND 
197 0.8 ± 2.5 ND 5.1 ± 2.2 no exchange 
198 1.4 ± 0.5 8.6 ± 8.9 2.3 ± 0.7 2.0 ± 0.6 
199 3.3 ± 0.7 ND 0.2 ± 0.4 3.6 ± 0.9 
200 4.3 ± 0.7 ND 2.1 ± 1.0 2.7 ± 0.4 
203 ND ND 3.2 ± 2.4 ND 
204 ND ND ND 0.7 ± 0.5 
205 5.7 ± 0.6 ND no exchange ND 
206 1.3 ± 0.7 ND no exchange 0.3 ± 0.5 
208 1.9 ± 0.9 no exchange no exchange 0.6 ± 0.8 
209 ND ND ND ND 
210 2.6 ± 1.2 24.6 ± 9.9 1.6 ± 1.1 1.1 ± 1.3 
211 ND 8.5 ± 2.7 no exchange ND 
212 2.7 ± 0.5 2.8 ± 1.6 0.3 ± 0.5 0.5 ± 0.5 
213 1.1 ± 0.6 3.8 ± 3.2 0.9 ± 0.4 0.9 ± 0.5 
214 2.2 ± 0.6 7.2 ± 4.9 4.0 ± 0.7 1.3 ± 0.5 
215 ND no exchange ND ND 
216 1.8 ± 0.7 17.7 ± 4.8 no exchange 0.8 ± 0.6 
217 ND ND 0.1 ± 0.4 ND 
218 ND 7.0 ± 3.7 ND ND 
219 1.2 ± 1.0 20.6 ± 12.6 no exchange ND 
220 ND ND 0.5 ± 0.7 ND 
221 0.8 ± 0.5 12.0 ± 6.8 0.4 ± 0.4 0.5 ± 0.4 
222 1.1 ± 0.5 no exchange ND ND 
225 ND ND 1.7 ± 2.4 ND 
227 ND ND 1.7 ± 0.5 ND 
228 no exchange ND 2.0 ± 2.6 ND 
230 ND ND 1.4 ± 3.0 0.3 ± 2.1 
231 ND no exchange ND ND 
232 ND 11.5 ± 5.6 0.5 ± 0.3 ND 
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233 1.9 ± 1.3 no exchange ND 4.4 ± 3.4 
234 18.9 ± 3.1 no exchange 4.3 ± 1.0 ND 
238 ND ND 1.3 ± 0.8 ND 
240 1.2 ± 0.6 26.2 ± 16.2 0.9 ± 1.5 3.5 ± 1.5 
241 no exchange 3.2 ± 2.1 0.5 ± 0.5 no exchange 
242 0.2 ± 0.3 9.6 ± 1.4 0.6 ± 0.2 2.1 ± 0.3 
244 1.5 ± 0.4 1.9 ± 1.9 0.7 ± 0.4 ND 
245 no exchange no exchange no exchange no exchange 
246 no exchange 8.2 ± 4.0 0.3 ± 0.8 no exchange 
247 ND ND 1.8 ± 0.4 ND 
248 ND no exchange 0.1 ± 0.5 0.1 ± 0.4 
249 no exchange ND 0.5 ± 0.3 2.0 ± 0.4 
250 ND no exchange ND ND 
251 0.8 ± 0.8 4.3 ± 3.2 no exchange 1.1 ± 0.7 
252 no exchange 7.4 ± 2.3 0.2 ± 0.5 no exchange 
253 no exchange 3.3 ± 1.6 no exchange no exchange 
254 no exchange 3.2 ± 1.4 0.2 ± 0.3 0.5 ± 0.2 
255 no exchange ND ND ND 
256 no exchange 2.4 ± 1.2 no exchange no exchange 
257 ND 3.2 ± 1.0 no exchange ND 
261 0.3 ± 0.3 5.6 ± 4.6 no exchange no exchange 
262 no exchange 4.8 ± 2.2 0.3 ± 0.6 no exchange 
263 no exchange 1.5 ± 1.1 no exchange no exchange 
264 ND 3.8 ± 0.9 no exchange 1.0 ± 0.2 
265 no exchange no exchange ND no exchange 
266 ND ND 2.6 ± 1.0 ND 
267 ND ND 0.1 ± 0.3 ND 
268 ND ND ND no exchange 
269 0.6 ± 2.3 no exchange ND 1.1 ± 2.1 
272 ND ND no exchange ND 
274 0.8 ± 1.1 no exchange ND ND 
275 no exchange 1.5 ± 2.6 no exchange 0.1 ± 0.3 
276 ND ND no exchange 0.6 ± 0.6 
277 no exchange ND no exchange no exchange 
278 no exchange 9.3 ± 3.6 no exchange no exchange 
279 no exchange 4.6 ± 2.1 1.8 ± 0.7 no exchange 
280 no exchange ND no exchange ND 
281 no exchange 3.3 ± 1.6 0.3 ± 0.5 no exchange 
282 no exchange no exchange no exchange ND 
283 ND 2.0 ± 0.9 1.1 ± 0.6 no exchange 
284 no exchange ND ND ND 
286 ND no exchange no exchange no exchange 
287 no exchange no exchange no exchange no exchange 
289 no exchange 3.7 ± 1.7 0.5 ± 0.4 1.1 ± 0.3 
290 no exchange no exchange no exchange no exchange 
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291 no exchange 1.5 ± 1.7 0.1 ± 0.6 no exchange 
292 no exchange ND no exchange ND 
293 no exchange 1.4 ± 1.6 no exchange no exchange 
294 no exchange ND no exchange no exchange 
295 0.4 ± 0.4 no exchange no exchange no exchange 
296 0.3 ± 0.7 no exchange no exchange no exchange 
297 no exchange ND 1.0 ± 0.9 no exchange 
298 no exchange no exchange no exchange no exchange 
299 no exchange no exchange no exchange no exchange 
300 ND ND no exchange 1.1 ± 0.2 
301 no exchange no exchange ND no exchange 
302 no exchange no exchange no exchange no exchange 
303 ND ND no exchange ND 
304 no exchange ND 1.0 ± 0.5 no exchange 
305 ND ND no exchange no exchange 
306 ND no exchange no exchange no exchange 
307 ND ND 0.9 ± 0.7 ND 
308 ND ND 0.4 ± 0.5 0.9 ± 0.2 
309 no exchange 2.4 ± 1.7 no exchange no exchange 
310 no exchange 9.4 ± 0.9 no exchange no exchange 
311 no exchange no exchange 0.8 ± 0.3 0.2 ± 0.3 
312 0.8 ± 0.3 no exchange 0.9 ± 0.4 0.3 ± 0.3 
314 8.2 ± 1.5 4.1 ± 4.3 2.6 ± 0.7 0.1 ± 0.5 
315 7.9 ± 0.4 3.9 ± 1.1 3.5 ± 0.4 1.3 ± 0.3 
317 ND 7.0 ± 4.3 0.4 ± 2.0 ND 
318 ND 3.1 ± 0.4 0.4 ± 0.2 0.9 ± 0.1 
320 ND ND 1.2 ± 0.5 1.5 ± 0.5 
322 4.1 ± 0.7 no exchange no exchange 2.8 ± 1.2 
323 ND ND ND no exchange 
326 ND ND ND no exchange 
328 no exchange ND ND ND 
331 ND 9.0 ± 1.1 0.2 ± 0.3 1.7 ± 0.3 
332 ND 15.2 ± 2.3 0.5 ± 0.3 2.9 ± 0.3 
333 ND 11.9 ± 1.5 0.9 ± 0.5 no exchange 
334 0.9 ± 0.3 8.9 ± 1.0 no exchange 0.4 ± 0.3 
335 ND 4.5 ± 1.3 no exchange 0.4 ± 0.3 
336 0.4 ± 0.2 2.9 ± 1.2 2.2 ± 0.3 no exchange 
337 5.3 ± 0.3 ND 6.7 ± 0.3 ND 
338 ND ND no exchange no exchange 
339 ND ND no exchange no exchange 
340 no exchange no exchange 0.4 ± 0.5 no exchange 
341 0.3 ± 0.2 3.4 ± 2.7 no exchange no exchange 
342 no exchange 2.3 ± 1.5 0.5 ± 0.4 no exchange 
343 no exchange 6.2 ± 1.0 0.1 ± 0.4 no exchange 
344 no exchange ND no exchange no exchange 
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345 ND 7.9 ± 4.8 no exchange 0.3 ± 0.4 
346 1.5 ± 1.1 ND 4.6 ± 1.5 ND 
347 no exchange no exchange ND no exchange 
348 2.2 ± 0.6 10.1 ± 7.5 ND no exchange 
349 1.2 ± 0.4 ND no exchange 0.2 ± 0.4 
350 ND ND no exchange no exchange 
 
Data were not determined for those residues marked ND because the resonances are either broadened or 
severely overlapped.  
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 kex (s-1) Pa (%) 
 
(ppm) 
Rex  
(700 MHz, s-1) 
Rex  
(850 MHz, s-1) 
LEU40Cδ1 810 ± 88 50.0 ± 16.4 0.2 ± 0.1 13.3 ± 0.6 19.8 ± 1.0 
ILE46Cδ1 2087 ± 280 65.6 ± 18.2 0.4 ± 0.2 18.0 ± 0.6 26.7 ± 1.2 
LEU49Cδ2 4032 ± 3867 61.5 ± 21.9 0.5 ± 1.5 21.5 ± 13.3 31.8 ± 19.6 
LEU59Cδ1 2116 ± 554 64.7 ± 20.7 0.3 ± 0.4 8.7 ± 0.9 12.8 ± 1.3 
ILE73Cδ1 269 ± 329 50.0 ± 20.2 0.1 ± 0.4 3.2 ± 10.2 4.8 ± 11.1 
LEU74Cδ1 2635 ± 768 65.6 ± 20.0 0.4 ± 0.4 19.7 ± 1.6 29.2 ± 2.9 
VAL79Cγ2 100 ± 542 97.6 ± 2.2 3.0 ± 0.4 2.4 ± 0.3 2.4 ± 0.3 
VAL80Cγ1 24 ± 53 75.8 ± 6.2 4.9 ± 0.2 7.2 ± 1.2 7.2 ± 1.2 
LEU82Cδ1 1683 ± 1652 85.2 ± 19.6 0.2 ± 0.7 2.5 ± 0.6 3.7 ± 1.0 
ILE85Cδ1 96 ± 183 94.2 ± 4.5 1.2 ± 0.1 5.6 ± 0.3 5.7 ± 0.4 
LEU89Cδ2 1918 ± 314 68.9 ± 20.5 0.2 ± 0.3 7.7 ± 0.5 11.3 ± 0.8 
ILE94Cδ1 1894 ± 294 90.2 ± 19.0 0.4 ± 0.2 9.5 ± 0.4 13.8 ± 0.6 
VAL98Cγ2 4087 ± 2811 50.0 ± 21.2 0.3 ± 1.4 6.9 ± 4.2 10.2 ± 5.6 
LEU103Cδ1 2433 ± 1260 99.0 ± 20.1 1.3 ± 0.7 5.9 ± 0.9 7.8 ± 1.8 
VAL104Cγ2 3896 ± 3371 50.0 ± 22.1 0.2 ± 1.8 2.0 ± 1.8 2.9 ± 2.2 
LEU106Cδ1 2296 ± 313 73.3 ± 20.1 0.3 ± 0.3 11.2 ± 0.5 16.6 ± 0.8 
LEU116Cδ1 530 ± 376 50.0 ± 20.7 0.1 ± 0.3 4.1 ± 3.1 6.1 ± 3.8 
LEU116Cδ2 3043 ± 2181 81.3 ± 21.1 0.3 ± 1.2 5.3 ± 2.9 7.9 ± 3.9 
VAL119Cγ1 997 ± 458 98.7 ± 11.7 0.8 ± 0.3 5.4 ± 0.4 6.7 ± 0.9 
VAL119Cγ2 1151 ± 2349 99.8 ± 12.0 1.7 ± 1.1 2.0 ± 1.2 2.2 ± 1.5 
VAL123Cγ2 3254 ± 1271 54.2 ± 19.6 0.3 ± 0.6 9.1 ± 2.3 13.5 ± 3.1 
LEU132Cδ1 2549 ± 394 50.4 ± 19.1 0.5 ± 0.3 28.1 ± 1.2 41.6 ± 2.6 
LEU132Cδ2 201 ± 162 94.9 ± 15.6 0.4 ± 0.2 8.2 ± 3.2 8.8 ± 5.8 
ILE135Cδ1 2052 ± 1540 99.5 ± 14.9 1.2 ± 1.0 3.1 ± 1.2 4.1 ± 1.7 
ILE150Cδ1 2181 ± 427 92.6 ± 15.2 1.0 ± 0.3 34.2 ± 1.5 46.6 ± 3.9 
LEU157Cδ1 1325 ± 256 68.9 ± 20.4 0.2 ± 0.2 9.1 ± 0.6 13.5 ± 1.1 
LEU160Cδ1 2266 ± 1135 71.4 ± 20.0 0.2 ± 0.4 4.5 ± 0.6 6.6 ± 1 
LEU160Cδ2 2353 ± 654 98.8 ± 11.3 1.3 ± 0.4 7.4 ± 0.5 9.7 ± 0.8 
LEU162Cδ1 1557 ± 586 56.4 ± 19.3 0.4 ± 0.3 36.0 ± 3.4 53.8 ± 6.9 
LEU162Cδ2 2116 ± 519 64.7 ± 20.1 0.3 ± 0.4 8.7 ± 0.7 12.8 ± 1.1 
ILE163Cδ1 422 ± 72 50.0 ± 16.9 0.1 ± 0.1 11.9 ± 1.9 17.8 ± 3.3 
Table 5.2. Results of the individual fits of methyl side chains in PKA-C/ATPN complex that have 
chemical exchange (𝑹𝒆𝒙> 2 s
-1) measured using 13C CPMG at 700 MHz and 850 MHz. 
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LEU167Cδ1 3254 ± 3974 74.2 ± 22.6 0.2 ± 2.1 2.5 ± 3.2 3.7 ± 3.6 
LEU172Cδ2 2685 ± 272 66.5 ± 18.3 0.5 ± 0.2 24.2 ± 0.7 35.8 ± 1.2 
LEU173Cδ1 2565 ± 466 58.8 ± 19.8 0.4 ± 0.3 19.0 ± 0.9 28.1 ± 2.2 
LEU173Cδ2 25 ± 2720 88.3 ± 14.7 1.2 ± 0.9 3.3 ± 2.1 3.3 ± 2.8 
ILE174Cδ1 863 ± 223 90.8 ± 9.9 0.7 ± 0.1 34.9 ± 1.5 43.4 ± 2.9 
ILE180Cδ1 2805 ± 1032 83.8 ± 19.7 1.0 ± 0.5 59.8 ± 4.7 85.7 ± 12.9 
VAL182Cγ2 2493 ± 282 61.2 ± 19.3 0.3 ± 0.2 12.5 ± 0.5 18.5 ± 0.8 
VAL191Cγ1 2703 ± 225 65.7 ± 19.6 0.2 ± 0.2 5.4 ± 0.2 8.0 ± 0.2 
LEU205Cδ1 8445 ± 2915 99.3 ± 12.2 3.9 ± 2.0 12.4 ± 4.4 16.7 ± 5.5 
VAL226Cγ2 1428 ± 1653 99.8 ± 6.0 2.2 ± 0.9 2.6 ± 1.1 2.8 ± 1.5 
LEU227Cδ2 4144 ± 2105 99.6 ± 1.4 6.6 ± 1.5 11.0 ± 6.7 11.9 ± 6.7 
ILE246Cδ1 4889 ± 4676 50.0 ± 19.9 0.2 ± 0.8 3.4 ± 2.3 5.0 ± 3.4 
VAL255Cγ2 2409 ± 1913 99.9 ± 0.9 5.0 ± 1.4 2.3 ± 1.9 2.4 ± 2.0 
VAL288Cγ1 1182 ± 224 50.0 ± 20.6 0.1 ± 0.2 2.3 ± 0.1 3.4 ± 0.2 
ILE303Cδ1 46 ± 743 93.6 ± 6.4 1.9 ± 0.4 3.0 ± 0.6 3.0 ± 0.7 
VAL310Cγ1 794 ± 151 97.6 ± 0.5 0.7 ± 0.1 9.0 ± 0.3 10.9 ± 0.5 
ILE315Cδ1 1275 ± 2589 77.6 ± 20.4 0.1 ± 0.5 2.6 ± 1.2 3.8 ± 2.0 
ILE335Cδ1 2469 ± 969 94.1 ± 15.6 1.6 ± 0.4 50.1 ± 3.2 64.4 ± 7.3 
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 kex (s-1) Pa (%)  (ppm) 
Rex  
(700 MHz, s-1) 
Rex  
(850 MHz, s-1) 
ILE46Cδ1 390 ± 222 50.0 ± 19.1 0.1 ± 0.3 6.0 ± 9.2 9.0 ± 11 
LEU49Cδ1 50 ± 113 91.7 ± 14.4 0.4 ± 0.2 4.2 ± 2.7 4.2 ± 4.1 
VAL57Cγ2 14 ± 13 74.0 ± 6.3 0.8 ± 0.1 5.3 ± 0.3 5.3 ± 0.3 
VAL80Cγ1 231 ± 540 94.8 ± 7.8 4.8 ± 0.5 12.1 ± 2.6 12.0 ± 2.7 
VAL80Cγ2 97 ± 74 90.9 ± 6.7 0.6 ± 0.1 8.9 ± 0.5 8.9 ± 0.7 
ILE85Cδ1 93 ± 45 91.8 ± 2.6 1.2 ± 0.04 7.8 ± 0.1 7.8 ± 0.1 
LEU89Cδ2 527 ± 172 50.0 ± 20.4 0.1 ± 0.1 4.4 ± 2.7 6.5 ± 5.5 
ILE94Cδ1 77 ± 77 81.6 ± 14.1 0.2 ± 0.2 13.4 ± 12.0 13.9 ± 15.3 
LEU95Cδ1 13 ± 94 73.4 ± 14.4 0.4 ± 0.2 5.1 ± 4.5 5.1 ± 6.6 
LEU103Cδ1 16 ± 142 86.5 ± 15.4 0.5 ± 0.2 2.6 ± 4.6 2.6 ± 6.1 
VAL104Cγ1 871 ± 347 50.0 ± 22.2 0.1 ± 0.3 2.3 ± 0.6 3.4 ± 0.8 
VAL104Cγ2 4 ± 3 71.7 ± 9.6 0.4 ± 0.1 3.1 ± 1.5 3.1 ± 1.5 
VAL119Cγ1 1193 ± 304 64.6 ± 20.8 0.1 ± 0.2 2.2 ± 0.2 3.3 ± 0.4 
VAL119Cγ2 1782 ± 389 82.0 ± 18.4 0.3 ± 0.3 6.8 ± 0.5 10.1 ± 0.7 
LEU132Cδ1 456 ± 179 94.8 ± 21.1 0.2 ± 0.2 3.7 ± 2.1 5.1 ± 3.8 
LEU152Cδ1 3695 ± 3996 75.7 ± 22.1 0.2 ± 1.1 2.3 ± 1.5 3.3 ± 2.2 
LEU160Cδ2 2225 ± 1786 99.8 ± 0.8 2.8 ± 0.9 3.5 ± 1.9 3.9 ± 2.3 
LEU173Cδ1 22 ± 67 77.4 ± 6.2 3.9 ± 0.3 6.3 ± 0.8 6.3 ± 0.8 
LEU198Cδ2 67 ± 184 94.9 ± 16.8 0.3 ± 0.3 3.3 ± 2.1 3.3 ± 3.2 
VAL288Cγ1 2040 ± 315 77.2 ± 20 0.2 ± 0.3 3.2 ± 0.2 4.7 ± 0.2 
ILE303Cδ1 2449 ± 1121 99.2 ± 12.9 1.6 ± 0.5 6.6 ± 0.8 8.4 ± 1.6 
  
Table 5.3. Results of the individual fits of methyl side chains in PKA-C/Balanol complex that have 
chemical exchange (𝑹𝒆𝒙 > 2 s-1) measured using 
13C CPMG at 700 MHz and 850 MHz. 
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 kex (s-1) Pa (%)  (ppm) 
Rex  
(700 MHz, s-1) 
Rex  
(850 MHz, s-1) 
LEU49Cδ1 667 ± 438 99.0 ± 8.8 0.9 ± 0.3 4.4 ± 0.4 4.9 ± 0.8 
VAL57Cγ2 36 ± 382 90.6 ± 7.1 1.4 ± 0.3 3.6 ± 0.5 3.6 ± 0.6 
LEU95Cδ2 780 ± 285 96.2 ± 21 0.3 ± 0.2 4.2 ± 0.5 5.8 ± 0.9 
LEU103Cδ1 1238 ± 944 50.0 ± 20.9 0.1 ± 0.6 3.6 ± 0.9 5.3 ± 1.4 
VAL104Cγ2 725 ± 32 50.0 ± 21.5 0.1 ± 0.2 3.6 ± 0.9 5.4 ± 1.6 
LEU160Cδ2 1837 ± 669 85.5 ± 18.9 0.2 ± 0.4 3.7 ± 0.4 5.5 ± 0.7 
LEU172Cδ1 57 ± 374 93.3 ± 5.0 2.4 ± 0.3 3.9 ± 0.6 3.9 ± 0.6 
ILE335Cδ1 420 ± 248 50.0 ± 20.2 0.1 ± 0.3 3.2 ± 4.2 4.8 ± 5.9 
 
  
Table 5.4. Results of the individual fits of methyl side chains in PKA-C/H89 complex that have 
chemical exchange (𝑹𝒆𝒙 > 2 s
-1) measured using 13C CPMG at 700 MHz and 850 MHz. 
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 kex = 2400  200 s-1  PA = 92.8  0.4 % 
 
Rex (700 MHz, s-1) Rex (850 MHz, s-1)  (ppm) 
Leu74C1 20.3 ± 1.7 28.7 ± 2.3 0.82 ± 0.04 
Ile94C1 9.4 ± 1.2 13.6 ± 1.8 0.54 ± 0.04 
Leu103C1 5.8  1.3 8.4  1.9 0.42 ± 0.05 
Leu106C1 11.2 ± 1.1 16.1 ± 1.6 0.60 ± 0.04 
Leu116C2 5.6 ± 1.9 8.2 ± 2.7 0.42 ± 0.08 
Ile150C1 33.8  1.8 46.3  1.4 1.09 ± 0.04 
Leu172C2 24.8  1.6 34.7  2.1 0.92 ± 0.04 
Leu173C1 18.8  2.0 26.6  2.7 0.79 ± 0.05 
Ile180C1 57.9  2.4 75.0  3.4 1.54 ± 0.04 
Val182C2 12.5  1.3 18.0  1.9 0.63 ± 0.04 
Val191C1 5.4 ± 1.3 7.9 ± 1.9 0.41 ± 0.05 
Ile335C1 51.1 ± 2.4 67.3 ± 3.0 1.42 ± 0.04 
 
  
Table 5.5. Group fit of 13C CPMG parameters of methyl side chains in PKA-C bound to ATPN. 
  166 
 
 kex = 90  50 s-1  PA = 90.9  3.9 % 
 
Rex (700 MHz, s-1) Rex (850 MHz, s-1)  (ppm) 
Val80C2 7.8  0.3 7.8  0.3 0.69 ± 0.06 
Ile85C1 7.9  0.4 7.9  0.4 1.20 ± 0.08 
Leu89C2 7.0  0.7 7.3  0.5 0.25 ± 0.02 
Ile94C1 7.3  0.5 7.5  0.4 0.30 ± 0.02 
Leu95C1 6.9  0.7 7.2  0.6 0.23 ± 0.02 
Leu103C1 6.6  0.9 7.0  0.7 0.20 ± 0.02 
Val104C1 6.5  1.0 6.9  0.8 0.19 ± 0.02 
 
 
 
 
 
 
 
 
  
Table 5.6. Group fit of 13C CPMG parameters of methyl side chains in PKA-C bound to balanol. 
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kex (s-1) Pa (%)  (ppm) 2red 
Apo PKA-C 
 
  
 L95 C2 457 ± 174 95.2 ± 0.6 2.48 ± 0.06 0.83 
I150 C1 804 ± 123 94.4 ± 0.5 1.24 ± 0.04 0.75 
Val104 C2 599  243 96.6  0.6 -1.55  0.09 1.53 
     
PKA-C/ATPN 
 
  
 V80 C1 47 ± 60 91.7 ± 8.7 -3.58 ± 1.66 1.14 
I85 C1 337 ± 79 97.3 ± 0.2 -1.04 ± 0.03 1.86 
  
  
 PKA-C/Balanol 
V80 C1 93 ± 17 93.2 ± 0.7 -4.45 ± 0.01 0.97 
I85 C1 209 ± 31 94.7 ± 0.3 -1.14 ± 0.01 1.69 
L173 C1 39 ± 25 92.5 ± 2.5 -3.58 ± 0.04 1.7 
  
  
 PKA-C/H89 
 
  
 L49 C1 51 ± 17 95.5 ± 0.9 1.09 ± 0.05 1.2 
L172 C1 42 ± 12 95.2 ± 1.4 1.61 ± 0.02 1.1 
 
  
Table 5.7. Results of the individual fits of 13C CEST for the methyl side chains of PKA-C in the 
absence (Apo) and presence of nucleotide (ATPN) or inhibitor (balanol and H89) measured at 900 
MHz. 
  168 
 
Residue 
Rex (s-1) 
apo ATPN-bound 
Balanol-
bound 
H89-bound 
3 11.8 ± 4.6 21.4 ± 5.7 15.0 ± 2.4 20.9 ± 3.7 
4 10.8 ± 1.2 11.1 ± 0.8 10.6 ± 0.7 13.7 ± 1.0 
5 11.8 ± 1.3 11.9 ± 0.9 10.5 ± 0.7 13.7 ± 1.0 
6 15.4 ± 2.0 12.2 ± 1.1 12.0 ± 1.0 15.2 ± 1.3 
7 11.8 ± 1.2 11.5 ± 0.8 10.1 ± 0.6 13.0 ± 0.9 
8 11.4 ± 1.1 12.1 ± 1.0 12.0 ± 0.9 16.6 ± 1.3 
9 12.1 ± 1.6 11.4 ± 1.0 11.0 ± 0.9 15.1 ± 1.3 
10 14.5 ± 1.9 14.2 ± 1.3 13.7 ± 1.2 18.7 ± 1.6 
11 11.0 ± 1.2 11.8 ± 1.0 13.2 ± 1.1 16.0 ± 1.3 
12 9.2 ± 0.9 9.7 ± 0.8 13.9 ± 1.2 13.1 ± 1.0 
13 10.4 ± 1.2 6.5 ± 0.5 10.8 ± 1.1 11.4 ± 1.0 
14 9.8 ± 1.5 5.9 ± 0.7 7.3 ± 0.8 7.9 ± 0.8 
15 4.8 ± 0.8 0.10 ± 0.01 8.4 ± 1.4 3.2 ± 0.4 
16 5.4 ± 0.8 7.5 ± 0.9 11.6 ± 1.5 9.1 ± 1.1 
17 ND 1.5 ± 0.2 2.2 ± 0.3 5.6 ± 0.7 
18 3.8 ± 0.6 -1.2 ± 0.1 -1.8 ± 0.3 ND 
19 ND 2.9 ± 0.5 3.8 ± 0.4 8.2 ± 1.1 
20 13.6 ± 4.4 2.6 ± 0.3 ND ND 
21 -0.5 ± 0.1 0.8 ± 0.1 5.4 ± 0.6 -0.20 ± 0.02 
24 1.5 ± 0.3 -3.1 ± 0.5 -1.9 ± 0.3 -1.7 ± 0.2 
25 ND -2.6 ± 0.4 -1.2 ± 0.1 2.9 ± 0.3 
26 ND -1.2 ± 0.2 -2.6 ± 0.4 0.5 ± 0.1 
27 3.7 ± 0.9 2.9 ± 0.6 -0.8 ± 0.1 ND 
28 -0.6 ± 0.1 -1.1 ± 0.2 -2.2 ± 0.3 0.8 ± 0.1 
29 ND 1.3 ± 0.3 -1.9 ± 0.3 1.4 ± 0.2 
30 3.6 ± 1.4 2.6 ± 0.6 6.9 ± 0.8 15.5 ± 2.1 
31 2.9 ± 0.9 3.3 ± 0.7 7.1 ± 1.7 10.3 ± 2.1 
32 2.4 ± 0.5 1.1 ± 0.2 ND 1.2 ± 0.2 
34 ND 4.9 ± 0.6 4.7 ± 0.4 7.8 ± 0.8 
35 6.5 ± 0.8 12.3 ± 1.3 5.4 ± 0.5 9.1 ± 0.9 
36 ND ND 7.6 ± 1.3 14.3 ± 2.5 
37 41.8 ± 23.4 48.5 ± 27.7 12.5 ± 2.0 16.2 ± 2.9 
38 ND 11.2 ± 1.8 6.3 ± 0.9 5.0 ± 0.6 
39 -2.1 ± 0.3 0.10 ± 0.01 ND -1.6 ± 0.2 
40 3.5 ± 0.7 ND 2.8 ± 0.4 ND 
Table 5.8. 𝑹𝒆𝒙 values for the different states of PKA-C (apo, ATPN-bound, balanol-bound, and H89 
bound) measured using 15N TROSY Hahn Echo measurements at 850 MHz and 27C. 
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41 0.5 ± 0.1 3.6 ± 0.5 0.8 ± 0.1 ND 
42 -0.10 ± 0.03 ND -1.3 ± 0.2 -2.0 ± 0.3 
43 ND 1.8 ± 0.3 3.2 ± 0.5 -1.1 ± 0.1 
44 ND 5.6 ± 0.8 3.4 ± 0.5 7.9 ± 1.3 
45 5.4 ± 0.8 3.1 ± 0.4 5.4 ± 0.6 7.8 ± 0.9 
46 9.7 ± 1.6 4.9 ± 1.1 6.6 ± 1.4 ND 
48 ND ND 22.8 ± 5.5 29.5 ± 9.0 
49 13.2 ± 3.7 16.5 ± 5.8 ND 10.3 ± 2.9 
50 5.4 ± 1.8 ND ND 3.6 ± 1.0 
52 12.9 ± 2.7 ND 1.4 ± 0.2 6.6 ± 1.1 
55 0.7 ± 0.1 17.3 ± 9.8 5.5 ± 0.9 2.5 ± 0.4 
56 16.8 ± 3.3 ND ND ND 
58 6.0 ± 1.1 17.4 ± 5.3 3.3 ± 0.5 8.8 ± 1.7 
59 15.2 ± 3.8 23.7 ± 8.4 2.4 ± 0.4 9.2 ± 2.0 
60 2.1 ± 0.4 2.7 ± 0.6 2.2 ± 0.4 4.7 ± 0.9 
61 -1.8 ± 0.3 -2.4 ± 0.5 6.2 ± 0.6 3.3 ± 0.6 
62 0.6 ± 0.1 3.5 ± 0.7 0.7 ± 0.1 3.7 ± 0.7 
63 2.6 ± 0.5 -3.5 ± 0.6 -1.6 ± -0.2 -0.30 ± 0.05 
64 3.2 ± 0.6 0.8 ± 0.1 3.9 ± 0.5 4.3 ± 0.5 
65 ND 1.3 ± 0.3 0.20 ± 0.05 7.6 ± 1.0 
66 0.3 ± 0.1 -0.30 ± 0.05 -0.9 ± 0.1 ND 
67 7.0 ± 0.8 -1.1 ± 0.1 ND ND 
68 6.0 ± 1.1 8.3 ± 1.2 2.2 ± 0.3 8.3 ± 1.1 
69 10.5 ± 2.1 7.7 ± 1.4 4.3 ± 0.5 7.5 ± 1.6 
70 6.0 ± 1.2 5.2 ± 1.0 1.0 ± 0.1 3.3 ± 0.6 
71 9.0 ± 1.5 7.4 ± 1.3 5.7 ± 0.8 17.7 ± 3.1 
72 10.6 ± 2.7 ND 0.10 ± 0.02 7.7 ± 1.8 
73 17.0 ± 4.8 ND ND 3.9 ± 0.5 
74 3.8 ± 0.7 9.8 ± 2.3 -0.3 ± 0.1 8.0 ± 1.5 
76 4.6 ± 0.9 9.5 ± 2.2 2.2 ± 0.2 4.4 ± 0.8 
77 5.2 ± 1.1 6.9 ± 1.6 10.4 ± 1.8 ND 
78 ND ND ND 3.0 ± 0.5 
79 ND ND ND 0.2 ± 0.04 
80 -1.3 ± 0.3 5.7 ± 1.3 6.2 ± 1.3 ND 
81 15.8 ± 5.5 7.7 ± 1.9 ND ND 
82 ND ND -0.40 ± 0.04 0.10 ± 0.03 
83 -3.6 ± 0.8 0.20 ± 0.03 ND 3.5 ± 0.7 
84 9.5 ± 2.3 20.2 ± 5.7 ND 6.9 ± 1.3 
85 7.2 ± 1.8 ND ND ND 
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88 8.4 ± 2.1 ND ND ND 
90 3.0 ± 0.6 5.0 ± 1.0 -5.0 ± 1.3 1.1 ± 0.4 
91 3.7 ± 0.8 ND ND ND 
92 1.6 ± 0.4 ND ND ND 
94 24.5 ± 14 ND ND ND 
95 1.9 ± 0.4 ND ND ND 
96 6.7 ± 1.3 7.4 ± 3.0 1.7 ± 0.3 4.4 ± 0.6 
97 -3.5 ± 0.6 11.4 ± 2.9 ND 0.007 ± 0.001 
98 0.7 ± 0.2 ND -1.4 ± 0.2 -2.3 ± 0.4 
99 3.7 ± 0.8 0.7 ± 0.1 2.0 ± 0.3 ND 
100 5.2 ± 0.9 3.1 ± 0.5 2.9 ± 0.3 ND 
102 ND 0.9 ± 0.2 -1.6 ± 0.3 -2.9 ± 0.5 
103 0.6 ± 0.1 -9.0 ± 2.2 0.20 ± 0.02 -4.9 ± 0.8 
104 0.4 ± 0.1 ND ND ND 
106 12.7 ± 2.4 3.4 ± 0.6 6.9 ± 0.8 ND 
107 5.5 ± 1.5 ND 3.0 ± 0.5 9.4 ± 2.4 
108 4.7 ± 1.0 6.5 ± 1.5 2.1 ± 0.6 ND 
109 5.0 ± 1.3 4.7 ± 0.8 3.1 ± 0.4 ND 
110 8.9 ± 1.9 8.9 ± 2.2 4.3 ± 0.6 8.3 ± 1.4 
111 5.1 ± 0.9 4.2 ± 0.6 7.4 ± 1.5 7.3 ± 1.0 
112 4.7 ± 0.9 3.7 ± 0.6 2.0 ± 0.3 5.8 ± 0.9 
113 5.3 ± 1.0 7.6 ± 1.3 6.0 ± 0.8 ND 
114 -0.8 ± 0.2 0.4 ± 0.1 3.4 ± 0.5 ND 
115 4.0 ± 1.1 4.8 ± 1.3 6.2 ± 1.5 8.0 ± 1.8 
116 2.5 ± 0.4 8.0 ± 1.9 3.9 ± 0.6 2.0 ± 0.4 
117 7.9 ± 1.5 9.3 ± 2.1 6.0 ± 1.1 11 ± 1.9 
118 2.8 ± 0.5 9.5 ± 1.5 7.3 ± 0.8 8.6 ± 1.6 
119 6.5 ± 1.4 ND 3.7 ± 0.8 8.7 ± 1.7 
120 13.9 ± 3.6 ND 6.2 ± 1.2 9.3 ± 2.1 
122 ND 9.0 ± 3.5 ND ND 
123 20.0 ± 6.1 ND ND 17.6 ± 5.3 
124 28.3 ± 10.8 ND 6.0 ± 0.9 3.0 ± 0.5 
125 28.5 ± 10.3 14.5 ± 10.4 -2.4 ± 0.4 1.3 ± 0.2 
126 ND ND -7.9 ± 1.0 -6.4 ± 1.1 
128 ND ND 11.1 ± 1.7 17.2 ± 5.0 
133 9.4 ± 2.3 ND ND ND 
134 4.6 ± 1.2 ND -2.6 ± 0.4 2.6 ± 0.4 
136 ND 11.4 ± 2.7 3.6 ± 0.7 4.5 ± 0.8 
137 ND 5.2 ± 0.7 2.0 ± 0.2 4.0 ± 0.5 
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138 26.8 ± 6.9 ND ND 3.7 ± 0.4 
139 13.0 ± 2.8 8.5 ± 1.3 6.5 ± 0.9 9.3 ± 1.5 
140 9.2 ± 1.7 6.9 ± 1.1 6.3 ± 0.9 12.0 ± 1.7 
142 0.4 ± 0.1 3.5 ± 0.6 -1.5 ± 0.2 0.20 ± 0.04 
143 5.2 ± 1.5 6.9 ± 2.1 -4.6 ± 1.3 5.8 ± 1.5 
144 2.5 ± 1.0 -0.2 ± 0.1 -1.1 ± 0.3 -1.8 ± 0.6 
145 -2.5 ± 0.5 ND -6.9 ± 1.6 ND 
147 12.9 ± 6.4 10.6 ± 5.6 3.9 ± 1.2 4.2 ± 1.8 
148 -5.9 ± 2.1 ND 4.4 ± 1.2 7.9 ± 2.5 
149 1.9 ± 0.5 7.1 ± 2.0 -4.8 ± 1.2 7.5 ± 2.0 
150 -9.9 ± 3.7 -10.7 ± 5.5 -4.3 ± 1.2 ND 
151 6.1 ± 2.1 3.6 ± 1.7 -0.4 ± 0.1 10.5 ± 1.3 
155 12.9 ± 3.4 4.7 ± 1.7 10.2 ± 3.3 14.2 ± 4.1 
160 -1.2 ± 0.3 ND ND -2.9 ± 0.4 
161 -0.3 ± 0.1 7.2 ± 1.4 -1.9 ± 0.2 1.8 ± 0.3 
162 3.1 ± 0.6 12.2 ± 2.7 1.7 ± 0.2 2.1 ± 0.3 
163 ND 31.0 ± 9.2 ND ND 
164 9.1 ± 4.4 ND ND 19.8 ± 8.2 
165 27.5 ± 20.3 ND 13.1 ± 4 20.6 ± 7.2 
166 2.6 ± 0.6 15.7 ± 5.1 0.10 ± 0.02 1.1 ± 0.2 
174 ND 12.2 ± 3.5 0.030 ± 0.004 ND 
175 12.3 ± 3.1 5.8 ± 1.3 -0.10 ± 0.02 6.2 ± 1.1 
176 5.6 ± 1.0 5.2 ± 1.4 3.4 ± 0.4 3.4 ± 0.6 
177 ND -0.10 ± 0.01 2.2 ± 0.3 4.5 ± 0.6 
178 -4.0 ± 1.3 -7.4 ± 2.5 -3.2 ± 0.9 2.4 ± 0.7 
179 0.10 ± 0.02 -0.4 ± 0.1 -0.3 ± 0.1 4.8 ± 0.9 
180 20.4 ± 6.6 ND 6.1 ± 1.2 9.4 ± 2.0 
181 ND 29.6 ± 15.2 ND ND 
182 21.1 ± 5.7 2.4 ± 1.0 2.0 ± 0.4 ND 
185 2.1 ± 0.4 ND ND ND 
186 17.4 ± 6.3 ND 3.7 ± 1.0 8.6 ± 1.7 
187 8.8 ± 2.6 ND ND ND 
188 6.4 ± 1.7 ND 4.9 ± 0.9 -0.3 ± 0.1 
189 3.7 ± 0.7 ND ND ND 
190 8.7 ± 2.0 11.9 ± 2.3 5.6 ± 0.7 5.4 ± 0.7 
191 8.1 ± 1.4 10.2 ± 2.3 11.4 ± 1.5 9.1 ± 1.3 
192 4.5 ± 0.9 11.4 ± 2.4 5.0 ± 0.7 ND 
193 13.8 ± 2.8 10.5 ± 2.4 13.7 ± 2.1 10.8 ± 1.3 
194 ND 4.6 ± 0.4 5.2 ± 0.4 ND 
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195 -1.2 ± 0.2 ND 0.7 ± 0.1 ND 
196 2.4 ± 0.6 6.7 ± 1.4 -2.2 ± 0.3 -9.2 ± 1.4 
197 20.7 ± 10.2 ND 13.6 ± 4.2 10.7 ± 2.7 
198 3.8 ± 0.7 8.4 ± 1.7 6.7 ± 1.0 10.7 ± 2.0 
199 4.1 ± 0.9 ND 2.4 ± 0.3 6.4 ± 1.2 
200 5.5 ± 1.2 ND 4.9 ± 0.9 5.5 ± 0.8 
203 10.3 ± 5.0 ND 16.0 ± 5.6 13.5 ± 5.2 
204 ND ND ND 4.8 ± 0.8 
205 5.8 ± 1.1 ND -4.8 ± 0.7 ND 
206 1.3 ± 0.3 2.5 ± 0.7 -1.0 ± 0.1 -0.6 ± 0.1 
208 20.3 ± 5.3 13.4 ± 3.5 13.8 ± 2.5 20.5 ± 5.1 
209 15.6 ± 4.9 19.0 ± 6.1 11.3 ± 3.4 17.5 ± 5.2 
210 0.5 ± 0.1 5.4 ± 1.4 -1.1 ± 0.2 -1.3 ± 0.3 
211 ND 0.4 ± 0.1 1.7 ± 0.2 ND 
212 1.8 ± 0.3 ND -0.20 ± 0.03 -1.3 ± 0.2 
213 ND 1.6 ± 0.3 2.6 ± 0.3 2.4 ± 0.4 
214 9.0 ± 1.9 17.8 ± 4.6 11.2 ± 1.9 9.4 ± 1.7 
215 ND 3.8 ± 0.6 ND ND 
216 5.3 ± 1.1 1.5 ± 0.3 2.7 ± 0.4 2.6 ± 0.4 
217 1.2 ± 0.2 6.3 ± 0.9 4.9 ± 0.5 ND 
219 4.8 ± 1.2 6.8 ± 1.6 3.7 ± 0.6 1.4 ± 0.3 
220 ND ND 0.20 ± 0.04 0.10 ± 0.02 
221 -0.8 ± 0.1 3.7 ± 0.6 -2.8 ± 0.3 -1.1 ± 0.1 
222 -2.0 ± 0.5 -4.2 ± 1.7 -8.0 ± 2.6 ND 
225 0.9 ± 0.4 1.8 ± 0.8 -6.2 ± 1.6 -0.9 ± 0.3 
226 1.3 ± 0.6 2.4 ± 1.1 -1.7 ± 0.5 4.9 ± 1.8 
227 ND ND 4.3 ± 0.6 ND 
228 5.2 ± 2.2 4.5 ± 2.6 0.10 ± 0.03 8.4 ± 3.4 
230 22.5 ± 10.8 ND 3.4 ± 1.1 5.3 ± 2.1 
231 ND ND ND 5.9 ± 2.4 
232 ND 1.9 ± 0.4 0.10 ± 0.01 ND 
233 19.9 ± 11.1 7.3 ± 3.4 7.2 ± 2.5 12.8 ± 5.6 
234 33.3 ± 16.1 4.4 ± 1.2 6.2 ± 1.5 6.9 ± 1.5 
238 ND ND 1.5 ± 0.2 ND 
240 0.20 ± 0.04 3.0 ± 0.5 3.8 ± 0.9 0.3 ± 0.1 
241 0.7 ± 0.1 5.3 ± 0.9 5.0 ± 0.7 4.6 ± 0.6 
242 0.7 ± 0.1 1.2 ± 0.1 2.3 ± 0.2 3.3 ± 0.3 
244 2.4 ± 0.4 4.2 ± 0.6 5.5 ± 0.6 3.8 ± 0.5 
245 -2.6 ± 0.5 -4.1 ± 0.7 -3.3 ± 0.4 -2.7 ± 0.4 
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246 -3.7 ± 0.7 -1.2 ± 0.2 -4.6 ± 0.7 -4.0 ± 0.7 
247 ND 3.1 ± 0.6 ND ND 
248 ND -2.1 ± 0.3 -2.3 ± 0.3 -3.0 ± 0.4 
249 -2.3 ± 0.4 ND -3.3 ± 0.3 -1.1 ± 0.1 
250 2.3 ± 0.4 ND 0.6 ± 0.1 ND 
251 1.1 ± 0.2 1.4 ± 0.3 0.10 ± 0.02 1.5 ± 0.2 
252 ND -1.6 ± 0.2 0.30 ± 0.03 -2.0 ± 0.3 
253 -0.10 ± 0.02 1.2 ± 0.2 -2.2 ± 0.2 0.5 ± 0.1 
254 0.6 ± 0.1 0.30 ± 0.03 5.1 ± 0.5 1.7 ± 0.2 
255 2.4 ± 0.2 7.0 ± 0.6 1.9 ± 0.1 ND 
256 0.20 ± 0.03 -1.2 ± 0.1 -0.20 ± 0.02 0.5 ± 0.1 
257 ND 19.6 ± 8.2 11.2 ± 3.6 ND 
261 -4.2 ± 0.7 -3.2 ± 0.4 -4.1 ± 0.5 -3.7 ± 0.4 
262 11.7 ± 2.6 9.3 ± 1.8 12.0 ± 2.0 17.0 ± 3.3 
263 6.0 ± 1.5 6.4 ± 1.6 3.0 ± 0.5 6.4 ± 1.2 
264 ND 0.7 ± 0.1 0.6 ± 0.1 4.9 ± 0.6 
265 7.3 ± 2.7 5.1 ± 1.9 ND -0.7 ± 0.2 
266 ND ND 9.2 ± 1.9 ND 
267 ND 4.1 ± 0.5 -2.9 ± 0.4 ND 
268 ND 0.9 ± 0.4 1.4 ± 0.4 2.2 ± 0.7 
269 4.6 ± 1.7 ND 1.7 ± 0.5 13.2 ± 5.0 
272 ND 6.9 ± 2.9 ND ND 
273 15.1 ± 5.6 ND ND ND 
274 -2.1 ± 0.5 -1.5 ± 0.5 -4.0 ± 0.9 -2.1 ± 0.5 
275 0.5 ± 0.1 3.5 ± 0.6 1.1 ± 0.1 5.9 ± 0.7 
276 3.9 ± 0.5 4.3 ± 0.6 1.9 ± 0.2 1.2 ± 0.2 
277 4.4 ± 0.7 2.3 ± 0.3 -0.20 ± 0.02 4.2 ± 0.6 
278 0.9 ± 0.3 4.5 ± 1.1 0.10 ± 0.02 7.8 ± 1.7 
279 1.6 ± 0.3 -9.2 ± 2.0 -1.6 ± 0.3 -0.20 ± 0.04 
280 -4.0 ± 0.7 -5.0 ± 0.8 -5.8 ± 0.7 -4.1 ± 0.6 
281 1.1 ± 0.2 1.9 ± 0.3 1.0 ± 0.1 3.1 ± 0.5 
282 -0.2 ± 0.1 2.2 ± 0.8 2.7 ± 0.7 ND 
283 3.7 ± 0.6 -2.0 ± 0.4 1.2 ± 0.2 3.1 ± 0.5 
284 2.2 ± 0.5 ND ND ND 
286 ND -1.2 ± 0.2 3.8 ± 0.5 5.1 ± 0.7 
287 0.8 ± 0.1 0.8 ± 0.1 1.4 ± 0.2 2.1 ± 0.3 
289 1.3 ± 0.2 -0.4 ± 0.1 -3.0 ± 0.4 3.0 ± 0.4 
290 -3.8 ± 0.7 -5.1 ± 0.8 -4.6 ± 0.6 -3.9 ± 0.6 
291 -3.4 ± 0.7 -2.3 ± 0.4 -3.5 ± 0.4 -4.0 ± 0.6 
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292 -5.1 ± 1.4 -1.8 ± 0.6 -3.9 ± 1.3 -3.2 ± 0.9 
293 -0.30 ± 0.04 0.10 ± 0.01 -0.9 ± 0.1 0.30 ± 0.03 
294 -5.1 ± 1.3 -4.0 ± 1.1 -3.9 ± 1.0 -1.9 ± 0.4 
295 -3.1 ± 0.5 -0.7 ± 0.1 -0.8 ± 0.1 0.20 ± 0.03 
296 31.9 ± 8.9 29.9 ± 7.0 31.2 ± 5.9 44.3 ± 11.5 
297 -1.2 ± 0.5 ND ND 5.0 ± 0.7 
298 -1.8 ± 0.3 -0.9 ± 0.1 -1.6 ± 0.2 -0.5 ± 0.1 
299 7.7 ± 2.6 2.5 ± 0.7 3.0 ± 0.6 6.0 ± 1.3 
300 ND 2.9 ± 0.3 2.3 ± 0.4 6.2 ± 0.6 
301 -0.6 ± 0.1 -1.1 ± 0.2 -1.8 ± 0.2 0.9 ± 0.1 
302 -0.2 ± 0 -0.5 ± 0.1 0.10 ± 0.02 0.7 ± 0.1 
303 ND ND -1.7 ± 0.2 ND 
304 -2.6 ± 0.4 -3.5 ± 0.5 1.1 ± 0.1 0.6 ± 0.1 
305 ND 32.8 ± 8.1 -3.1 ± 0.6 1.7 ± 0.4 
306 -0.3 ± 0.1 -3.1 ± 0.8 1.1 ± 0.2 4.4 ± 0.8 
307 1.2 ± 0.2 2.3 ± 0.4 -0.8 ± 0.1 ND 
308 ND -2.3 ± 0.4 -2.7 ± 0.4 0.7 ± 0.1 
309 5.0 ± 1.0 0.4 ± 0.1 2.7 ± 0.4 4.6 ± 0.8 
310 -2.2 ± 0.4 -3.1 ± 0.6 -3.6 ± 0.5 -3.2 ± 0.5 
311 0.8 ± 0.1 -0.9 ± 0.1 0.40 ± 0.05 2.1 ± 0.3 
312 0.9 ± 0.1 3.3 ± 0.4 2.2 ± 0.2 3.3 ± 0.4 
314 6.2 ± 1.9 2.1 ± 0.4 1.0 ± 0.2 -5.1 ± 0.7 
315 11.0 ± 1.8 3.8 ± 0.5 4.5 ± 0.5 1.7 ± 0.2 
317 ND 6.0 ± 2.7 0.5 ± 0.2 5.5 ± 0.6 
318 4.1 ± 0.8 ND 4.2 ± 0.4 4.9 ± 0.4 
320 ND ND 4.3 ± 0.6 6.2 ± 0.8 
322 16.3 ± 3.9 14.7 ± 5.5 19.7 ± 4.4 21.9 ± 5.3 
323 ND 0.4 ± 0.1 ND -1.1 ± 0.2 
325 ND ND ND 1.7 ± 0.4 
326 ND ND ND 8.5 ± 1.6 
329 ND ND ND 4.1 ± 0.4 
331 ND 13.0 ± 7.5 3.7 ± 0.4 6.9 ± 0.7 
332 ND 33.4 ± 16.4 5.8 ± 0.6 11.6 ± 1.3 
333 ND ND 4.5 ± 0.9 ND 
334 7.8 ± 1.3 11.1 ± 1.6 3.6 ± 0.3 6.5 ± 0.7 
335 ND 4.9 ± 0.6 ND 6.2 ± 0.7 
336 2.5 ± 0.3 5.2 ± 0.6 5.6 ± 0.5 4.7 ± 0.5 
337 9.3 ± 1.3 37.2 ± 8.2 10.3 ± 1.1 ND 
338 ND -0.6 ± 0.1 1.5 ± 0.2 1.0 ± 0.2 
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339 ND 4.6 ± 0.6 3.5 ± 0.5 5.8 ± 1.0 
340 -0.6 ± 0.1 -2.4 ± 0.3 0.10 ± 0.02 -0.30 ± 0.03 
341 3.3 ± 0.4 1.8 ± 0.2 2.3 ± 0.2 5.9 ± 0.6 
342 5.2 ± 0.9 5.0 ± 0.8 3.4 ± 0.4 5.5 ± 0.8 
343 6.3 ± 1.2 2.8 ± 0.4 3.7 ± 0.5 9.5 ± 1.3 
344 3.5 ± 0.6 4.2 ± 0.6 1.7 ± 0.2 6.1 ± 0.9 
345 ND 1.6 ± 0.2 2.7 ± 0.4 3.8 ± 0.5 
346 5.3 ± 1.6 9.4 ± 2.7 14.5 ± 3.9 ND 
347 -1.8 ± 0.4 -1.4 ± 0.2 12.3 ± 2.9 -1.9 ± 0.4 
348 1.5 ± 0.3 3.1 ± 0.5 2.2 ± 0.4 3.1 ± 0.5 
349 6.9 ± 1.2 5.9 ± 0.9 5.2 ± 0.7 7.0 ± 1.0 
350 ND -0.30 ± 0.04 -5.6 ± 0.6 -3.0 ± 0.4 
 
ND=not determined due to broadening or overlap.  
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Residue 
HX NOE 
apo ATPN-bound 
Balanol-
bound 
H89-bound 
3 -1.84 ± -0.05 -1.71 ± 0.11 -0.69 ± 0.03 -0.91 ± 0.03 
4 -0.33 ± -0.01 -0.31 ± 0.01 -0.20 ± 0.01 -0.20 ± 0.01 
5 -0.14 ± -0.01 -0.11 ± 0.01 ND ND 
6 -0.76 ± -0.01 -0.84 ± 0.02 -0.92 ± 0.02 -0.54 ± 0.01 
7 0.32 ± 0.01 0.27 ± 0.01 0.490 ± 0.004 0.260 ± 0.005 
8 0.240 ± 0.004 0.11 ± 0.01 0.21 ± 0.01 0.23 ± 0.01 
9 0.29 ± 0.01 0.25 ± 0.01 0.33 ± 0.01 0.36 ± 0.01 
10 0.52 ± 0.01 0.50 ± 0.01 0.52 ± 0.01 0.50 ± 0.01 
11 0.45 ± 0.01 0.45 ± 0.01 0.48 ± 0.01 0.50 ± 0.01 
12 0.52 ± 0.01 0.48 ± 0.01 0.49 ± 0.01 0.53 ± 0.01 
13 0.48 ± 0.01 0.51 ± 0.01 0.62 ± 0.01 0.59 ± 0.01 
14 0.60 ± 0.01 0.55 ± 0.02 0.62 ± 0.01 ND 
15 ND 0.61 ± 0.03 1.00 ± 0.02 0.71 ± 0.01 
16 0.66 ± 0.01 0.70 ± 0.02 0.70 ± 0.02 0.61 ± 0.01 
17 ND 0.73 ± 0.02 0.74 ± 0.02 0.78 ± 0.01 
18 0.79 ± 0.01 0.81 ± 0.02 0.83 ± 0.02 0.85 ± 0.01 
19 ND 0.72 ± 0.05 0.88 ± 0.01 0.91 ± 0.01 
20 ND ND 0.81 ± 0.01 ND 
21 0.82 ± 0.02 0.81 ± 0.03 0.80 ± 0.01 0.84 ± 0.01 
24 0.92 ± 0.05 0.87 ± 0.03 0.87 ± 0.02 0.93 ± 0.02 
25 0.91 ± 0.02 0.87 ± 0.03 0.91 ± 0.02 0.93 ± 0.01 
26 ND 0.82 ± 0.03 0.82 ± 0.02 0.90 ± 0.02 
27 0.83 ± 0.03 0.88 ± 0.03 0.91 ± 0.01 0.91 ± 0.02 
28 0.86 ± 0.02 0.88 ± 0.03 0.80 ± 0.02 0.93 ± 0.02 
29 ND 0.89 ± 0.03 0.77 ± 0.02 0.86 ± 0.02 
30 0.89 ± 0.05 0.94 ± 0.04 0.73 ± 0.01 0.78 ± 0.02 
31 0.77 ± 0.04 0.79 ± 0.03 0.96 ± 0.03 0.81 ± 0.02 
32 0.76 ± 0.03 0.66 ± 0.03 ND 0.91 ± 0.02 
34 ND 0.68 ± 0.02 0.68 ± 0.01 0.67 ± 0.01 
35 0.67 ± 0.01 0.67 ± 0.02 0.66 ± 0.01 0.64 ± 0.01 
36 ND ND 0.81 ± 0.03 0.67 ± 0.02 
37 0.78 ± 0.07 0.83 ± 0.06 0.79 ± 0.02 0.81 ± 0.02 
38 ND 0.78 ± 0.02 0.91 ± 0.02 0.79 ± 0.01 
39 0.86 ± 0.02 0.73 ± 0.02 ND 0.97 ± 0.01 
40 0.87 ± 0.03 ND 0.88 ± 0.01 ND 
Table 5.9. HX-NOE values for the backbone residues the different states of PKA-C (apo, ATPN-
bound, balanol-bound, and H89-bound) measured on a 900 MHz spectrometer at 27C. 
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41 0.86 ± 0.02 0.85 ± 0.02 0.87 ± 0.01 ND 
42 0.89 ± 0.02 0.93 ± 0.02 0.93 ± 0.02 0.89 ± 0.02 
43 ND 0.89 ± 0.03 0.82 ± 0.02 0.93 ± 0.01 
44 ND 0.94 ± 0.02 0.91 ± 0.02 0.95 ± 0.02 
45 0.79 ± 0.01 0.67 ± 0.07 0.84 ± 0.01 0.86 ± 0.01 
46 0.88 ± 0.02 0.89 ± 0.03 0.94 ± 0.03 ND 
48 ND ND 0.89 ± 0.03 0.94 ± 0.03 
49 0.85 ± 0.03 0.85 ± 0.06 ND 0.96 ± 0.03 
50 0.74 ± 0.05 ND ND 0.88 ± 0.03 
52 0.69 ± 0.02 ND 0.98 ± 0.02 0.88 ± 0.02 
55 0.78 ± 0.02 0.86 ± 0.09 0.81 ± 0.02 0.88 ± 0.02 
56 0.78 ± 0.02 ND ND ND 
58 0.90 ± 0.02 1.01 ± 0.05 0.88 ± 0.02 0.97 ± 0.02 
59 0.84 ± 0.03 1.05 ± 0.05 0.92 ± 0.03 0.91 ± 0.02 
60 0.93 ± 0.03 0.91 ± 0.03 0.97 ± 0.03 0.89 ± 0.02 
61 0.83 ± 0.02 0.91 ± 0.03 0.89 ± 0.01 0.94 ± 0.02 
62 0.84 ± 0.02 0.96 ± 0.03 0.89 ± 0.02 0.93 ± 0.02 
63 0.84 ± 0.02 0.85 ± 0.03 0.82 ± 0.02 0.80 ± 0.02 
64 0.34 ± 0.02 0.34 ± 0.02 0.29 ± 0.01 ND 
65 ND ND 0.68 ± 0.03 0.89 ± 0.01 
66 0.91 ± 0.03 ND 0.98 ± 0.02 ND 
67 0.82 ± 0.01 ND 0.97 ± 0.02 ND 
68 0.87 ± 0.02 0.94 ± 0.04 0.92 ± 0.02 0.92 ± 0.01 
69 0.79 ± 0.02 0.88 ± 0.03 0.89 ± 0.01 0.91 ± 0.03 
70 0.85 ± 0.02 0.93 ± 0.03 0.95 ± 0.01 0.99 ± 0.02 
71 0.88 ± 0.02 0.92 ± 0.02 0.89 ± 0.02 0.80 ± 0.02 
72 0.94 ± 0.03 1.00 ± 0.16 0.96 ± 0.02 0.96 ± 0.02 
73 0.89 ± 0.04 ND ND 0.92 ± 0.02 
74 0.90 ± 0.02 0.93 ± 0.03 0.95 ± 0.03 0.94 ± 0.02 
76 0.94 ± 0.02 0.84 ± 0.03 0.49 ± 0.01 0.88 ± 0.02 
77 0.84 ± 0.02 0.84 ± 0.04 0.89 ± 0.02 ND 
78 0.92 ± 0.03 0.84 ± 0.05 ND 0.80 ± 0.02 
79 ND ND ND 0.88 ± 0.03 
80 0.91 ± 0.03 ND 0.85 ± 0.03 0.91 ± 0.01 
81 0.94 ± 0.02 0.92 ± 0.04 ND ND 
82 0.91 ± 0.02 0.74 ± 0.04 0.88 ± 0.01 0.89 ± 0.02 
83 0.85 ± 0.02 1.01 ± 0.04 ND 0.95 ± 0.02 
84 0.83 ± 0.04 0.87 ± 0.05 ND 0.89 ± 0.02 
85 0.77 ± 0.03 ND ND ND 
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88 0.87 ± 0.06 ND ND ND 
90 0.86 ± 0.02 1.02 ± 0.03 0.94 ± 0.04 0.89 ± 0.06 
91 0.92 ± 0.03 ND ND ND 
94 0.76 ± 0.05 ND ND ND 
95 0.88 ± 0.03 ND ND ND 
96 0.86 ± 0.02 0.99 ± 0.05 0.96 ± 0.02 0.69 ± 0.01 
97 0.87 ± 0.03 0.90 ± 0.04 ND 0.86 ± 0.02 
98 0.90 ± 0.04 0.87 ± 0.03 0.91 ± 0.02 0.87 ± 0.02 
99 0.86 ± 0.03 ND 0.88 ± 0.02 ND 
100 0.78 ± 0.02 0.89 ± 0.03 0.86 ± 0.01 ND 
102 ND 1.00 ± 0.04 0.89 ± 0.03 0.99 ± 0.03 
103 0.86 ± 0.02 0.89 ± 0.03 0.88 ± 0.02 0.90 ± 0.02 
104 0.97 ± 0.05 ND ND ND 
106 0.86 ± 0.02 0.83 ± 0.03 0.91 ± 0.02 ND 
107 0.80 ± 0.03 ND 0.85 ± 0.02 0.94 ± 0.03 
108 0.84 ± 0.03 0.96 ± 0.04 0.91 ± 0.04 ND 
109 1.01 ± 0.04 0.85 ± 0.03 0.86 ± 0.02 ND 
110 0.94 ± 0.03 0.97 ± 0.04 0.88 ± 0.02 0.91 ± 0.02 
111 0.9 ± 0.02 0.94 ± 0.02 0.98 ± 0.05 0.93 ± 0.01 
112 0.88 ± 0.02 0.88 ± 0.03 1.01 ± 0.02 0.92 ± 0.01 
113 0.87 ± 0.02 0.90 ± 0.02 0.88 ± 0.02 ND 
114 0.87 ± 0.03 ND 0.87 ± 0.01 ND 
115 0.90 ± 0.02 0.78 ± 0.03 1.06 ± 0.04 1.03 ± 0.03 
116 0.94 ± 0.02 0.90 ± 0.04 0.95 ± 0.02 1.00 ± 0.02 
117 0.93 ± 0.02 0.93 ± 0.03 0.90 ± 0.03 0.98 ± 0.02 
118 0.89 ± 0.02 0.90 ± 0.02 0.91 ± 0.01 0.89 ± 0.02 
119 0.94 ± 0.04 0.85 ± 0.02 1.03 ± 0.05 0.94 ± 0.02 
120 1.00 ± 0.04 1.10 ± 0.23 0.89 ± 0.03 0.86 ± 0.01 
122 ND 0.88 ± 0.09 ND ND 
123 0.70 ± 0.04 ND ND 1.06 ± 0.04 
124 0.75 ± 0.05 0.73 ± 0.09 ND 0.81 ± 0.02 
125 0.66 ± 0.05 ND 0.80 ± 0.02 0.93 ± 0.02 
126 ND ND 0.98 ± 0.02 0.93 ± 0.02 
128 ND ND 1.01 ± 0.02 0.93 ± 0.03 
133 0.82 ± 0.03 ND ND ND 
134 0.90 ± 0.03 ND 0.98 ± 0.03 0.87 ± 0.02 
136 ND 0.82 ± 0.04 0.89 ± 0.03 0.86 ± 0.02 
137 ND 0.77 ± 0.03 0.74 ± 0.01 0.93 ± 0.02 
138 0.90 ± 0.02 ND ND 0.85 ± 0.01 
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139 0.91 ± 0.02 0.96 ± 0.03 0.88 ± 0.01 0.89 ± 0.02 
140 0.96 ± 0.02 0.91 ± 0.02 0.88 ± 0.02 0.89 ± 0.01 
142 0.89 ± 0.02 0.93 ± 0.03 0.92 ± 0.02 0.94 ± 0.02 
143 0.69 ± 0.04 0.80 ± 0.06 0.92 ± 0.05 1.01 ± 0.04 
144 1.11 ± 0.1 1.01 ± 0.12 0.86 ± 0.09 0.99 ± 0.07 
145 0.79 ± 0.04 ND 0.95 ± 0.02 ND 
147 ND 0.78 ± 0.14 1.07 ± 0.10 0.99 ± 0.10 
148 0.87 ± 0.08 1.02 ± 0.13 0.92 ± 0.08 1.07 ± 0.07 
149 0.55 ± 0.05 0.29 ± 0.05 1.09 ± 0.08 0.58 ± 0.04 
150 0.54 ± 0.03 0.82 ± 0.12 1.19 ± 0.11 0.84 ± 0.06 
151 0.87 ± 0.12 1.11 ± 0.12 0.85 ± 0.02 0.77 ± 0.01 
155 0.87 ± 0.04 1.08 ± 0.11 0.89 ± 0.06 0.88 ± 0.04 
160 0.82 ± 0.05 ND ND ND 
161 0.84 ± 0.02 0.84 ± 0.02 0.99 ± 0.01 0.89 ± 0.01 
162 0.89 ± 0.02 1.10 ± 0.04 0.90 ± 0.02 0.91 ± 0.01 
163 ND 0.97 ± 0.07 ND ND 
164 ND ND ND 0.96 ± 0.05 
165 1.11 ± 0.10 ND 0.88 ± 0.05 0.97 ± 0.04 
166 0.82 ± 0.03 0.96 ± 0.08 0.74 ± 0.02 0.78 ± 0.02 
174 ND 0.84 ± 0.04 0.84 ± 0.01 ND 
175 0.87 ± 0.02 0.95 ± 0.04 0.94 ± 0.03 0.90 ± 0.02 
176 0.81 ± 0.02 0.84 ± 0.07 0.75 ± 0.01 0.92 ± 0.02 
177 ND 0.96 ± 0.03 0.88 ± 0.01 0.93 ± 0.01 
178 1.07 ± 0.05 0.80 ± 0.05 0.84 ± 0.05 0.96 ± 0.04 
179 0.90 ± 0.03 0.98 ± 0.05 0.98 ± 0.03 0.98 ± 0.02 
180 0.93 ± 0.04 ND 0.82 ± 0.02 0.87 ± 0.02 
181 ND 1.00 ± 0.09 ND ND 
182 0.87 ± 0.03 ND 0.96 ± 0.04 ND 
186 0.78 ± 0.04 ND 0.90 ± 0.04 0.79 ± 0.02 
187 0.72 ± 0.03 ND ND ND 
188 0.92 ± 0.03 ND 0.81 ± 0.02 0.87 ± 0.02 
189 0.91 ± 0.03 ND ND ND 
190 0.83 ± 0.03 0.83 ± 0.04 0.90 ± 0.02 0.88 ± 0.02 
191 0.90 ± 0.02 0.95 ± 0.05 0.84 ± 0.01 0.87 ± 0.01 
192 0.69 ± 0.01 ND 0.73 ± 0.01 ND 
193 ND 0.36 ± 0.03 0.49 ± 0.01 0.64 ± 0.01 
194 ND ND 0.69 ± 0.01 ND 
195 0.86 ± 0.02 ND 0.84 ± 0.02 ND 
196 0.91 ± 0.03 ND 0.87 ± 0.01 0.89 ± 0.01 
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197 1.02 ± 0.07 ND 0.88 ± 0.05 0.91 ± 0.03 
198 0.89 ± 0.02 0.82 ± 0.03 0.84 ± 0.02 0.88 ± 0.02 
199 ND ND 0.85 ± 0.02 0.93 ± 0.02 
200 0.73 ± 0.02 ND 0.78 ± 0.03 0.79 ± 0.02 
203 0.91 ± 0.08 ND 0.65 ± 0.04 0.86 ± 0.06 
205 0.92 ± 0.02 ND 0.90 ± 0.02 ND 
206 0.90 ± 0.03 ND 0.84 ± 0.02 0.91 ± 0.02 
208 0.89 ± 0.03 0.89 ± 0.04 0.95 ± 0.02 0.99 ± 0.03 
209 0.96 ± 0.04 0.97 ± 0.05 0.88 ± 0.03 0.89 ± 0.03 
210 1.03 ± 0.03 0.94 ± 0.05 0.82 ± 0.02 0.91 ± 0.03 
211 ND ND 0.94 ± 0.02 ND 
212 0.84 ± 0.02 0.91 ± 0.02 0.88 ± 0.02 0.88 ± 0.01 
213 0.88 ± 0.02 0.76 ± 0.03 0.83 ± 0.02 0.91 ± 0.02 
214 0.83 ± 0.02 1.00 ± 0.04 0.85 ± 0.02 0.92 ± 0.02 
215 ND ND 0.85 ± 0.01 ND 
216 0.99 ± 0.03 0.87 ± 0.04 0.91 ± 0.02 0.91 ± 0.02 
217 0.72 ± 0.02 ND 0.85 ± 0.01 ND 
218 ND 0.81 ± 0.04 ND 0.94 ± 0.01 
219 1.00 ± 0.03 0.97 ± 0.04 0.99 ± 0.03 0.94 ± 0.02 
220 ND 0.98 ± 0.08 0.97 ± 0.02 0.95 ± 0.02 
221 0.94 ± 0.02 0.95 ± 0.03 0.94 ± 0.02 0.93 ± 0.02 
222 0.80 ± 0.02 0.89 ± 0.06 ND ND 
225 1.02 ± 0.13 0.77 ± 0.09 0.88 ± 0.09 0.90 ± 0.07 
226 ND 0.96 ± 0.14 0.92 ± 0.10 1.08 ± 0.09 
227 ND 0.96 ± 0.19 0.83 ± 0.02 ND 
228 1.02 ± 0.13 1.10 ± 0.16 0.90 ± 0.09 0.92 ± 0.09 
230 ND 0.76 ± 0.10 0.97 ± 0.10 0.85 ± 0.06 
231 ND 1.03 ± 0.19 ND 0.84 ± 0.05 
232 ND 0.91 ± 0.03 0.75 ± 0.01 0.94 ± 0.02 
233 ND 1.13 ± 0.24 0.89 ± 0.10 0.92 ± 0.09 
234 0.99 ± 0.09 0.94 ± 0.04 0.97 ± 0.02 0.92 ± 0.02 
238 ND ND 0.96 ± 0.02 ND 
240 0.71 ± 0.03 0.64 ± 0.05 0.77 ± 0.04 0.79 ± 0.04 
241 0.59 ± 0.02 0.61 ± 0.03 0.62 ± 0.01 0.63 ± 0.02 
242 0.50 ± 0.01 0.57 ± 0.02 0.60 ± 0.01 0.60 ± 0.01 
244 0.64 ± 0.02 0.77 ± 0.02 0.67 ± 0.01 ND 
245 0.68 ± 0.02 0.68 ± 0.02 0.69 ± 0.02 0.76 ± 0.02 
246 0.81 ± 0.02 0.92 ± 0.04 0.82 ± 0.02 0.83 ± 0.02 
247 ND ND 0.88 ± 0.01 ND 
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248 0.83 ± 0.02 0.86 ± 0.02 0.83 ± 0.01 0.84 ± 0.01 
249 0.89 ± 0.02 ND 0.80 ± 0.01 0.83 ± 0.02 
250 0.86 ± 0.03 0.85 ± 0.04 0.97 ± 0.02 1.01 ± 0.03 
251 0.92 ± 0.03 0.94 ± 0.03 0.87 ± 0.02 1.01 ± 0.02 
252 0.88 ± 0.02 0.87 ± 0.02 0.81 ± 0.01 0.88 ± 0.01 
253 0.74 ± 0.01 0.81 ± 0.02 0.74 ± 0.01 0.84 ± 0.01 
254 0.69 ± 0.01 0.69 ± 0.02 0.66 ± 0.01 0.70 ± 0.01 
255 ND ND 0.57 ± 0.01 ND 
256 0.75 ± 0.01 0.79 ± 0.02 0.80 ± 0.01 0.76 ± 0.01 
257 ND ND 0.84 ± 0.03 ND 
261 0.91 ± 0.01 0.91 ± 0.02 0.86 ± 0.01 0.91 ± 0.01 
262 0.91 ± 0.02 0.90 ± 0.03 0.99 ± 0.02 0.93 ± 0.02 
263 0.95 ± 0.02 0.89 ± 0.03 0.96 ± 0.02 0.88 ± 0.02 
264 ND 0.98 ± 0.02 0.87 ± 0.01 0.94 ± 0.01 
265 0.70 ± 0.08 1.11 ± 0.11 1.07 ± 0.08 0.93 ± 0.05 
266 ND ND 0.85 ± 0.03 ND 
267 ND ND 0.98 ± 0.01 ND 
268 0.87 ± 0.09 1.18 ± 0.13 0.92 ± 0.08 0.97 ± 0.06 
269 1.02 ± 0.10 0.98 ± 0.11 0.83 ± 0.09 0.85 ± 0.07 
273 0.97 ± 0.10 ND ND ND 
274 0.66 ± 0.09 0.94 ± 0.08 0.99 ± 0.07 1.00 ± 0.05 
275 0.86 ± 0.02 0.90 ± 0.03 0.91 ± 0.02 0.95 ± 0.01 
276 0.80 ± 0.01 0.83 ± 0.02 0.89 ± 0.01 0.97 ± 0.02 
277 0.85 ± 0.02 0.85 ± 0.02 ND 0.82 ± 0.01 
278 0.93 ± 0.04 0.89 ± 0.04 0.77 ± 0.02 0.92 ± 0.03 
279 0.86 ± 0.02 0.85 ± 0.03 0.84 ± 0.02 0.92 ± 0.02 
280 0.79 ± 0.02 0.86 ± 0.02 0.87 ± 0.02 0.81 ± 0.02 
281 0.97 ± 0.02 1.00 ± 0.02 0.88 ± 0.01 0.97 ± 0.02 
282 0.84 ± 0.05 1.02 ± 0.07 0.93 ± 0.04 ND 
283 0.87 ± 0.02 0.88 ± 0.03 0.96 ± 0.02 0.90 ± 0.02 
284 0.88 ± 0.03 ND ND ND 
286 ND ND 0.75 ± 0.01 0.84 ± 0.02 
287 0.88 ± 0.02 0.93 ± 0.02 0.88 ± 0.01 0.91 ± 0.01 
289 0.85 ± 0.02 0.97 ± 0.02 0.88 ± 0.02 0.90 ± 0.01 
290 0.90 ± 0.02 0.82 ± 0.02 0.93 ± 0.02 0.89 ± 0.02 
291 0.91 ± 0.02 0.92 ± 0.03 0.88 ± 0.02 0.89 ± 0.02 
292 ND 0.95 ± 0.06 0.91 ± 0.04 0.97 ± 0.04 
293 0.93 ± 0.02 0.86 ± 0.02 0.96 ± 0.01 0.93 ± 0.01 
294 1.12 ± 0.08 0.86 ± 0.05 0.94 ± 0.03 0.91 ± 0.03 
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295 0.92 ± 0.02 0.95 ± 0.02 0.90 ± 0.01 0.87 ± 0.01 
296 ND 0.88 ± 0.02 0.96 ± 0.02 0.98 ± 0.02 
297 0.93 ± 0.10 0.86 ± 0.10 0.98 ± 0.09 0.86 ± 0.02 
298 0.87 ± 0.01 0.91 ± 0.02 0.93 ± 0.01 0.92 ± 0.01 
299 0.81 ± 0.03 0.70 ± 0.03 0.81 ± 0.02 0.93 ± 0.03 
300 ND ND 0.86 ± 0.03 0.62 ± 0.01 
301 0.82 ± 0.02 0.81 ± 0.02 ND 0.82 ± 0.01 
302 0.86 ± 0.02 0.87 ± 0.02 0.85 ± 0.02 0.85 ± 0.01 
303 0.81 ± 0.03 ND 0.87 ± 0.01 ND 
304 0.90 ± 0.02 0.87 ± 0.02 0.89 ± 0.02 0.90 ± 0.01 
305 ND 0.96 ± 0.08 0.97 ± 0.03 0.89 ± 0.03 
306 ND 0.93 ± 0.07 0.91 ± 0.04 0.82 ± 0.02 
307 0.81 ± 0.02 0.86 ± 0.03 0.86 ± 0.02 ND 
308 ND 1.01 ± 0.03 0.98 ± 0.02 0.88 ± 0.01 
309 0.82 ± 0.02 0.92 ± 0.03 0.95 ± 0.02 0.90 ± 0.02 
310 0.81 ± 0.03 0.78 ± 0.04 0.77 ± 0.02 0.87 ± 0.02 
311 0.82 ± 0.01 0.77 ± 0.02 0.84 ± 0.01 0.83 ± 0.01 
312 0.63 ± 0.01 0.72 ± 0.02 0.72 ± 0.01 0.72 ± 0.01 
314 1.01 ± 0.05 0.96 ± 0.04 0.94 ± 0.02 0.86 ± 0.02 
315 0.82 ± 0.02 0.85 ± 0.02 0.89 ± 0.01 0.89 ± 0.01 
317 ND ND 1.02 ± 0.09 0.67 ± 0.01 
318 ND 0.78 ± 0.03 0.68 ± 0.01 0.69 ± 0.01 
320 ND ND 0.24 ± 0.02 0.30 ± 0.02 
322 0.55 ± 0.02 0.74 ± 0.08 0.64 ± 0.03 0.69 ± 0.03 
323 ND ND ND 0.86 ± 0.02 
325 ND ND ND 0.79 ± 0.03 
326 ND ND ND 0.88 ± 0.02 
329 ND ND ND 0.79 ± 0.01 
331 0.57 ± 0.02 0.71 ± 0.05 0.74 ± 0.01 0.79 ± 0.01 
332 ND 0.82 ± 0.06 0.72 ± 0.01 0.70 ± 0.01 
333 ND 0.73 ± 0.03 0.93 ± 0.03 ND 
334 0.58 ± 0.02 0.49 ± 0.02 0.48 ± 0.01 0.55 ± 0.01 
335 ND 0.53 ± 0.02 ND 0.56 ± 0.01 
336 0.62 ± 0.01 0.53 ± 0.02 0.61 ± 0.01 0.62 ± 0.01 
337 0.66 ± 0.02 ND 0.51 ± 0.01 ND 
338 ND 0.93 ± 0.02 0.85 ± 0.02 0.91 ± 0.02 
339 ND 0.77 ± 0.02 0.77 ± 0.02 0.83 ± 0.02 
340 0.89 ± 0.01 0.89 ± 0.02 0.90 ± 0.02 0.87 ± 0.01 
341 0.76 ± 0.01 0.76 ± 0.02 0.87 ± 0.01 0.85 ± 0.01 
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342 0.88 ± 0.02 0.91 ± 0.02 0.90 ± 0.01 0.87 ± 0.01 
343 0.89 ± 0.02 0.91 ± 0.02 0.82 ± 0.01 0.81 ± 0.01 
344 0.83 ± 0.02 0.85 ± 0.02 0.78 ± 0.02 0.79 ± 0.01 
345 0.77 ± 0.01 0.84 ± 0.02 0.83 ± 0.01 0.82 ± 0.02 
346 0.80 ± 0.04 0.81 ± 0.04 0.93 ± 0.04 ND 
347 1.08 ± 0.03 0.90 ± 0.03 ND 1.00 ± 0.03 
348 0.90 ± 0.03 0.80 ± 0.03 0.93 ± 0.03 0.86 ± 0.02 
349 0.87 ± 0.02 0.90 ± 0.02 0.83 ± 0.01 0.91 ± 0.01 
350 ND 0.84 ± 0.02 0.81 ± 0.01 0.81 ± 0.01 
 
 
ND=not determined due to broadening or overlap. 
  
  184 
Bibliography 
 
1. Krebs, E.G., The phosphorylation of proteins: a major mechanism for biological 
regulation. Biochemical Society Transactions, 1985. 13(5): p. 813-820. 
2. Manning, G., D.B. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam, The 
protein kinase complement of the human genome. Science, 2002. 298(5600): p. 
1912-34. 
3. Pearce, L.R., D. Komander, and D.R. Alessi, The nuts and bolts of AGC protein 
kinases. Nat Rev Mol Cell Biol, 2010. 11(1): p. 9-22. 
4. Collett, M.S. and R.L. Erikson, Protein kinase activity associated with the avian 
sarcoma virus src gene product. Proc Natl Acad Sci U S A, 1978. 75(4): p. 2021-
4. 
5. Lahiry, P., A. Torkamani, N.J. Schork, and R.A. Hegele, Kinase mutations in 
human disease: interpreting genotype-phenotype relationships. Nat Rev Genet, 
2010. 11(1): p. 60-74. 
6. Naranjan, S.D., Role of protein kinase C and protein kinase A in heart function in 
health and disease. Experimental and clinical cardiology., 1999. 4(1): p. 7. 
7. George, S., J.J. Rochford, C. Wolfrum, S.L. Gray, S. Schinner, J.C. Wilson, M.A. 
Soos, P.R. Murgatroyd, R.M. Williams, C.L. Acerini, D.B. Dunger, D. Barford, 
A.M. Umpleby, N.J. Wareham, H.A. Davies, A.J. Schafer, M. Stoffel, S. 
O'Rahilly, and I. Barroso, A family with severe insulin resistance and diabetes due 
to a mutation in AKT2. Science, 2004. 304(5675): p. 1325-8. 
8. Knighton, D.R., J.H. Zheng, L.F. Ten Eyck, V.A. Ashford, N.H. Xuong, S.S. 
Taylor, and J.M. Sowadski, Crystal structure of the catalytic subunit of cyclic 
adenosine monophosphate-dependent protein kinase. Science, 1991. 253(5018): 
p. 407-14. 
9. Knighton, D.R., J.H. Zheng, L.F. Ten Eyck, N.H. Xuong, S.S. Taylor, and J.M. 
Sowadski, Structure of a peptide inhibitor bound to the catalytic subunit of cyclic 
adenosine monophosphate-dependent protein kinase. Science, 1991. 253(5018): 
p. 414-20. 
10. Gill, G.N. and L.D. Garren, A cyclic-3',5'-adenosine monophosphate dependent 
protein kinase from the adrenal cortex: comparison with a cyclic AMP binding 
protein. Biochem Biophys Res Commun, 1970. 39(3): p. 335-43. 
11. Brostrom, M.A., E.M. Reimann, D.A. Walsh, and E.G. Krebs, A cyclic 3',5'-amp-
stimulated protein kinase from cardiac muscle. Adv Enzyme Regul, 1970. 8: p. 
191-203. 
12. Shabb, J.B., Physiological substrates of cAMP-dependent protein kinase. Chem 
Rev, 2001. 101(8): p. 2381-411. 
13. Kemp, B.E., Phosphorylation of acyl and dansyl derivatives of the peptide Leu-
Arg-Arg-Ala-Ser-Leu-Gly by the cAMP-dependent protein kinase. Journal of 
Biological Chemistry, 1980. 255(7): p. 2914-2918. 
  185 
14. Johnson, D.A., P. Akamine, E. Radzio-Andzelm, M. Madhusudan, and S.S. 
Taylor, Dynamics of cAMP-dependent protein kinase. Chem Rev, 2001. 101(8): 
p. 2243-70. 
15. Hanks, S.K. and T. Hunter, Protein kinases 6. The eukaryotic protein kinase 
superfamily: kinase (catalytic) domain structure and classification. FASEB J, 
1995. 9(8): p. 576-96. 
16. Meharena, H.S., P. Chang, M.M. Keshwani, K. Oruganty, A.K. Nene, N. Kannan, 
S.S. Taylor, and A.P. Kornev, Deciphering the structural basis of eukaryotic 
protein kinase regulation. PLoS Biol, 2013. 11(10): p. e1001680. 
17. Meharena, H.S., X. Fan, L.G. Ahuja, M.M. Keshwani, C.L. McClendon, A.M. 
Chen, J.A. Adams, and S.S. Taylor, Decoding the Interactions Regulating the 
Active State Mechanics of Eukaryotic Protein Kinases. PLOS Biology, 2016. 
14(11): p. e2000127. 
18. De Bondt, H.L., J. Rosenblatt, J. Jancarik, H.D. Jones, D.O. Morgan, and S.H. 
Kim, Crystal structure of cyclin-dependent kinase 2. Nature, 1993. 363(6430): p. 
595-602. 
19. Jeffrey, P.D., A.A. Russo, K. Polyak, E. Gibbs, J. Hurwitz, J. Massague, and N.P. 
Pavletich, Mechanism of CDK activation revealed by the structure of a cyclinA-
CDK2 complex. Nature, 1995. 376(6538): p. 313-20. 
20. Taylor, S.S. and A.P. Kornev, Protein kinases: evolution of dynamic regulatory 
proteins. Trends Biochem Sci, 2011. 36(2): p. 65-77. 
21. Taylor, S.S., M.M. Keshwani, J.M. Steichen, and A.P. Kornev, Evolution of the 
eukaryotic protein kinases as dynamic molecular switches. Philos Trans R Soc 
Lond B Biol Sci, 2012. 367(1602): p. 2517-28. 
22. Yang, J., S.M. Garrod, M.S. Deal, G.S. Anand, V.L. Woods Jr, and S. Taylor, 
Allosteric Network of cAMP-dependent Protein Kinase Revealed by Mutation of 
Tyr204 in the P+1 Loop. Journal of Molecular Biology, 2005. 346(1): p. 191-201. 
23. Kornev, A.P., S.S. Taylor, and L.F. Ten Eyck, A helix scaffold for the assembly of 
active protein kinases. Proc Natl Acad Sci U S A, 2008. 105(38): p. 14377-82. 
24. Dar, A.C., T.E. Dever, and F. Sicheri, Higher-order substrate recognition of 
eIF2alpha by the RNA-dependent protein kinase PKR. Cell, 2005. 122(6): p. 887-
900. 
25. Herberg, F.W., B. Zimmermann, M. McGlone, and S.S. Taylor, Importance of the 
A-helix of the catalytic subunit of cAMP-dependent protein kinase for stability 
and for orienting subdomains at the cleft interface. Protein Science, 1997. 6(3): p. 
569-579. 
26. Kannan, N., N. Haste, S.S. Taylor, and A.F. Neuwald, The hallmark of AGC 
kinase functional divergence is its C-terminal tail, a cis-acting regulatory module. 
Proceedings of the National Academy of Sciences, 2007. 104(4): p. 1272-1277. 
27. Romano, R.A., N. Kannan, A.P. Kornev, C.J. Allison, and S.S. Taylor, A chimeric 
mechanism for polyvalent trans-phosphorylation of PKA by PDK1. Protein Sci, 
2009. 18(7): p. 1486-97. 
28. Narayana, N., S. Cox, S. Shaltiel, S.S. Taylor, and N. Xuong, Crystal structure of 
a polyhistidine-tagged recombinant catalytic subunit of cAMP-dependent protein 
  186 
kinase complexed with the peptide inhibitor PKI(5-24) and adenosine. 
Biochemistry, 1997. 36(15): p. 4438-48. 
29. Batkin, M., I. Schvartz, and S. Shaltiel, Snapping of the Carboxyl Terminal Tail of 
the Catalytic Subunit of PKA onto Its Core:  Characterization of the Sites by 
Mutagenesis†. Biochemistry, 2000. 39(18): p. 5366-5373. 
30. Keshwani, M.M., C. Klammt, S. von Daake, Y. Ma, A.P. Kornev, S. Choe, P.A. 
Insel, and S.S. Taylor, Cotranslational cis-phosphorylation of the COOH-
terminal tail is a key priming step in the maturation of cAMP-dependent protein 
kinase. Proceedings of the National Academy of Sciences, 2012. 109(20): p. 
E1221–E1229. 
31. Kornev, A.P., N.M. Haste, S.S. Taylor, and L.F. Eyck, Surface comparison of 
active and inactive protein kinases identifies a conserved activation mechanism. 
Proc Natl Acad Sci U S A, 2006. 103(47): p. 17783-8. 
32. Shaw, A.S., A.P. Kornev, J. Hu, L.G. Ahuja, and S.S. Taylor, Kinases and 
pseudokinases: lessons from RAF. Mol Cell Biol, 2014. 34(9): p. 1538-46. 
33. Boudeau, J., D. Miranda-Saavedra, G.J. Barton, and D.R. Alessi, Emerging roles 
of pseudokinases. Trends Cell Biol, 2006. 16(9): p. 443-52. 
34. Taylor, S.S., A. Shaw, J. Hu, H.S. Meharena, and A. Kornev, Pseudokinases from 
a structural perspective. Biochem Soc Trans, 2013. 41(4): p. 981-6. 
35. Poulikakos, P.I., C. Zhang, G. Bollag, K.M. Shokat, and N. Rosen, RAF inhibitors 
transactivate RAF dimers and ERK signalling in cells with wild-type BRAF. 
Nature, 2010. 464(7287): p. 427-30. 
36. Hu, J., H. Yu, A.P. Kornev, J. Zhao, E.L. Filbert, S.S. Taylor, and A.S. Shaw, 
Mutation that blocks ATP binding creates a pseudokinase stabilizing the 
scaffolding function of kinase suppressor of Ras, CRAF and BRAF. Proc Natl 
Acad Sci U S A, 2011. 108(15): p. 6067-72. 
37. Zheng, J., D.R. Knighton, N.H. Xuong, S.S. Taylor, J.M. Sowadski, and L.F. Ten 
Eyck, Crystal structures of the myristylated catalytic subunit of cAMP-dependent 
protein kinase reveal open and closed conformations. Protein Sci, 1993. 2(10): p. 
1559-73. 
38. Akamine, P., Madhusudan, J. Wu, N.H. Xuong, L.F. Ten Eyck, and S.S. Taylor, 
Dynamic features of cAMP-dependent protein kinase revealed by apoenzyme 
crystal structure. J Mol Biol, 2003. 327(1): p. 159-71. 
39. Narayana, N., S. Cox, X. Nguyen-huu, L.F. Ten Eyck, and S.S. Taylor, A binary 
complex of the catalytic subunit of cAMP-dependent protein kinase and adenosine 
further defines conformational flexibility. Structure, 1997. 5(7): p. 921-35. 
40. Masterson, L.R., C. Cheng, T. Yu, M. Tonelli, A. Kornev, S.S. Taylor, and G. 
Veglia, Dynamics connect substrate recognition to catalysis in protein kinase A. 
Nat Chem Biol, 2010. 6(11): p. 821-8. 
41. Masterson, L.R., L. Shi, E. Metcalfe, J. Gao, S.S. Taylor, and G. Veglia, 
Dynamically committed, uncommitted, and quenched states encoded in protein 
kinase A revealed by NMR spectroscopy. Proc Natl Acad Sci U S A, 2011. 
108(17): p. 6969-74. 
  187 
42. Gangal, M., S. Cox, J. Lew, T. Clifford, S.M. Garrod, M. Aschbaher, S.S. Taylor, 
and D.A. Johnson, Backbone Flexibility of Five Sites on the Catalytic Subunit of 
cAMP-Dependent Protein Kinase in the Open and Closed Conformations. 
Biochemistry, 1998. 37(39): p. 13728-13735. 
43. Srivastava, A.K., L.R. McDonald, A. Cembran, J. Kim, L.R. Masterson, C.L. 
McClendon, S.S. Taylor, and G. Veglia, Synchronous opening and closing 
motions are essential for cAMP-dependent protein kinase A signaling. Structure, 
2014. 22(12): p. 1735-43. 
44. Masterson, L.R., A. Mascioni, N.J. Traaseth, S.S. Taylor, and G. Veglia, 
Allosteric cooperativity in protein kinase A. Proc Natl Acad Sci U S A, 2008. 
105(2): p. 506-11. 
45. Colledge, M. and J.D. Scott, AKAPs: from structure to function. Trends Cell Biol, 
1999. 9(6): p. 216-21. 
46. Herberg, F.W. and S.S. Taylor, Physiological inhibitors of the catalytic subunit of 
cAMP-dependent protein kinase: effect of magnesium-ATP on protein-protein 
interactions. Biochemistry, 1993. 32(50): p. 14015-14022. 
47. Scott, J.D., E.H. Fischer, J.G. Demaille, and E.G. Krebs, Identification of an 
inhibitory region of the heat-stable protein inhibitor of the cAMP-dependent 
protein kinase. Proc Natl Acad Sci U S A, 1985. 82(13): p. 4379-83. 
48. Hauer, J.A., P. Barthe, S.S. Taylor, J. Parello, and A. Padilla, Two well-defined 
motifs in the cAMP-dependent protein kinase inhibitor (PKIα) correlate with 
inhibitory and nuclear export function. Protein Science, 1999. 8(3): p. 545-553. 
49. Wen, W., S.S. Taylor, and J.L. Meinkoth, The Expression and Intracellular 
Distribution of the Heat-stable Protein Kinase Inhibitor Is Cell Cycle Regulated. 
Journal of Biological Chemistry, 1995. 270(5): p. 2041-2046. 
50. Boehr, D.D., H.J. Dyson, and P.E. Wright, An NMR perspective on enzyme 
dynamics. Chem Rev, 2006. 106(8): p. 3055-79. 
51. Kern, D. and E.R. Zuiderweg, The role of dynamics in allosteric regulation. Curr 
Opin Struct Biol, 2003. 13(6): p. 748-57. 
52. Boehr, D.D., D. McElheny, H.J. Dyson, and P.E. Wright, The dynamic energy 
landscape of dihydrofolate reductase catalysis. Science, 2006. 313(5793): p. 
1638-42. 
53. Carr, H.Y. and E.M. Purcell, Effects of Diffusion on Free Precession in Nuclear 
Magnetic Resonance Experiments. Physical Review, 1954. 94(3): p. 630-638. 
54. Meiboom, S. and D. Gill, Modified Spin‐Echo Method for Measuring Nuclear 
Relaxation Times. Review of Scientific Instruments, 1958. 29(8): p. 688-691. 
55. Forsén, S. and R. Hoffman, Study of Moderately Rapid Chemical Exchange 
Reactions by Means of Nuclear Magnetic Double Resonance. The Journal of 
Chemical Physics, 1963. 39(11): p. 2892-2901. 
56. Vallurupalli, P., G. Bouvignies, and L.E. Kay, Studying "invisible" excited protein 
states in slow exchange with a major state conformation. J Am Chem Soc, 2012. 
134(19): p. 8148-61. 
57. Wang, C., M. Rance, and A.G. Palmer, 3rd, Mapping chemical exchange in 
proteins with MW > 50 kD. J Am Chem Soc, 2003. 125(30): p. 8968-9. 
  188 
58. Palmer, A.G., 3rd, C.D. Kroenke, and J.P. Loria, Nuclear magnetic resonance 
methods for quantifying microsecond-to-millisecond motions in biological 
macromolecules. Methods Enzymol, 2001. 339: p. 204-38. 
59. Bloch, F., Nuclear Induction. Physical Review, 1946. 70(7-8): p. 460-474. 
60. McConnell, H.M., Reaction Rates by Nuclear Magnetic Resonance. The Journal 
of Chemical Physics, 1958. 28(3): p. 430-431. 
61. Ishima, R. and D.A. Torchia, Estimating the time scale of chemical exchange of 
proteins from measurements of transverse relaxation rates in solution. Journal of 
Biomolecular Nmr, 1999. 14(4): p. 369-372. 
62. Millet, O., J.P. Loria, C.D. Kroenke, M. Pons, and A.G. Palmer, The static 
magnetic field dependence of chemical exchange linebroadening defines the NMR 
chemical shift time scale. Journal of the American Chemical Society, 2000. 
122(12): p. 2867-2877. 
63. Korzhnev, D.M., T.L. Religa, P. Lundstrom, A.R. Fersht, and L.E. Kay, The 
folding pathway of an FF domain: characterization of an on-pathway 
intermediate state under folding conditions by (15)N, (13)C(alpha) and (13)C-
methyl relaxation dispersion and (1)H/(2)H-exchange NMR spectroscopy. J Mol 
Biol, 2007. 372(2): p. 497-512. 
64. Deverell, C., R.E. Morgan, and J.H. Strange, Studies of chemical exchange by 
nuclear magnetic relaxation in the rotating frame. Molecular Physics, 1970. 
18(4): p. 553-559. 
65. Jeener, J., B.H. Meier, P. Bachmann, and R.R. Ernst, Investigation of exchange 
processes by two‐dimensional NMR spectroscopy. The Journal of Chemical 
Physics, 1979. 71(11): p. 4546-4553. 
66. Palmer, A.G., 3rd and F. Massi, Characterization of the dynamics of 
biomacromolecules using rotating-frame spin relaxation NMR spectroscopy. 
Chem Rev, 2006. 106(5): p. 1700-19. 
67. Farrow, N.A., O. Zhang, J.D. Forman-Kay, and L.E. Kay, A heteronuclear 
correlation experiment for simultaneous determination of 15N longitudinal decay 
and chemical exchange rates of systems in slow equilibrium. Journal of 
biomolecular NMR, 1994. 4(5): p. 727-34. 
68. Loria, J.P., M. Rance, and A.G. Palmer, A Relaxation-Compensated 
Carr−Purcell−Meiboom−Gill Sequence for Characterizing Chemical Exchange 
by NMR Spectroscopy. Journal of the American Chemical Society, 1999. 121(10): 
p. 2331-2332. 
69. Carver, J.P. and R.E. Richards, A general two-site solution for the chemical 
exchange produced dependence of T2 upon the carr-Purcell pulse separation. 
Journal of Magnetic Resonance (1969), 1972. 6(1): p. 89-105. 
70. Jen, J., Chemical exchange and nmr T2 relaxation—The multisite case. Journal of 
Magnetic Resonance (1969), 1978. 30(1): p. 111-128. 
71. Davis, D.G., M.E. Perlman, and R.E. London, Direct Measurements of the 
Dissociation-Rate Constant for Inhibitor-Enzyme Complexes via the T1ρ and T2 
(CPMG) Methods. Journal of Magnetic Resonance, Series B, 1994. 104(3): p. 
266-275. 
  189 
72. Luz, Z. and S. Meiboom, Nuclear Magnetic Resonance Study of the Protolysis of 
Trimethylammonium Ion in Aqueous Solution—Order of the Reaction with 
Respect to Solvent. The Journal of Chemical Physics, 1963. 39(2): p. 366-370. 
73. Kroenke, C.D., J.P. Loria, L.K. Lee, M. Rance, and A.G. Palmer, Longitudinal 
and transverse H-1-N-15 dipolar N-15 chemical shift anisotropy relaxation 
interference: Unambiguous determination of rotational diffusion tensors and 
chemical exchange effects in biological macromolecules. Journal of the American 
Chemical Society, 1998. 120(31): p. 7905-7915. 
74. Fushman, D., N. Tjandra, and D. Cowburn, Direct measurement of N-15 chemical 
shift anisotropy in solution. Journal of the American Chemical Society, 1998. 
120(42): p. 10947-10952. 
75. Palmer, A.G., N.J. Skelton, W.J. Chazin, P.E. Wright, and M. Rance, Suppression 
of the effects of cross-correlation between dipolar and anisotropic chemical shift 
relaxation mechanisms in the measurement of spin-spin relaxation rates. 
Molecular Physics, 1992. 75(3): p. 699-711. 
76. Farrow, N.A., R. Muhandiram, A.U. Singer, S.M. Pascal, C.M. Kay, G. Gish, S.E. 
Shoelson, T. Pawson, J.D. Forman-Kay, and L.E. Kay, Backbone dynamics of a 
free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR 
relaxation. Biochemistry, 1994. 33(19): p. 5984-6003. 
77. Vold, R.L., J.S. Waugh, M.P. Klein, and D.E. Phelps, Measurement of Spin 
Relaxation in Complex Systems. The Journal of Chemical Physics, 1968. 48(8): p. 
3831-3832. 
78. Lipari, G. and A. Szabo, Model-Free Approach to the Interpretation of Nuclear 
Magnetic-Resonance Relaxation in Macromolecules .2. Analysis of Experimental 
Results. Journal of the American Chemical Society, 1982. 104(17): p. 4559-4570. 
79. Lipari, G. and A. Szabo, Model-Free Approach to the Interpretation of Nuclear 
Magnetic-Resonance Relaxation in Macromolecules .1. Theory and Range of 
Validity. Journal of the American Chemical Society, 1982. 104(17): p. 4546-4559. 
80. Goodey, N.M. and S.J. Benkovic, Allosteric regulation and catalysis emerge via a 
common route. Nat Chem Biol, 2008. 4(8): p. 474-82. 
81. Changeux, J.P. and S.J. Edelstein, Allosteric mechanisms of signal transduction. 
Science, 2005. 308(5727): p. 1424-8. 
82. Monod, J., J. Wyman, and J.P. Changeux, On the Nature of Allosteric 
Transitions: A Plausible Model. J Mol Biol, 1965. 12: p. 88-118. 
83. Perutz, M.F., Stereochemistry of Cooperative Effects in Haemoglobin: Haem-
Haem Interaction and the Problem of Allostery. Nature, 1970. 228(5273): p. 726-
734. 
84. Perutz, M.F., Mechanisms of cooperativity and allosteric regulation in proteins. 
Q Rev Biophys, 1989. 22(2): p. 139-237. 
85. Koshland, D.E., Jr., G. Nemethy, and D. Filmer, Comparison of experimental 
binding data and theoretical models in proteins containing subunits. 
Biochemistry, 1966. 5(1): p. 365-85. 
86. Cui, Q. and M. Karplus, Allostery and cooperativity revisited. Protein Sci, 2008. 
17(8): p. 1295-307. 
  190 
87. Popovych, N., S. Sun, R.H. Ebright, and C.G. Kalodimos, Dynamically driven 
protein allostery. Nat Struct Mol Biol, 2006. 13(9): p. 831-8. 
88. Cooper, A. and D.T. Dryden, Allostery without conformational change. A 
plausible model. Eur Biophys J, 1984. 11(2): p. 103-9. 
89. Tsai, C.J., A. del Sol, and R. Nussinov, Allostery: absence of a change in shape 
does not imply that allostery is not at play. J Mol Biol, 2008. 378(1): p. 1-11. 
90. Ascenzi, P. and M. Fasano, Allostery in a monomeric protein: the case of human 
serum albumin. Biophys Chem, 2010. 148(1-3): p. 16-22. 
91. Gunasekaran, K., B. Ma, and R. Nussinov, Is allostery an intrinsic property of all 
dynamic proteins? Proteins, 2004. 57(3): p. 433-43. 
92. Kumar, S., B. Ma, C.J. Tsai, N. Sinha, and R. Nussinov, Folding and binding 
cascades: dynamic landscapes and population shifts. Protein Sci, 2000. 9(1): p. 
10-9. 
93. McClendon, C.L., A.P. Kornev, M.K. Gilson, and S.S. Taylor, Dynamic 
architecture of a protein kinase. Proc Natl Acad Sci U S A, 2014. 111(43): p. 
E4623-31. 
94. Azam, M., M.A. Seeliger, N.S. Gray, J. Kuriyan, and G.Q. Daley, Activation of 
tyrosine kinases by mutation of the gatekeeper threonine. Nat Struct Mol Biol, 
2008. 15(10): p. 1109-18. 
95. Hu, J., E.C. Stites, H. Yu, E.A. Germino, H.S. Meharena, P.J. Stork, A.P. Kornev, 
S.S. Taylor, and A.S. Shaw, Allosteric activation of functionally asymmetric RAF 
kinase dimers. Cell, 2013. 154(5): p. 1036-46. 
96. Mirsky, A.E. and L. Pauling, On the Structure of Native, Denatured, and 
Coagulated Proteins. Proc Natl Acad Sci U S A, 1936. 22(7): p. 439-47. 
97. Loh, S.N. and J.L. Markley. Measurement of amide hydrogen 
deuterium/hydrogen fractionation factors in proteins by NMR spectroscopy. 1993. 
Academic. 
98. Schowen, K.B. and R.L. Schowen, Solvent isotope effects of enzyme systems. 
Methods Enzymol, 1982. 87: p. 551-606. 
99. Kreevoy, M.M., T. Liang, and K.C. Chang, Structures and Isotopic Fractionation 
Factors of Complexes Aha-. Journal of the American Chemical Society, 1977. 
99(15): p. 5207-5209. 
100. Cleland, W.W., P.A. Frey, and J.A. Gerlt, The low barrier hydrogen bond in 
enzymatic catalysis. J Biol Chem, 1998. 273(40): p. 25529-32. 
101. Loh, S.N. and J.L. Markley, Hydrogen bonding in proteins as studied by amide 
hydrogen D/H fractionation factors: application to staphylococcal nuclease. 
Biochemistry, 1994. 33(4): p. 1029-36. 
102. Harris, T.K., C. Abeygunawardana, and A.S. Mildvan, NMR studies of the role of 
hydrogen bonding in the mechanism of triosephosphate isomerase. Biochemistry, 
1997. 36(48): p. 14661-75. 
103. Cao, Z. and J.U. Bowie, An energetic scale for equilibrium H/D fractionation 
factors illuminates hydrogen bond free energies in proteins. Protein Sci, 2014. 
23(5): p. 566-75. 
  191 
104. Selvaratnam, R., S. Chowdhury, B. VanSchouwen, and G. Melacini, Mapping 
allostery through the covariance analysis of NMR chemical shifts. Proc Natl Acad 
Sci U S A, 2011. 108(15): p. 6133-8. 
105. Selvaratnam, R., M.T. Mazhab-Jafari, R. Das, and G. Melacini, The Auto-
Inhibitory Role of the EPAC Hinge Helix as Mapped by NMR. PLoS ONE, 2012. 
7(11): p. e48707. 
106. Selvaratnam, R., B. VanSchouwen, F. Fogolari, M.T. Mazhab-Jafari, R. Das, and 
G. Melacini, The projection analysis of NMR chemical shifts reveals extended 
EPAC autoinhibition determinants. Biophys J, 2012. 102(3): p. 630-9. 
107. Cembran, A., L.R. Masterson, C.L. McClendon, S.S. Taylor, J. Gao, and G. 
Veglia, Conformational equilibrium of N-myristoylated cAMP-dependent protein 
kinase A by molecular dynamics simulations. Biochemistry, 2012. 51(51): p. 
10186-96. 
108. Englander, S.W. and M.M. Krishna, Hydrogen exchange. Nat Struct Biol, 2001. 
8(9): p. 741-2. 
109. Skinner, J.J., W.K. Lim, S. Bedard, B.E. Black, and S.W. Englander, Protein 
dynamics viewed by hydrogen exchange. Protein Sci, 2012. 21(7): p. 996-1005. 
110. Korzhnev, D.M., T.L. Religa, W. Banachewicz, A.R. Fersht, and L.E. Kay, A 
transient and low-populated protein-folding intermediate at atomic resolution. 
Science, 2010. 329(5997): p. 1312-6. 
111. Neudecker, P., P. Robustelli, A. Cavalli, P. Walsh, P. Lundstrom, A. Zarrine-
Afsar, S. Sharpe, M. Vendruscolo, and L.E. Kay, Structure of an intermediate 
state in protein folding and aggregation. Science, 2012. 336(6079): p. 362-6. 
112. Tzeng, S.R. and C.G. Kalodimos, Protein activity regulation by conformational 
entropy. Nature, 2012. 488(7410): p. 236-40. 
113. Tzeng, S.R. and C.G. Kalodimos, Allosteric inhibition through suppression of 
transient conformational states. Nat Chem Biol, 2013. 9(7): p. 462-5. 
114. Lipchock, J.M. and J.P. Loria, Nanometer propagation of millisecond motions in 
V-type allostery. Structure, 2010. 18(12): p. 1596-607. 
115. Whittier, S.K., A.C. Hengge, and J.P. Loria, Conformational motions regulate 
phosphoryl transfer in related protein tyrosine phosphatases. Science, 2013. 
341(6148): p. 899-903. 
116. Li, Y., N.L. Altorelli, F. Bahna, B. Honig, L. Shapiro, and A.G. Palmer, 3rd, 
Mechanism of E-cadherin dimerization probed by NMR relaxation dispersion. 
Proc Natl Acad Sci U S A, 2013. 110(41): p. 16462-7. 
117. Slice, L.W. and S.S. Taylor, Expression of the catalytic subunit of cAMP-
dependent protein kinase in Escherichia coli. J Biol Chem, 1989. 264(35): p. 
20940-6. 
118. Pervushin, K., R. Riek, G. Wider, and K. Wüthrich, Attenuated T2 relaxation by 
mutual cancellation of dipole–dipole coupling and chemical shift anisotropy 
indicates an avenue to NMR structures of very large biological macromolecules 
in solution. Proceedings of the National Academy of Sciences, 1997. 94(23): p. 
12366-12371. 
  192 
119. Nietlispach, D., Suppression of anti-TROSY lines in a sensitivity enhanced 
gradient selection TROSY scheme. Journal of Biomolecular NMR, 2005. 31(2): p. 
161-166. 
120. Delaglio, F., S. Grzesiek, G.W. Vuister, G. Zhu, J. Pfeifer, and A. Bax, NMRPipe: 
a multidimensional spectral processing system based on UNIX pipes. J Biomol 
NMR, 1995. 6(3): p. 277-93. 
121. Goddard, T.D.K., D.G. SPARKY 3. 1999. 
122. Kim, J., L.R. Masterson, A. Cembran, R. Verardi, L. Shi, J. Gao, S.S. Taylor, and 
G. Veglia, Dysfunctional conformational dynamics of protein kinase A induced by 
a lethal mutant of phospholamban hinder phosphorylation. Proc Natl Acad Sci U 
S A, 2015. 112(12): p. 3716-21. 
123. Mildvan, A.S., T.K. Harris, and C. Abeygunawardana, Nuclear magnetic 
resonance methods for the detection and study of low-barrier hydrogen bonds on 
enzymes. Methods Enzymol, 1999. 308: p. 219-45. 
124. Bastidas, A.C., M.S. Deal, J.M. Steichen, Y. Guo, J. Wu, and S.S. Taylor, 
Phosphoryl transfer by protein kinase A is captured in a crystal lattice. J Am 
Chem Soc, 2013. 135(12): p. 4788-98. 
125. Cembran, A., J. Kim, J. Gao, and G. Veglia, NMR mapping of protein 
conformational landscapes using coordinated behavior of chemical shifts upon 
ligand binding. Phys Chem Chem Phys, 2014. 16(14): p. 6508-18. 
126. LiWang, A.C. and A. Bax, Equilibrium protium/deuterium fractionation of 
backbone amides in U-C-13/N-15 labeled human ubiquitin by triple resonance 
NMR. Journal of the American Chemical Society, 1996. 118(50): p. 12864-12865. 
127. Khare, D., P. Alexander, and J. Orban, Hydrogen Bonding and Equilibrium 
Protium−Deuterium Fractionation Factors in the Immunoglobulin G Binding 
Domain of Protein G. Biochemistry, 1999. 38(13): p. 3918-3925. 
128. Bowers, P.M. and R.E. Klevit, Hydrogen bonding and equilibrium isotope 
enrichment in histidine-containing proteins. Nat Struct Biol, 1996. 3(6): p. 522-
31. 
129. Bastidas, A.C., J. Wu, and S.S. Taylor, Molecular features of product release for 
the PKA catalytic cycle. Biochemistry, 2015. 54(1): p. 2-10. 
130. Chestukhin, A., L. Litovchick, D. Schourov, S. Cox, S.S. Taylor, and S. Shaltiel, 
Functional malleability of the carboxyl-terminal tail in protein kinase A. J Biol 
Chem, 1996. 271(17): p. 10175-82. 
131. Nick Pace, C., J.M. Scholtz, and G.R. Grimsley, Forces stabilizing proteins. 
FEBS Lett, 2014. 588(14): p. 2177-84. 
132. Gardino, A.K., J. Villali, A. Kivenson, M. Lei, C.F. Liu, P. Steindel, E.Z. 
Eisenmesser, W. Labeikovsky, M. Wolf-Watz, M.W. Clarkson, and D. Kern, 
Transient non-native hydrogen bonds promote activation of a signaling protein. 
Cell, 2009. 139(6): p. 1109-18. 
133. Levinson, N.M. and S.G. Boxer, A conserved water-mediated hydrogen bond 
network defines bosutinib's kinase selectivity. Nat Chem Biol, 2014. 10(2): p. 
127-132. 
  193 
134. Andersen, M.D., J. Shaffer, P.A. Jennings, and J.A. Adams, Structural 
characterization of protein kinase A as a function of nucleotide binding. 
Hydrogen-deuterium exchange studies using matrix-assisted laser desorption 
ionization-time of flight mass spectrometry detection. J Biol Chem, 2001. 
276(17): p. 14204-11. 
135. Das, R., M. Abu-Abed, and G. Melacini, Mapping allostery through equilibrium 
perturbation NMR spectroscopy. Journal of the American Chemical Society, 
2006. 128(26): p. 8406-8407. 
136. Mazhab-Jafari, M.T., R. Das, S.A. Fotheringham, S. SilDas, S. Chowdhury, and 
G. Melacini, Understanding cAMP-dependent allostery by NMR spectroscopy: 
comparative analysis of the EPAC1 cAMP-binding domain in its apo and cAMP-
bound states. J Am Chem Soc, 2007. 129(46): p. 14482-92. 
137. Das, R., S. Chowdhury, M.T. Mazhab-Jafari, S. Sildas, R. Selvaratnam, and G. 
Melacini, Dynamically driven ligand selectivity in cyclic nucleotide binding 
domains. J Biol Chem, 2009. 284(35): p. 23682-96. 
138. Abu-Abed, M., R. Das, L. Wang, and G. Melacini, Definition of an electrostatic 
relay switch critical for the cAMP-dependent activation of protein kinase A as 
revealed by the D170A mutant of RIalpha. Proteins, 2007. 69(1): p. 112-24. 
139. Das, R., V. Esposito, M. Abu-Abed, G.S. Anand, S.S. Taylor, and G. Melacini, 
cAMP activation of PKA defines an ancient signaling mechanism. Proc Natl Acad 
Sci U S A, 2007. 104(1): p. 93-8. 
140. McNicholl, E.T., R. Das, S. SilDas, S.S. Taylor, and G. Melacini, Communication 
between tandem cAMP binding domains in the regulatory subunit of protein 
kinase A-Ialpha as revealed by domain-silencing mutations. J Biol Chem, 2010. 
285(20): p. 15523-37. 
141. Lin, J., W.M. Westler, W.W. Cleland, J.L. Markley, and P.A. Frey, Fractionation 
factors and activation energies for exchange of the low barrier hydrogen bonding 
proton in peptidyl trifluoromethyl ketone complexes of chymotrypsin. Proc Natl 
Acad Sci U S A, 1998. 95(25): p. 14664-8. 
142. Veglia, G. and A. Cembran, Role of conformational entropy in the activity and 
regulation of the catalytic subunit of protein kinase A. FEBS J, 2013. 280(22): p. 
5608-15. 
143. Masterson, L.R., A. Cembran, L. Shi, and G. Veglia, Allostery and binding 
cooperativity of the catalytic subunit of protein kinase A by NMR spectroscopy 
and molecular dynamics simulations. Adv Protein Chem Struct Biol, 2012. 87: p. 
363-89. 
144. Li, F., M. Gangal, C. Juliano, E. Gorfain, S.S. Taylor, and D.A. Johnson, 
Evidence for an internal entropy contribution to phosphoryl transfer: a study of 
domain closure, backbone flexibility, and the catalytic cycle of cAMP-dependent 
protein kinase. J Mol Biol, 2002. 315(3): p. 459-69. 
145. Herberg, F.W., M.L. Doyle, S. Cox, and S.S. Taylor, Dissection of the Nucleotide 
and Metal−Phosphate Binding Sites in cAMP-Dependent Protein Kinase. 
Biochemistry, 1999. 38(19): p. 6352-6360. 
  194 
146. Crespi, H.L. and J.J. Katz, High resolution proton magnetic resonance studies of 
fully deuterated and isotope hybrid proteins. Nature, 1969. 224(5219): p. 560-2. 
147. Crespi, H.L., Rosenberg, R.M. Katzz, J.J., proton magnetic resonance of proteins 
fully deuterated except for 1H-leucine side chains. Science, 1968. 161: p. 795-
796. 
148. Markley, J.L., I. Putter, and O. Jardetzky, High-resolution nuclear magnetic 
resonance spectra of selectively deuterated staphylococcal nuclease. Science, 
1968. 161(3847): p. 1249-51. 
149. Putter, I., A. Barreto, J.L. Markley, and O. Jardetzky, Nuclear magnetic 
resonance studies of the structure and binding sites of enzymes. X. Preparation of 
selectively deuterated analogs of staphylococcal nuclease. Proc Natl Acad Sci U 
S A, 1969. 64(4): p. 1396-403. 
150. Meissner, A. and O.W. Sorensen, Optimization of three-dimensional TROSY-type 
HCCH NMR correlation of aromatic (1)H-(13)C groups in proteins. J Magn 
Reson, 1999. 139(2): p. 447-50. 
151. Kainosho, M., T. Torizawa, Y. Iwashita, T. Terauchi, A. Mei Ono, and P. Guntert, 
Optimal isotope labelling for NMR protein structure determinations. Nature, 
2006. 440(7080): p. 52-7. 
152. Kasinath, V., K.G. Valentine, and A.J. Wand, A 13C labeling strategy reveals a 
range of aromatic side chain motion in calmodulin. J Am Chem Soc, 2013. 
135(26): p. 9560-3. 
153. Venters, R.A., C.C. Huang, B.T. Farmer, 2nd, R. Trolard, L.D. Spicer, and C.A. 
Fierke, High-level 2H/13C/15N labeling of proteins for NMR studies. J Biomol 
NMR, 1995. 5(4): p. 339-44. 
154. Nietlispach, D., R.T. Clowes, R.W. Broadhurst, Y. Ito, J. Keeler, M. Kelly, J. 
Ashurst, H. Oschkinat, P.J. Domaille, and E.D. Laue, An Approach to the 
Structure Determination of Larger Proteins Using Triple Resonance NMR 
Experiments in Conjunction with Random Fractional Deuteration. Journal of the 
American Chemical Society, 1996. 118(2): p. 407-415. 
155. Goto, N.K., K.H. Gardner, G.A. Mueller, R.C. Willis, and L.E. Kay, A robust and 
cost-effective method for the production of Val, Leu, Ile (delta 1) methyl-
protonated 15N-, 13C-, 2H-labeled proteins. J Biomol NMR, 1999. 13(4): p. 369-
74. 
156. Gardner, K.H. and L.E. Kay, Production and Incorporation of15N,13C,2H (1H-
δ1 Methyl) Isoleucine into Proteins for Multidimensional NMR Studies. Journal of 
the American Chemical Society, 1997. 119(32): p. 7599-7600. 
157. Gelis, I., A.M. Bonvin, D. Keramisanou, M. Koukaki, G. Gouridis, S. 
Karamanou, A. Economou, and C.G. Kalodimos, Structural basis for signal-
sequence recognition by the translocase motor SecA as determined by NMR. Cell, 
2007. 131(4): p. 756-69. 
158. Velyvis, A., A.M. Ruschak, and L.E. Kay, An economical method for production 
of (2)H, (13)CH3-threonine for solution NMR studies of large protein complexes: 
application to the 670 kDa proteasome. PLoS One, 2012. 7(9): p. e43725. 
  195 
159. Ayala, I., R. Sounier, N. Use, P. Gans, and J. Boisbouvier, An efficient protocol 
for the complete incorporation of methyl-protonated alanine in perdeuterated 
protein. J Biomol NMR, 2009. 43(2): p. 111-9. 
160. Tugarinov, V., P.M. Hwang, J.E. Ollerenshaw, and L.E. Kay, Cross-correlated 
relaxation enhanced 1H[bond]13C NMR spectroscopy of methyl groups in very 
high molecular weight proteins and protein complexes. J Am Chem Soc, 2003. 
125(34): p. 10420-8. 
161. Religa, T.L., R. Sprangers, and L.E. Kay, Dynamic regulation of archaeal 
proteasome gate opening as studied by TROSY NMR. Science, 2010. 328(5974): 
p. 98-102. 
162. Ruschak, A.M., T.L. Religa, S. Breuer, S. Witt, and L.E. Kay, The proteasome 
antechamber maintains substrates in an unfolded state. Nature, 2010. 467(7317): 
p. 868-71. 
163. Sprangers, R. and L.E. Kay, Quantitative dynamics and binding studies of the 20S 
proteasome by NMR. Nature, 2007. 445(7128): p. 618-22. 
164. Shi, L. and L.E. Kay, Tracing an allosteric pathway regulating the activity of the 
HslV protease. Proc Natl Acad Sci U S A, 2014. 111(6): p. 2140-5. 
165. Saio, T., X. Guan, P. Rossi, A. Economou, and C.G. Kalodimos, Structural basis 
for protein antiaggregation activity of the trigger factor chaperone. Science, 
2014. 344(6184): p. 1250494. 
166. Ruschak, A.M., A. Velyvis, and L.E. Kay, A simple strategy for (1)(3)C, (1)H 
labeling at the Ile-gamma2 methyl position in highly deuterated proteins. J 
Biomol NMR, 2010. 48(3): p. 129-35. 
167. Religa, T.L., A.M. Ruschak, R. Rosenzweig, and L.E. Kay, Site-directed methyl 
group labeling as an NMR probe of structure and dynamics in supramolecular 
protein systems: applications to the proteasome and to the ClpP protease. J Am 
Chem Soc, 2011. 133(23): p. 9063-8. 
168. Hemmer, W., M. McGlone, and S.S. Taylor, Recombinant strategies for rapid 
purification of catalytic subunits of cAMP-dependent protein kinase. Anal 
Biochem, 1997. 245(2): p. 115-22. 
169. Yonemoto, W.M., M.L. McGlone, L.W. Slice, and S.S. Taylor, Prokaryotic 
expression of catalytic subunit of adenosine cyclic monophosphate-dependent 
protein kinase. Methods Enzymol, 1991. 200: p. 581-96. 
170. Gardner, K.H., X. Zhang, K. Gehring, and L.E. Kay, Solution NMR Studies of a 
42 KDaEscherichiaColiMaltose Binding Protein/β-Cyclodextrin 
Complex:  Chemical Shift Assignments and Analysis. Journal of the American 
Chemical Society, 1998. 120(45): p. 11738-11748. 
171. Studier, F.W., Protein production by auto-induction in high density shaking 
cultures. Protein Expr Purif, 2005. 41(1): p. 207-34. 
172. Kay, L.E., M. Ikura, R. Tschudin, and A. Bax, Three-dimensional triple-
resonance NMR spectroscopy of isotopically enriched proteins. Journal of 
Magnetic Resonance (1969), 1990. 89(3): p. 496-514. 
  196 
173. Yang, D.W. and L.E. Kay, TROSY triple-resonance four-dimensional NMR 
spectroscopy of a 46 ns tumbling protein. Journal of the American Chemical 
Society, 1999. 121(11): p. 2571-2575. 
174. Salzmann, M., K. Pervushin, G. Wider, H. Senn, and K. Wuthrich, TROSY in 
triple-resonance experiments: new perspectives for sequential NMR assignment of 
large proteins. Proc Natl Acad Sci U S A, 1998. 95(23): p. 13585-90. 
175. Salzmann, M., G. Wider, K. Pervushin, H. Senn, and K. Wuthrich, TROSY-type 
triple-resonance experiments for sequential NMR assignments of large proteins. 
Journal of the American Chemical Society, 1999. 121(4): p. 844-848. 
176. Sattler, M., J. Schleucher, and C. Griesinger, Heteronuclear multidimensional 
NMR experiments for the structure determination of proteins in solutions 
employing pulsed field gradients. Prog. Nucl. Magn. Reson. Spectrosc., 1999. 34: 
p. 93-158. 
177. Tugarinov, V. and L.E. Kay, Side chain assignments of Ile delta 1 methyl groups 
in high molecular weight proteins: an application to a 46 ns tumbling molecule. J 
Am Chem Soc, 2003. 125(19): p. 5701-6. 
178. Tugarinov, V. and L.E. Kay, Ile, Leu, and Val methyl assignments of the 723-
residue malate synthase G using a new labeling strategy and novel NMR methods. 
J Am Chem Soc, 2003. 125(45): p. 13868-78. 
179. Sheppard, D., C. Guo, and V. Tugarinov, Methyl-detected 'out-and-back' NMR 
experiments for simultaneous assignments of Alabeta and Ilegamma2 methyl 
groups in large proteins. J Biomol NMR, 2009. 43(4): p. 229-38. 
180. Tugarinov, V., V. Venditti, and G. Marius Clore, A NMR experiment for 
simultaneous correlations of valine and leucine/isoleucine methyls with carbonyl 
chemical shifts in proteins. J Biomol NMR, 2014. 58(1): p. 1-8. 
181. Velyvis, A., H.K. Schachman, and L.E. Kay, Assignment of Ile, Leu, and Val 
methyl correlations in supra-molecular systems: an application to aspartate 
transcarbamoylase. J Am Chem Soc, 2009. 131(45): p. 16534-43. 
182. Xu, Y., M. Liu, P.J. Simpson, R. Isaacson, E. Cota, J. Marchant, D. Yang, X. 
Zhang, P. Freemont, and S. Matthews, Automated assignment in selectively 
methyl-labeled proteins. J Am Chem Soc, 2009. 131(27): p. 9480-1. 
183. Chao, F.A., J. Kim, Y. Xia, M. Milligan, N. Rowe, and G. Veglia, FLAMEnGO 
2.0: an enhanced fuzzy logic algorithm for structure-based assignment of methyl 
group resonances. J Magn Reson, 2014. 245: p. 17-23. 
184. Xu, Y. and S. Matthews, MAP-XSII: an improved program for the automatic 
assignment of methyl resonances in large proteins. J Biomol NMR, 2013. 55(2): 
p. 179-87. 
185. Venditti, V., N.L. Fawzi, and G.M. Clore, Automated sequence- and stereo-
specific assignment of methyl-labeled proteins by paramagnetic relaxation and 
methyl-methyl nuclear Overhauser enhancement spectroscopy. J Biomol NMR, 
2011. 51(3): p. 319-28. 
186. Chao, F.A., L. Shi, L.R. Masterson, and G. Veglia, FLAMEnGO: a fuzzy logic 
approach for methyl group assignment using NOESY and paramagnetic 
relaxation enhancement data. J Magn Reson, 2012. 214(1): p. 103-10. 
  197 
187. Battiste, J.L. and G. Wagner, Utilization of site-directed spin labeling and high-
resolution heteronuclear nuclear magnetic resonance for global fold 
determination of large proteins with limited nuclear overhauser effect data. 
Biochemistry, 2000. 39(18): p. 5355-65. 
188. Sahakyan, A.B., W.F. Vranken, A. Cavalli, and M. Vendruscolo, Structure-based 
prediction of methyl chemical shifts in proteins. J Biomol NMR, 2011. 50(4): p. 
331-46. 
189. Han, B., Y. Liu, S.W. Ginzinger, and D.S. Wishart, SHIFTX2: significantly 
improved protein chemical shift prediction. J Biomol NMR, 2011. 50(1): p. 43-
57. 
190. Li, D.W. and R. Bruschweiler, PPM: a side-chain and backbone chemical shift 
predictor for the assessment of protein conformational ensembles. J Biomol 
NMR, 2012. 54(3): p. 257-65. 
191. Fischer, E.H. and E.G. Krebs, Conversion of phosphorylase b to phosphorylase a 
in muscle extracts. J Biol Chem, 1955. 216(1): p. 121-32. 
192. Manning, G., G.D. Plowman, T. Hunter, and S. Sudarsanam, Evolution of protein 
kinase signaling from yeast to man. Trends Biochem Sci, 2002. 27(10): p. 514-20. 
193. Johnson, L.N. and R.J. Lewis, Structural basis for control by phosphorylation. 
Chem Rev, 2001. 101(8): p. 2209-42. 
194. Manning, G., D.B. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam, The 
Protein Kinase Complement of the Human Genome. Science, 2002. 298(5600): p. 
1912-1934. 
195. Endicott, J.A., M.E. Noble, and L.N. Johnson, The structural basis for control of 
eukaryotic protein kinases. Annu Rev Biochem, 2012. 81: p. 587-613. 
196. Reiterer, V., P.A. Eyers, and H. Farhan, Day of the dead: pseudokinases and 
pseudophosphatases in physiology and disease. Trends Cell Biol, 2014. 24(9): p. 
489-505. 
197. Iyer, G.H., M.J. Moore, and S.S. Taylor, Consequences of lysine 72 mutation on 
the phosphorylation and activation state of cAMP-dependent kinase. J Biol Chem, 
2005. 280(10): p. 8800-7. 
198. Dar, A.C. and K.M. Shokat, The evolution of protein kinase inhibitors from 
antagonists to agonists of cellular signaling. Annu Rev Biochem, 2011. 80: p. 
769-95. 
199. Hatzivassiliou, G., K. Song, I. Yen, B.J. Brandhuber, D.J. Anderson, R. Alvarado, 
M.J. Ludlam, D. Stokoe, S.L. Gloor, G. Vigers, T. Morales, I. Aliagas, B. Liu, S. 
Sideris, K.P. Hoeflich, B.S. Jaiswal, S. Seshagiri, H. Koeppen, M. Belvin, L.S. 
Friedman, and S. Malek, RAF inhibitors prime wild-type RAF to activate the 
MAPK pathway and enhance growth. Nature, 2010. 464(7287): p. 431-5. 
200. Cowan-Jacob, S.W., W. Jahnke, and S. Knapp, Novel approaches for targeting 
kinases: allosteric inhibition, allosteric activation and pseudokinases. Future Med 
Chem, 2014. 6(5): p. 541-61. 
201. Fang, Z., C. Grutter, and D. Rauh, Strategies for the selective regulation of 
kinases with allosteric modulators: exploiting exclusive structural features. ACS 
Chem Biol, 2013. 8(1): p. 58-70. 
  198 
202. Arencibia, J.M., D. Pastor-Flores, A.F. Bauer, J.O. Schulze, and R.M. Biondi, 
AGC protein kinases: from structural mechanism of regulation to allosteric drug 
development for the treatment of human diseases. Biochim Biophys Acta, 2013. 
1834(7): p. 1302-21. 
203. Wu, P., T.E. Nielsen, and M.H. Clausen, FDA-approved small-molecule kinase 
inhibitors. Trends Pharmacol Sci, 2015. 
204. Whitehouse, S., J.R. Feramisco, J.E. Casnellie, E.G. Krebs, and D.A. Walsh, 
Studies on the kinetic mechanism of the catalytic subunit of the cAMP-dependent 
protein kinase. J Biol Chem, 1983. 258(6): p. 3693-701. 
205. Taylor, S.S., J. Yang, J. Wu, N.M. Haste, E. Radzio-Andzelm, and G. Anand, 
PKA: a portrait of protein kinase dynamics. Biochim Biophys Acta, 2004. 
1697(1-2): p. 259-69. 
206. Taylor, S.S., C. Kim, D. Vigil, N.M. Haste, J. Yang, J. Wu, and G.S. Anand, 
Dynamics of signaling by PKA. Biochim Biophys Acta, 2005. 1754(1-2): p. 25-
37. 
207. Sims, P.C., I.S. Moody, Y. Choi, C. Dong, M. Iftikhar, B.L. Corso, O.T. Gul, P.G. 
Collins, and G.A. Weiss, Electronic measurements of single-molecule catalysis by 
cAMP-dependent protein kinase A. J Am Chem Soc, 2013. 135(21): p. 7861-8. 
208. Adams, J.A., Kinetic and catalytic mechanisms of protein kinases. Chem Rev, 
2001. 101(8): p. 2271-90. 
209. Cheng, H.C., B.E. Kemp, R.B. Pearson, A.J. Smith, L. Misconi, S.M. Van Patten, 
and D.A. Walsh, A potent synthetic peptide inhibitor of the cAMP-dependent 
protein kinase. J Biol Chem, 1986. 261(3): p. 989-92. 
210. Bhatnagar, D., R. Roskoski, Jr., M.S. Rosendahl, and N.J. Leonard, Adenosine 
cyclic 3',5'-monophosphate dependent protein kinase: a new fluorescence 
displacement titration technique for characterizing the nucleotide binding site on 
the catalytic subunit. Biochemistry, 1983. 22(26): p. 6310-7. 
211. Ni, D.Q., J. Shaffer, and J.A. Adams, Insights into nucleotide binding in protein 
kinase A using fluorescent adenosine derivatives. Protein Science, 2000. 9(9): p. 
1818-1827. 
212. Zimmermann, B., S. Schweinsberg, S. Drewianka, and F.W. Herberg, Effect of 
metal ions on high-affinity binding of pseudosubstrate inhibitors to PKA. 
Biochem J, 2008. 413(1): p. 93-101. 
213. Freire, E., A. Schön, and A. Velazquez‐Campoy, Chapter 5 Isothermal Titration 
Calorimetry. 2009. 455: p. 127-155. 
214. Masterson, L.R., T. Yu, L. Shi, Y. Wang, M. Gustavsson, M.M. Mueller, and G. 
Veglia, cAMP-dependent protein kinase A selects the excited state of the 
membrane substrate phospholamban. J Mol Biol, 2011. 412(2): p. 155-64. 
215. Metcalfe, E.E., N.J. Traaseth, and G. Veglia, Serine 16 phosphorylation induces 
an order-to-disorder transition in monomeric phospholamban. Biochemistry, 
2005. 44(11): p. 4386-96. 
216. Axe, J.M., E.M. Yezdimer, K.F. O’Rourke, N.E. Kerstetter, W. You, C.-e.A. 
Chang, and D.D. Boehr, Amino Acid Networks in a (β/α)8 Barrel Enzyme Change 
  199 
during Catalytic Turnover. Journal of the American Chemical Society, 2014. 
136(19): p. 6818-6821. 
217. Boulton, S., M. Akimoto, R. Selvaratnam, A. Bashiri, and G. Melacini, A tool set 
to map allosteric networks through the NMR chemical shift covariance analysis. 
Sci Rep, 2014. 4: p. 7306. 
218. Ruschak, A.M. and L.E. Kay, Proteasome allostery as a population shift between 
interchanging conformers. Proc Natl Acad Sci U S A, 2012. 109(50): p. E3454-
62. 
219. Velyvis, A. and L.E. Kay, Measurement of active site ionization equilibria in the 
670 kDa proteasome core particle using methyl-TROSY NMR. J Am Chem Soc, 
2013. 135(25): p. 9259-62. 
220. Chijiwa, T., A. Mishima, M. Hagiwara, M. Sano, K. Hayashi, T. Inoue, K. Naito, 
T. Toshioka, and H. Hidaka, Inhibition of forskolin-induced neurite outgrowth 
and protein phosphorylation by a newly synthesized selective inhibitor of cyclic 
AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-
isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol 
Chem, 1990. 265(9): p. 5267-72. 
221. Kulanthaivel, P., Y.F. Hallock, C. Boros, S.M. Hamilton, W.P. Janzen, L.M. 
Ballas, C.R. Loomis, J.B. Jiang, and B. Katz, Balanol: a novel and potent 
inhibitor of protein kinase C from the fungus Verticillium balanoides. Journal of 
the American Chemical Society, 1993. 115(14): p. 6452-6453. 
222. Koide, K., M.E. Bunnage, L. Gomez Paloma, J.R. Kanter, S.S. Taylor, L.L. 
Brunton, and K.C. Nicolaou, Molecular design and biological activity of potent 
and selective protein kinase inhibitors related to balanol. Chem Biol, 1995. 2(9): 
p. 601-8. 
223. Kivi, R., P. Jemth, and J. Jarv, Thermodynamic aspects of cAMP dependent 
protein kinase catalytic subunit allostery. Protein J, 2014. 33(4): p. 386-93. 
224. Fersht, A.R., Catalysis, binding and enzyme-substrate complementarity. Proc R 
Soc Lond B Biol Sci, 1974. 187(1089): p. 397-407. 
225. Schramm, V.L., Enzymatic transition states, transition-state analogs, dynamics, 
thermodynamics, and lifetimes. Annu Rev Biochem, 2011. 80(1): p. 703-32. 
226. Gerlits, O., M.J. Waltman, S. Taylor, P. Langan, and A. Kovalevsky, Insights into 
the phosphoryl transfer catalyzed by cAMP-dependent protein kinase: an X-ray 
crystallographic study of complexes with various metals and peptide substrate 
SP20. Biochemistry, 2013. 52(21): p. 3721-7. 
227. Whitehouse, S. and D.A. Walsh, Mg X ATP2-dependent interaction of the 
inhibitor protein of the cAMP-dependent protein kinase with the catalytic subunit. 
Journal of Biological Chemistry, 1983. 258(6): p. 3682-3692. 
228. Toyoshima, C. and T. Mizutani, Crystal structure of the calcium pump with a 
bound ATP analogue. Nature, 2004. 430(6999): p. 529-35. 
229. Polier, S., R.S. Samant, P.A. Clarke, P. Workman, C. Prodromou, and L.H. Pearl, 
ATP-competitive inhibitors block protein kinase recruitment to the Hsp90-Cdc37 
system. Nat Chem Biol, 2013. 9(5): p. 307-12. 
  200 
230. Gibbs, C.S. and M.J. Zoller, Rational scanning mutagenesis of a protein kinase 
identifies functional regions involved in catalysis and substrate interactions. J 
Biol Chem, 1991. 266(14): p. 8923-31. 
231. Narayana, N., T.C. Diller, K. Koide, M.E. Bunnage, K.C. Nicolaou, L.L. Brunton, 
N.H. Xuong, L.F. Ten Eyck, and S.S. Taylor, Crystal structure of the potent 
natural product inhibitor balanol in complex with the catalytic subunit of cAMP-
dependent protein kinase. Biochemistry, 1999. 38(8): p. 2367-76. 
232. Foda, Z.H., Y. Shan, E.T. Kim, D.E. Shaw, and M.A. Seeliger, A dynamically 
coupled allosteric network underlies binding cooperativity in Src kinase. Nat 
Commun, 2015. 6: p. 5939. 
233. Wiseman, T., S. Williston, J.F. Brandts, and L.N. Lin, Rapid Measurement of 
Binding Constants and Heats of Binding Using a New Titration Calorimeter. 
Analytical Biochemistry, 1989. 179(1): p. 131-137. 
234. Kim, J., L.R. Masterson, A. Cembran, R. Verardi, L. Shi, J. Gao, S.S. Taylor, and 
G. Veglia, Dysfunctional conformational dynamics of protein kinase A induced by 
a lethal mutant of phospholamban hinder phosphorylation. Proc Natl Acad Sci U 
S A, 2015: p. 201502299. 
235. Roberts, P.J. and C.J. Der, Targeting the Raf-MEK-ERK mitogen-activated 
protein kinase cascade for the treatment of cancer. Oncogene, 2007. 26(22): p. 
3291-3310. 
236. Patterson, H., R. Nibbs, I. McInnes, and S. Siebert, Protein kinase inhibitors in 
the treatment of inflammatory and autoimmune diseases. Clin Exp Immunol, 
2014. 176(1): p. 1-10. 
237. Zhang, J., P.L. Yang, and N.S. Gray, Targeting cancer with small molecule kinase 
inhibitors. Nat Rev Cancer, 2009. 9(1): p. 28-39. 
238. Dar, A.C. and K.M. Shokat, The evolution of protein kinase inhibitors from 
antagonists to agonists of cellular signaling. Annu Rev Biochem, 2011. 80(1): p. 
769-95. 
239. Wang, Q., J.A. Zorn, and J. Kuriyan, Chapter Two - A Structural Atlas of Kinases 
Inhibited by Clinically Approved Drugs, in Methods in Enzymology, M.S. Kevan, 
Editor. 2014, Academic Press. p. 23-67. 
240. Tong, M. and M.A. Seeliger, Targeting conformational plasticity of protein 
kinases. ACS Chem Biol, 2015. 10(1): p. 190-200. 
241. Dar, A.C. and K.M. Shokat, The Evolution of Protein Kinase Inhibitors from 
Antagonists to Agonists of Cellular Signaling. Annual Review of Biochemistry, 
Vol 80, 2011. 80: p. 769-795. 
242. Huse, M. and J. Kuriyan, The conformational plasticity of protein kinases. Cell, 
2002. 109(3): p. 275-82. 
243. Taylor, S.S., R. Ilouz, P. Zhang, and A.P. Kornev, Assembly of allosteric 
macromolecular switches: lessons from PKA. Nat Rev Mol Cell Biol, 2012. 
13(10): p. 646-58. 
244. Kim J., A.L.G., Chao F.A., Xia, Y., McClendon, C., Kornev A., Taylor S.S. and 
Veglia G, A Dynamic Hydrophobic Core Orchestrates Allostery in Protein 
Kinases. (under review), 2016. 
  201 
245. Hanks, S.K., A.M. Quinn, and T. Hunter, The protein kinase family: conserved 
features and deduced phylogeny of the catalytic domains. Science, 1988. 
241(4861): p. 42-52. 
246. Murray, A.J., Pharmacological PKA inhibition: all may not be what it seems. Sci 
Signal, 2008. 1(22): p. re4. 
247. Kulanthaivel, P., Y.F. Hallock, C. Boros, S.M. Hamilton, W.P. Janzen, L.M. 
Ballas, C.R. Loomis, J.B. Jiang, B. Katz, J.R. Steiner, and J. Clardy, Balanol - a 
Novel and Potent Inhibitor of Protein-Kinase-C from the Fungus Verticillium-
Balanoides (Vol 115, Pg 6452, 1993). Journal of the American Chemical Society, 
1993. 115(22): p. 10468-10468. 
248. Lochner, A. and J.A. Moolman, The many faces of H89: a review. Cardiovasc 
Drug Rev, 2006. 24(3-4): p. 261-74. 
249. Kim, J., G. Li, M.A. Walters, S.S. Taylor, and G. Veglia, Uncoupling Catalytic 
and Binding Functions in the Cyclic AMP-Dependent Protein Kinase A. Structure, 
2016. 24(3): p. 353-63. 
250. Li, G.C., A.K. Srivastava, J. Kim, S.S. Taylor, and G. Veglia, Mapping the 
Hydrogen Bond Networks in the Catalytic Subunit of Protein Kinase A Using H/D 
Fractionation Factors. Biochemistry, 2015. 54(26): p. 4042-9. 
251. Engh, R.A., A. Girod, V. Kinzel, R. Huber, and D. Bossemeyer, Crystal 
structures of catalytic subunit of cAMP-dependent protein kinase in complex with 
isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural 
implications for selectivity. J Biol Chem, 1996. 271(42): p. 26157-64. 
252. Pucheta-Martinez, E., G. Saladino, M.A. Morando, J. Martinez-Torrecuadrada, 
M. Lelli, L. Sutto, N. D'Amelio, and F.L. Gervasio, An Allosteric Cross-Talk 
Between the Activation Loop and the ATP Binding Site Regulates the Activation of 
Src Kinase. Sci Rep, 2016. 6: p. 24235. 
253. Pasi, M., M. Tiberti, A. Arrigoni, and E. Papaleo, xPyder: a PyMOL plugin to 
analyze coupled residues and their networks in protein structures. J Chem Inf 
Model, 2012. 52(7): p. 1865-74. 
254. Baldwin, A.J. and L.E. Kay, NMR spectroscopy brings invisible protein states 
into focus. Nat Chem Biol, 2009. 5(11): p. 808-14. 
255. Kim J., A.L.G., Chao F.A., Xia, Y., McClendon, C., Kornev A., Taylor S.S. and 
Veglia G, A Dynamic Hydrophobic Core Orchestrates Allostery in Protein 
Kinases. (submitted), 2016. 
256. Mittermaier, A. and L.E. Kay, New tools provide new insights in NMR studies of 
protein dynamics. Science, 2006. 312(5771): p. 224-8. 
257. Bouvignies, G. and L.E. Kay, A 2D (1)(3)C-CEST experiment for studying slowly 
exchanging protein systems using methyl probes: an application to protein 
folding. J Biomol NMR, 2012. 53(4): p. 303-10. 
258. Kleckner, I.R. and M.P. Foster, GUARDD: user-friendly MATLAB software for 
rigorous analysis of CPMG RD NMR data. J Biomol NMR, 2012. 52(1): p. 11-
22. 
  202 
259. Massi, F., M.J. Grey, and A.G. Palmer, Microsecond timescale backbone 
conformational dynamics in ubiquitin studied with NMR R-1p relaxation 
experiments. Protein Science, 2005. 14(3): p. 735-742. 
260. Kung, J.E. and N. Jura, Structural Basis for the Non-catalytic Functions of 
Protein Kinases. Structure, 2016. 24(1): p. 7-24. 
261. Lavoie, H., N. Thevakumaran, G. Gavory, J.J. Li, A. Padeganeh, S. Guiral, J. 
Duchaine, D.Y.L. Mao, M. Bouvier, F. Sicheri, and M. Therrien, Inhibitors that 
stabilize a closed RAF kinase domain conformation induce dimerization. Nature 
Chemical Biology, 2013. 9(7): p. 428-+. 
262. Hari, S.B., E.A. Merritt, and D.J. Maly, Conformation-selective ATP-competitive 
inhibitors control regulatory interactions and noncatalytic functions of mitogen-
activated protein kinases. Chem Biol, 2014. 21(5): p. 628-35. 
263. Hantschel, O., Unexpected off-targets and paradoxical pathway activation by 
kinase inhibitors. ACS Chem Biol, 2015. 10(1): p. 234-45. 
264. Lisi, G.P. and J.P. Loria, Solution NMR Spectroscopy for the Study of Enzyme 
Allostery. Chem Rev, 2016. 
265. Bhabha, G., J. Lee, D.C. Ekiert, J. Gam, I.A. Wilson, H.J. Dyson, S.J. Benkovic, 
and P.E. Wright, A dynamic knockout reveals that conformational fluctuations 
influence the chemical step of enzyme catalysis. Science, 2011. 332(6026): p. 234-
8. 
266. Gustavsson, M., N.J. Traaseth, and G. Veglia, Probing ground and excited states 
of phospholamban in model and native lipid membranes by magic angle spinning 
NMR spectroscopy. Biochim Biophys Acta, 2012. 1818(2): p. 146-53. 
267. Gustavsson, M., R. Verardi, D.G. Mullen, K.R. Mote, N.J. Traaseth, T. Gopinath, 
and G. Veglia, Allosteric regulation of SERCA by phosphorylation-mediated 
conformational shift of phospholamban. Proc Natl Acad Sci U S A, 2013. 
110(43): p. 17338-43. 
268. Carroll, M.J., R.V. Mauldin, A.V. Gromova, S.F. Singleton, E.J. Collins, and A.L. 
Lee, Evidence for dynamics in proteins as a mechanism for ligand dissociation. 
Nature Chemical Biology, 2012. 8(3): p. 246-252. 
269. Long, D., C.B. Marshall, G. Bouvignies, M.T. Mazhab-Jafari, M.J. Smith, M. 
Ikura, and L.E. Kay, A comparative CEST NMR study of slow conformational 
dynamics of small GTPases complexed with GTP and GTP analogues. Angew 
Chem Int Ed Engl, 2013. 52(41): p. 10771-4. 
270. Akimoto, M., R. Selvaratnam, E.T. McNicholl, G. Verma, S.S. Taylor, and G. 
Melacini, Signaling through dynamic linkers as revealed by PKA. Proc Natl Acad 
Sci U S A, 2013. 110(35): p. 14231-6. 
271. Lisi, G.P., G.A. Manley, H. Hendrickson, I. Rivalta, V.S. Batista, and J.P. Loria, 
Dissecting Dynamic Allosteric Pathways Using Chemically Related Small-
Molecule Activators. Structure, 2016. 
272. Gardner, K.H. and L.E. Kay, Production and Incorporation of 15N, 13C, 2H (1H-
δ1 Methyl) Isoleucine into Proteins for Multidimensional NMR Studies. Journal of 
the American Chemical Society, 1997. 119(32): p. 7599-7600. 
  203 
273. Tugarinov, V. and L.E. Kay, Methyl Groups as Probes of Structure and Dynamics 
in NMR Studies of High-Molecular-Weight Proteins. ChemBioChem, 2005. 6(9): 
p. 1567-1577. 
274. Long, D., M. Liu, and D. Yang, Accurately Probing Slow Motions on Millisecond 
Timescales with a Robust NMR Relaxation Experiment. Journal of the American 
Chemical Society, 2008. 130(8): p. 2432-2433. 
275. Lundstrom, P., P. Vallurupalli, T.L. Religa, F.W. Dahlquist, and L.E. Kay, A 
single-quantum methyl 13C-relaxation dispersion experiment with improved 
sensitivity. J Biomol NMR, 2007. 38(1): p. 79-88. 
276. Mulder, F.A.A., N.R. Skrynnikov, B. Hon, F.W. Dahlquist, and L.E. Kay, 
Measurement of Slow (μs−ms) Time Scale Dynamics in Protein Side Chains 
by15N Relaxation Dispersion NMR Spectroscopy:  Application to Asn and Gln 
Residues in a Cavity Mutant of T4 Lysozyme. Journal of the American Chemical 
Society, 2001. 123(5): p. 967-975. 
277. Mulder, F.A., N.R. Skrynnikov, B. Hon, F.W. Dahlquist, and L.E. Kay, 
Measurement of slow (micros-ms) time scale dynamics in protein side chains by 
(15)N relaxation dispersion NMR spectroscopy: application to Asn and Gln 
residues in a cavity mutant of T4 lysozyme. J Am Chem Soc, 2001. 123(5): p. 
967-75. 
278. Fenwick, M.K. and R.E. Oswald, NMR spectroscopy of the ligand-binding core of 
ionotropic glutamate receptor 2 bound to 5-substituted willardiine partial 
agonists. J Mol Biol, 2008. 378(3): p. 673-85. 
279. Palmer, A.G., 3rd, Nmr probes of molecular dynamics: overview and comparison 
with other techniques. Annu Rev Biophys Biomol Struct, 2001. 30: p. 129-55. 
 
